NoCell	NoD@ NA
LoVo|LoVo|colon adenocarcinoma	Dig@ LoVo
H9 hESC line|N/A|N/A|N/A|N/A	PSC@ hESC H9
K562|K562|leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC|mesoderm	Bld@ K-562
B-Lymphocyte	Bld@ B-Lymphocytes
HeLa-S3|HeLa-S3|cervical carcinoma|ectoderm	Utr@ HeLa
IMR90|Cell Line|NA|None|Fetal lung fibroblast	Lng@ IMR-90
K562	Bld@ K-562
lymphoblastoid cell line|lymphoblastoid cell line	Bld@ Lymphoblastoid cell line
IMR90|IMR90 Human Diploid Fibroblasts	Lng@ IMR-90
H1|Cell Line|Embryonic Stem Cell|None|None	PSC@ hESC H1
GM12878	Bld@ GM12878
GM12878|GM12878|B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus|mesoderm	Bld@ GM12878
H9|Cell Line|Embryonic Stem Cell|None|None	PSC@ hESC H9
Mammary Epithelial|Mammary gland|N/A|N/A|Cancer	Brs@ T-47D
H1|Cell Line|Embryonic Stem Cell|None|Embryonic stem cell differentiated into trophoblast by treatment with BMP4	PSC@ hESC derived trophoblast cells
HUES64|HUES64|HUES64	PSC@ hESC HUES64
RAMOS|Burkitt's lymphoma cell line	Bld@ RAMOS
HepG2|HepG2|hepatocellular carcinoma|endoderm	Liv@ Hep G2
HepG2|hepatocellular carcinoma	Liv@ Hep G2
Primary Cell|CD34 Primary Cells|None|CD34+	Bld@ CD34+
H1-hESC	PSC@ hESC H1
H1|Cell Line|Embryonic Stem Cell|None|Embryonic stem cell differentiated into neural progenitor cells	PSC@ hESC derived neural cells
HUES64|dEN|dEN	PSC@ hESC derived mesendodermal cells
liver|adult	Liv@ Liver
H1|Cell Line|Embryonic Stem Cell|None|Embryonic stem cell differentiated into mesenchymal stem cells	PSC@ hESC derived mesendodermal cells
H1|Cell Line|Embryonic Stem Cell|None|Embryonic stem cell differentiated into mesendoderm by treatment with BMP4	PSC@ hESC derived mesendodermal cells
MCF-7|epithelial	Brs@ MCF-7
A549|epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male. - ATCC, newly promoted to tier 2: not in 2011 analysis|endoderm	Lng@ A549
VCaP|Prosate cancer cells|vertebral metastatic lesion derived prostate cancer cells	Prs@ VCaP
GM12878|B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus	Bld@ GM12878
HUES64|dMS|dMS	PSC@ hESC derived mesendodermal cells
A549|a549 3D culture	Lng@ A549
breast carcinoma|primary breast tumor	Brs@ Breast cancer
B-cell lymphoma|P493-6	Bld@ P493-6
MCF-7|breast|epithelial	Brs@ MCF-7
Jurkat|Peripheral blood cells	Bld@ Jurkat
293T-Rex|293T-Rex	Kid@ 293
CD19+ B cells|follicular lymphoma|LN	Bld@ B-Lymphocytes
MCF7|MCF7|beast cancer cell line	Brs@ MCF-7
HUES64|dME|dME	PSC@ hESC derived mesendodermal cells
LNCaP|prostate cancer cells	Prs@ LNCAP
H7-hESC|H7-hESC|undifferentiated embryonic stem cells|inner cell mass	PSC@ hESC H7
lymphoblastoid cells	Bld@ Lymphoblastoid cells
GM12878|B-lymphocyte, lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus|mesoderm	Bld@ GM12878
HeLa S3	Utr@ HeLa
MCF-7|breast cancer	Brs@ MCF-7
GP5d|GP5d|colon adenocarcinoma	Dig@ GP5d
K562|leukemia, The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC|mesoderm	Bld@ K-562
Primary Human Umbilical Vein Endothelial Cells|Primary Human Umbilical Vein Endothelial Cells	CDV@ Primary umbilical vein endothelial cells
islet of Langerhans|adult	Pan@ Pancreatic islets
MDA-MB-453|epithelial	Brs@ MDA-MB-453
MCF7|MCF7 breast cancer cells|Human breast adenocarcinoma	Brs@ MCF-7
Gastric Primary Sample|Tumor	Dig@ Gastric primary sample
Gastric Primary Sample|Normal	Dig@ Gastric primary sample
Human Embryonic Kidney 293 cells|HEK293T cell	Kid@ 293
ECC-1|epithelial cell line derived from an endometrium adenocarcinoma, fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes|endoderm	Utr@ ECC-1
sperm	Gon@ Sperm
H1-hESC|H1-hESC|embryonic stem cells|inner cell mass	PSC@ hESC H1
Pancreatic islets|Pancreatic islets	Pan@ Pancreatic islets
KB cells	Utr@ KB
hMADS-3|human adipose-derived stem cells|human adipose-derived stem cells	Adp@ Adipose-Derived Mesenchymal Stem Cells
12878|Lymphoblastoid Cell Lines	Bld@ GM12878
HUVECs|Human umbilical vein cells	CDV@ HUVEC
Primary Tissue|Fetal Intestine, Large|UW|None	Dig@ Colon
SK-N-SH|neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual.|ectoderm	Neu@ SK-N-SH
Cyt49|embryonic stem cell|embryo	PSC@ hESC Cyt49
U20S	Bon@ U2OS
HCT116|Colon cancer cell line|human colon cancer cell	Dig@ HCT 116
LNCaP cells|prostate cancer cells	Prs@ LNCAP
CD4+ T cell|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
MCF-7|mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis|ectoderm	Brs@ MCF-7
Fibroblast-derived iPSC	PSC@ iPS cells
low passage primary melanoma cultures|low passage primary melanoma cultures	Epd@ Melanoma
MCF7|Human breast adenocarcinoma cell-line MCF7	Brs@ MCF-7
Primary Tissue|Fetal Muscle, Leg|UW|None	Myo@ Fetal muscle
MCF-7|MCF-7|mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis|ectoderm	Brs@ MCF-7
K562|cultured K562 cells	Bld@ K-562
IMR90|Fibroblasts	Lng@ IMR-90
MCF-7|breast epithelial	Brs@ MCF-7
MCF7|breast	Brs@ MCF-7
Peripheral blood cells|CD14+ monocytes	Bld@ Monocytes-CD14+
MCF10A|breast|Epithelial|MCF10A-Er-Src	Brs@ MCF 10A
HUVEC|endothelium	CDV@ HUVEC
A549	Lng@ A549
Primary Tissue|Fetal Stomach|UW|None	Dig@ Stomach
CAL51	Brs@ CAL-51
IMR90 human primary lung embryo fibroblasts|Lung Fibroblasts|contact-inhibited IMR90	Lng@ IMR-90
Human endometrial stromal cells|Endometrial stromal cells	Utr@ Endometrial stromal cells
LNCaP|Prostate cancer cell line LNCaP	Prs@ LNCAP
MS1|Lymphoblastoid Cell Lines	Bld@ MS1
19240|Lymphoblastoid Cell Lines	Bld@ GM19240
fetal lung fibroblast	Lng@ Lung fibroblasts
Primary Tissue|Fetal Intestine, Small|UW|None	Dig@ Intestine, Small
H1-hESC|embryonic stem cells|inner cell mass	PSC@ hESC H1
NHLF|cultured NHLF cells	Lng@ NHLF
NHEK|cultured NHEK cells	Epd@ NHEK
HUVEC|cultured HUVEC cells	CDV@ HUVEC
HSMM|cultured HSMM cells	Myo@ HSMM
HMEC|cultured HMEC cells	Brs@ HMEC
GM12878|cultured GM12878 cells	Bld@ GM12878
HeLa B2|HeLa B2 cells|immortal cervical cancer cell	Utr@ HeLa
HeLa Kyoto cell line|Human cervical carcinoma cell line	Utr@ HeLa
diploid fibroblast	Oth@ Fibroblasts
19239|Lymphoblastoid Cell Lines	Bld@ GM19239
12892|Lymphoblastoid Cell Lines	Bld@ GM12892
12891|Lymphoblastoid Cell Lines	Bld@ GM12891
Primary Tissue|Fetal Muscle, Arm|UW|None	Myo@ Fetal muscle
HepG2|cultured HepG2 cells	Liv@ Hep G2
H1|cultured H1 cells	PSC@ hESC H1
Primary Tissue|Fetal Thymus|UW|None	Oth@ Thymus
HepG2|hepatocellular carcinoma|endoderm	Liv@ Hep G2
MCF-7	Brs@ MCF-7
Primary Tissue|fetal lung|UW|None	Lng@ Fetal lung
19238|Lymphoblastoid Cell Lines	Bld@ GM19238
HeLa Cells|HeLa Cells	Utr@ HeLa
H3396 cells|H3396 cells	Brs@ H3396
NB4 cells	Bld@ NB-4
Multiple myeloma|MM1.S	Bld@ MM.1S
ME-1|ME-1 cell line (leukemic)|leukemic cell line	Bld@ ME-1
K562 cells|K562 cells	Bld@ K-562
MCF10A-Er-Src|MCF10A-Er-Src|mammary gland, non-tumorigenic epithelial, inducible cell line, derived from the MCF-10A parental cells and contain ER-Src, a derivative of the Src kinase oncoprotein (v-Src) that is fused to the ligand-binding domain of the estrogen receptor (ER)|ectoderm	Brs@ MCF 10A
LNCaP|Prostate cancer cell line (LNCaP)	Prs@ LNCAP
hASC, ChIP|Adipose stromal cell (ASC) adipocyte	Adp@ Adipose stromal cell
HCT-116|colorectal carcinoma (PMID: 7214343)|endoderm	Dig@ HCT 116
IMR90|IMR90 fetal lung fibroblasts	Lng@ IMR-90
MCF-7 breast cancer cells|MCF-7	Brs@ MCF-7
Multiple myeloma|Multiple myeloma	Bld@ Multiple Myeloma
12890|Lymphoblastoid Cell Lines	Bld@ Lymphoblastoid cell lines
Small Cell Lung Carcinoma|H2171	Lng@ NCI-H2171
Primary Tissue|Fetal Muscle, Back|UW|None	Myo@ Fetal muscle
A549|A549|epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male. - ATCC, newly promoted to tier 2: not in 2011 analysis|endoderm	Lng@ A549
MCF-7|MCF-7 breast cancer cells|breast cancer cells	Brs@ MCF-7
Hes6_OE	Unc@ Unclassified
HeLa cell	Utr@ HeLa
macrophage	Bld@ Macrophages
GM12878|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM12878
Th cells	Bld@ Th1 Cells
Raji B|Raji B-cell line	Bld@ RAJI
CUTLL1|CUTLL1|T lymphocyte|T lymphoblastic leukemia/lymphoma cell line	Bld@ CUTLL1
2630|Lymphoblastoid Cell Lines	Bld@ Lymphoblastoid cell lines
2610|Lymphoblastoid Cell Lines	Bld@ Lymphoblastoid cell lines
2588|Lymphoblastoid Cell Lines	Bld@ Lymphoblastoid cell lines
2255|Lymphoblastoid Cell Lines	Bld@ Lymphoblastoid cell lines
18486|Lymphoblastoid Cell Lines	Bld@ Lymphoblastoid cell lines
10847|Lymphoblastoid Cell Lines	Bld@ GM10847
CD4+ T cells|CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
HUVEC|HUVEC|umbilical vein endothelial cells|mesoderm	CDV@ HUVEC
H1|embryonic stem cell	PSC@ hESC H1
HUES64|dEC|dEC	PSC@ hESC derived ectodermal cells
Jurkat-NRSF|Jurkat	Bld@ Jurkat
HCT-116|HCT-116|colorectal carcinoma (PMID: 7214343)|endoderm	Dig@ HCT 116
Primary Tissue|Gastric|N/A|None	Dig@ Gastric primary sample
MCF7|MCF7 Tet-On Inducible stable line|beast cancer cell line	Brs@ MCF-7
Jurkat|T-ALL cell line	Bld@ Jurkat
Lymphoblastoid cell lines|lymphoblastic cell line	Bld@ Lymphoblastoid cell line
MM1.S|Multiple myeloma	Bld@ MM.1S
Hs68|Cultured fibroblasts|normal foreskin	Epd@ Hs 68
293T Rex cell line	Kid@ 293
19193|Lymphoblastoid Cell Lines	Bld@ GM19193
19099|Lymphoblastoid Cell Lines	Bld@ GM19099
18951|Lymphoblastoid Cell Lines	Bld@ GM18951
18526|Lymphoblastoid Cell Lines	Bld@ GM18526
18505|Lymphoblastoid Cell Lines	Bld@ GM18505
FACS-sorted pancreatic islet|Beta|pancreatic islets	Pan@ Pancreatic islets
DU145 prostate cancer cells|DU145 prostate cancer cells	Prs@ DU 145
LNCaP-1F5 cells|LNCaP-1F5 cells|Prostate epithelial cells derived from metastatic prostate carcinoma, genetically engineered to express rat glucocorticoid receptor (Cleutjens et al., 1997).	Prs@ LNCAP
iPS 19.11|Cell Line|Induced pluripotent stem cell line derived from foreskin fibroblasts|None|Induced pluripotent stem cell	PSC@ iPS cells
A549|epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male. - ATCC, newly promoted to tier 2: not in 2011 analysis	Lng@ A549
HUVEC|umbilical vein endothelial cells	CDV@ HUVEC
K562|chronic myeloid leukemia cell line	Bld@ K-562
prefrontal cortex|neurons from prefrontal cortex	Neu@ Prefrontal Cortex
iMSC3|immortalized mesenchymal stem cell|day-0 undifferentiated	Oth@ Mesenchymal stem cells
GM12878|GM12878-p300	Bld@ GM12878
Empty_Vector	Unc@ Unclassified
HeLa-S3	Utr@ HeLa
Primary Tissue|Psoas Muscle|N/A|None	Myo@ Muscles
Glioblastoma|U87	Neu@ U-87 MG
GM12891|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM12891
GM10847|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM10847
GM18505|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM18526
dESC Tissue Culture|Decidualized DSC	Unc@ Unclassified
VCaP|prostate cancer cells	Prs@ VCaP
OCI-LY3|ABC DLBCL|Diffuse large B-cell lymphoma (DLBCL)	Bld@ OCI-LY-3
Human neonatal foreskin keratinocytes	Epd@ Keratinocytes
FACS-sorted pancreatic islet|Alpha|pancreatic islets	Pan@ Pancreatic islets
CD4+CD25+CD45RA+ expanded naive regulatory T cells|CD4+CD25+CD45RA+ expanded naive regulatory T cells	Bld@ CD4-Positive T-Lymphocytes
Primary Tissue|Fetal Lung, Left|UW|None	Lng@ Fetal lung
LS180 cells|cultured CRC cells	Dig@ LS-180
HSMM|skeletal muscle myoblasts|mesoderm	Myo@ HSMM
hASC, ChIP|Adipose stromal cell (ASC) pre-adipocyte	Adp@ Adipose stromal cell
CD19+/CD10+/CD44low/CXCR4- B cells|centrocyte|Tonsil	Bld@ B-Lymphocytes
CD19+/CD10+/CD44low/CXCR4+ B cells|centroblast|Tonsil	Bld@ B-Lymphocytes
HEK293T/17	Kid@ 293
Dnd41	Bld@ DND-41
Primary Tissue|Fetal Placenta|UW|None	Plc@ Placenta
MCF-7|breast|adult	Brs@ MCF-7
HeLa	Utr@ HeLa
Primary Tissue|Fetal Heart|UW|None	CDV@ Heart
Primary Tissue|fetal brain|UW|None	Neu@ Fetal brain
GM18951|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM18951
GM15510|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM15510
U2OS	Bon@ U2OS
Primary CXCR5hi CD4 T cells isolated from human tonsils|CXCR5hi PD1hi CD45RO+ CD4+ T cells, CD19|tonsil	Bld@ CD4-Positive T-Lymphocytes
ICM-derived LIS2|human ICM-derived ES cell line|ESCs	PSC@ hESC LIS2
CyT49|Pancreatic endoderm|hESC derived pancreatic endoderm	PSC@ hESC derived mesendodermal cells
Human breast cells|MCF7	Brs@ MCF-7
Human breast cells|MCF10A	Brs@ MCF 10A
BEAS-2B cells	Lng@ BEAS-2B
HEK 293T|Human Embryonic Kidney	Kid@ 293
C1|iPS Cells|iPS Cells	PSC@ iPS cells
Primary Tissue|Sigmoid Colon|N/A|None	Dig@ Colon
Primary Cell|CD19 Primary Cells|None|CD19+	Bld@ B-cell (CD19+)
Primary Tissue|Fetal Spinal Cord|UW|None	Neu@ Fetal Spinal Cord
Primary Cell|CD8 Primary Cells|None|CD8+	Bld@ CD8+
Multiple myeloma|Plasma cell	Bld@ Multiple Myeloma
HCT116|HCT116 cell culture	Dig@ HCT 116
Primary Tissue|Fetal Adrenal Gland|UW|None	Oth@ Adrenal Glands
OC-LY1|Diffuse Large B-Cell Lymphoma	Bld@ OCI-LY1
AML-patient-derived cell lines t(8;21) Kasumi-1|Kasumi-1 cell culture	Bld@ Kasumi-1
derived from biopsy of fibrosarcoma of Human male	Oth@ Fibrosarcoma
Primary (live-frozen) CD4+ cells	Bld@ CD4+
Cultured CD4+ cells	Bld@ CD4+
IMR90|IMR90|fetal lung fibroblasts, newly promoted to tier 2: not in 2011 analysis|endoderm	Lng@ IMR-90
C4-2B|prostate cancer cells	Bld@ C4-2
HeLa S3|cervical cancer cell line	Utr@ HeLa
Primary Tissue|Left Ventricle|N/A|None	CDV@ Heart Ventricles
HCT116|human colorectal carcinoma cell line HCT116	Dig@ HCT 116
A549|A549 cells	Lng@ A549
CCRF-CEM|T-ALL cell line	Bld@ CCRF-CEM
IMR90 human primary lung embryo fibroblasts|lung fibroblasts|contact-inhibited IMR90	Lng@ IMR-90
HeLa, cycling|Suspension HeLa cells	Utr@ HeLa
HUES64|Cell Line|embrionic stem cell|none|undifferentiated	PSC@ hESC HUES64
HUES48|Cell Line|embrionic stem cell|none|undifferentiated	PSC@ hESC HUES48
NHEK|epidermal keratinocytes	Epd@ NHEK
H1|Cell Line|undifferentiated|none|stage_zero	PSC@ hESC H1
MV4-11|AML	Bld@ MV-4-11
GM12878|GM12878-NRSF	Bld@ GM12878
WIBR3|hES Cells|hES Cells	PSC@ hESC WIBR3
Monocytes-CD14+_RO01746	Bld@ Monocytes-CD14+
CD36	Bld@ CD36+
HepG2|liver|adult	Liv@ Hep G2
LNCaP|LNCaP	Prs@ LNCAP
MCF7|MCF7	Brs@ MCF-7
GM18526|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM18526
GM19193|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM19193
ICM-derived WIS2|human ICM-derived ES cell line|ESCs	PSC@ hESC WIS2
neural precursor cell: mid radial glial|ES-derived neural progenitor cells	PSC@ hESC derived neural cells
neural precursor cell: neuroepithelial|ES-derived neural progenitor cells	PSC@ hESC derived neural cells
OCI-LY1|Human DLBCL cell line	Bld@ OCI-LY1
iSLK-219|Kidney epithelium|Kidney epithelial cells	Kid@ iSLK
BF|Cultured fibroblasts|normal breast	Brs@ Breast cells
MCF7|MCF7 cell line	Brs@ MCF-7
Primary Tissue|Right Ventricle|N/A|None	CDV@ Heart Ventricles
Primary Cell|CD4 Primary Cells|None|CD4+	Bld@ CD4+
Human Embryonal Kidney Cells|Isogenic HEK293 Cells	Kid@ 293
M0-91 cells|M0-91 cells|acute myelogenous leukemia cell line	Bld@ M0-91
HeLa cell|HeLa cell	Utr@ HeLa
CD56+ mesoderm|Cell Line|mesoderm|presumed normal|intermediate	PSC@ hESC derived mesendodermal cells
Primary Tissue|Fetal Lung, Right|UW|None	Lng@ Fetal lung
Primary Tissue|Fetal Renal Cortex|UW|None	Kid@ Kidney Cortex
WI-38|WI-38 cell culture|hTERT-immortalized WI-38 primary human lung fibroblasts	Lng@ WI-38
Human erythromyeloblastoid leukemia cell line K562|Chronic myeloid leukaemia|Cultured cancer cell line	Bld@ K-562
iPS 6.9|Cell Line|Induced pluripotent stem cell line derived from foreskin fibroblasts|None|Induced pluripotent stem cell	PSC@ iPS cells
HSMMtube|skeletal muscle myotubes differentiated from the HSMM cell line|mesoderm	Myo@ HSMM
HUES 6|Cell Line|embrionic stem cell|none|undifferentiated	PSC@ hESC HUES6
Tumor	Oth@ Tumor
Primary Tissue|Fetal Kidney|UW|None	Kid@ Fetal kidney
HeLa-S3|ectoderm	Utr@ HeLa
HeLa|HeLa	Utr@ HeLa
GM12892|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM12892
GM19099|Lymphoblastoid Cells|Lymphoblastoid cell	Bld@ GM19099
MCF7|Breast cancer cells	Brs@ MCF-7
neural precursor cell: early radial glial|ES-derived neural progenitor cells	PSC@ hESC derived neural cells
H9|human H9 cell lines	PSC@ hESC H9
HeLa|HeLa|IP with Ab  RNAPII rabbit polyclonal N20 (Santa Cruz, sc-899)	Utr@ HeLa
B-cell lymphoma cell line|P493-6	Bld@ P493-6
Breast cancer cell line T47D-MTVL|Breast cancer cell line	Brs@ T-47D
TIVE-LTC|TIVE-LTC|Long-Term-Infected Telomerase-Immortalized Vein Endothelial Cells	Utr@ TIVE-LTC
Human breast cancer cell line|MCF7	Brs@ MCF-7
Human Kidney Embryonic Cell line HEK293|HEK293	Kid@ 293
VCaP|VCaP cell line	Prs@ VCaP
U2OS cells|U2OS Cells	Bon@ U2OS
Primary Tissue|Fetal Muscle, Trunk|UW|None	Myo@ Fetal muscle
MCF7 cells|MCF7 cells|breast cancer cell line	Brs@ MCF-7
Primary Cell|CD14 Primary Cells|None|CD14+	Bld@ Monocytes-CD14+
Primary Tissue|Fetal Renal Pelvis|UW|None	Kid@ Kidney Pelvis
T-47D|epithelial cell line derived from a mammary ductal carcinoma.	Brs@ T-47D
SK-N-SH|SK-N-SH|neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual.|ectoderm	Neu@ SK-N-SH
HUES64 derived CD184+|Cell Line|NA|presumed normal|differentiated	PSC@ hESC derived mesendodermal cells
Colon cancer_input DNA|Colon Cancer	Dig@ Colon cancer
Colon cancer_H3K4me1_ChIPSeq|Colon Cancer	Dig@ Colon cancer
HMEC|mammary epithelial cells|ectoderm	Brs@ HMEC
CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
CD36+ primary hematopoietic stem cells/progenitor cells (HSCs/HPCs)cells	Bld@ CD36+
skin fibroblast	Epd@ Dermal fibroblast
Testis	Gon@ Testis
Primary Tissue|Spleen|N/A|None	Oth@ Spleen
NHLF|lung fibroblasts|endoderm	Lng@ NHLF
UPR9 cells	Bld@ UPR9
Pancreas	Pan@ Pancreas
HEPG2|liver	Liv@ Hep G2
Raji cells|Raji cells	Bld@ RAJI
HEK293 cells, retrovirally transduced|cultured cell line	Kid@ 293
umbilical cord blood|CD34+ cells	Bld@ CD34+
HCT116 colorectal cancer cells	Dig@ HCT 116
FACS-sorted pancreatic islet|Exocrine|pancreatic islets	Pan@ Pancreatic islets
Primary Tissue|Small Intestine|N/A|None	Dig@ Intestine, Small
Primary Cell|CD3 Primary Cells|None|CD3+	Bld@ CD3+
CD4+CD25- expanded conventional T cells|CD4+CD25- expanded conventional T cells	Bld@ CD4-Positive T-Lymphocytes
Primary Cell|CD56 Primary Cells|None|CD56+	Bld@ CD56+
Primary Tissue|Fetal Kidney, Right|UW|None	Kid@ Fetal kidney
PANC-1|PANC-1|pancreatic carcinoma, (PMID: 1140870) PANC-1 was established from a pancreatic carcinoma, which was extracted via pancreatico-duodenectomy specimen from a 56-year-old Caucasian individual. Malignancy of this cell line was verified via in vitro and in vivo assays.|endoderm	Pan@ PANC-1
UKE-1|UKE-1|Leukemia cell line	Bld@ UKE-1
LX2|human LX2 cells|human hepatic stellate cells	Liv@ LX2
Monocytes|primary monocyte	Bld@ Monocytes
VCaP|Hormone refractory prostate cancer cells	Prs@ VCaP
HEK293|Transformed embryonic kidney cell line	Kid@ 293
H9|endoderm precursor cells|ESC-derived endoderm	PSC@ hESC derived mesendodermal cells
H9|human embryonic stem cells|embryonic stem cells	PSC@ hESC H9
H1|embryonic stem cells	PSC@ hESC H1
CD133+ primary hematopoietic stem cells/progenitor cells (HSCs/HPCs)cells	Bld@ Hematopoietic Stem Cells
H9|embryonic stem cell	PSC@ hESC H9
NA12892|lymphoblastoid cell	Bld@ GM12892
NA12878|lymphoblastoid cell	Bld@ GM12878
NA12891|lymphoblastoid cell	Bld@ GM12891
NA19238|lymphoblastoid cell	Bld@ GM19238
NA19239|lymphoblastoid cell	Bld@ GM19239
NA19240|lymphoblastoid cell	Bld@ GM19240
T-ALL|Jurkat	Bld@ Jurkat
hepatocytes	Liv@ Hepatocytes
EWS502|Ewing Sarcoma cells	Bon@ EWS502
MOLM-1|myeloblast	Bld@ MOLM-1
CyT49|Posterior foregut|hESC derived posterior foregut	PSC@ hESC derived mesendodermal cells
CyT49|Primitive gut tube|hESC derived primitive gut tube	PSC@ hESC derived mesendodermal cells
CD19+ B cells|peripheral blood B cells|Activated (IL4, anti-CD40, IgM, and IgD) peripheral blood	Bld@ B-Lymphocytes
human embryonic stem cell line H9|embryonic stem cells	PSC@ hESC H9
Hela cells|Hela Cells	Utr@ HeLa
Vertebral Cancer of Prostate (VCaP)|VCaP cells|bone metastasis of prostate cancer	Prs@ VCaP
DKO1|DKO1 cells|colon cancer cell line; DNMT3B &amp; DNM1 KO	Dig@ Colon cancer
HCT116|HCT116 cells|colon cancer cell line	Dig@ HCT 116
HeLa|HeLa|IP with non-commercial rabbit anti-ELL2 Ref PMID 20159561	Utr@ HeLa
HeLa|HeLa|IP with non-commercial rabbit anti-AFF4 Ref PMID 20159561	Utr@ HeLa
MCF-7 TTE-MBD2	Brs@ MCF-7
LNCaP cells	Prs@ LNCAP
PC-3 prostate cancer cells|PC-3 cells	Prs@ PC-3
LY1|Diffuse Large B-Cell Lymphoma|Diffuse Large B-Cell Lymphoma	Bld@ OCI-LY1
DLD1 colon cancer cells|DLD1 colon cancer cells	Dig@ DLD-1
HeLa|HeLa cells	Utr@ HeLa
WA09|WA09|Human embryonic stem cells	PSC@ hESC WA09
BCBL-1|BCBL-1|Primary effusion lymphoma (PEL) cell line	Bld@ BCBL1
Diffuse Large B-Cell Lymphoma|primary diffuse large B-cell lymphoma tumor	Bld@ Lymphoma, B-Cell
Primary Tissue|Pancreas|N/A|iron deficiency, bipolar	Pan@ Pancreas
peripheral blood|monocyte derived macrophages	Bld@ Macrophages
MCF7|breast cancer cells|breast cancer cells	Brs@ MCF-7
CD34+ cells|CD34+ cells	Bld@ CD34+
MCF7|Breast cancer cells|Pleural effusion	Brs@ MCF-7
Jurkat E6-1|T-ALL cell line	Bld@ Jurkat (Clone E6-1)
LNCaP prostate cancer cells|LNCaP cells	Prs@ LNCAP
Monocyte-derived macrophage|Monocyte-derived macrophage	Bld@ Macrophages
Primary Tissue|Fetal Kidney, Left|UW|None	Kid@ Fetal kidney
WI-38|WI-38|embryonic lung fibroblast cells, hTERT immortalized, includes Raf1 construct|endoderm	Lng@ WI-38
NB4|NB4|acute promyelocytic leukemia cell line. (PMID: 1995093)|mesoderm	Bld@ NB-4
CD34-pos cell in erythroid differentiation|primary CD34+ stem/progenitor cells	Bld@ CD34 Hematopoietic stem cells
LNCaP-abl (abl) prostate cancer cells|prostate cancer cells	Prs@ LNCAP
fibroblast derived from H1|Fibroblasts differentiated from H1 ES cells (dH1f)	PSC@ hESC derived fibroblasts
T-ALL primagraft	Bld@ T-ALL
GM12891|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed	Bld@ GM12891
HepG2|HepG2|liver carcinoma|endoderm	Liv@ Hep G2
HCT-116|colon cancer cell line	Dig@ HCT 116
NHDF-Ad|adult dermal fibroblasts|mesoderm	Epd@ NHDF
LNCaP androgen-dependent prostate cancer cell line|LNCaP prostate cancer cells	Prs@ LNCAP
T cell|T cell	Bld@ T-Lymphocytes
H9 ESC|Human embryonic stem cells	PSC@ hESC H9
epithelial|breast|breast cancer	Brs@ Breast cancer cells
PrEC|PrEC	Prs@ PrEC
MCF-7|breast cancer cells	Brs@ MCF-7
Primary Tissue|fetal kidney|UW|None	Kid@ Fetal kidney
AsiSI-ER-U20S	Bon@ U2OS
MCF-7|MCF-7	Brs@ MCF-7
U2OS cell line|osteosarcoma	Bon@ U2OS
primary HUVECs|endothelial cells	CDV@ HUVEC
Osteobl|osteoblasts (NHOst)|mesoderm	Bon@ Osteobl
NA19239|lymphoblastoid cell line|Yoruba from Ibadan, Nigeria (YRI)	Bld@ GM19239
NA18507|lymphoblastoid cell line|Yoruba from Ibadan, Nigeria (YRI)	Bld@ GM18507
UAE (leukemic)|hematopoietic cell|leukemic	Bld@ U-937
WPMY1|myofibroblast stromal cell	Prs@ WPMY-1
kelly|high-MYCN-Neuroblastoma cell line|Neuroblastoma cell line	Neu@ KELLY
Ewing sarcoma cell line A673|A673	Myo@ A-673
Ewing sarcoma cell line SKMNC|SKMNC after 96 hrs shFLI1	Bon@ SKMNC
Ewing sarcoma cell line SKMNC|SKMNC after 96 hrs shGFP	Bon@ SKMNC
Ewing sarcoma cell line SKMNC|SKMNC	Bon@ SKMNC
prostate cancer cell line|R1-AD1	Prs@ R1-AD1
Retinal pigment cells, science cell|Retinal pigment cells #6540	Oth@ HRPEpiC
DKO1|DKO1 cells|colon cancer	Dig@ Colon cancer
MCF-7 WT	Brs@ MCF-7
DND-41|DND-41 persister cells|T-cell acute lymphoblastic leukemia	Bld@ DND-41
DND-41|DND-41 nave cells|T-cell acute lymphoblastic leukemia	Bld@ DND-41
KOPT-K1|KOPT-K1 nave cells|T-cell acute lymphoblastic leukemia	Bld@ KOPT-K1
glioblastoma tumor intiating cells, 0308 line	Neu@ Glioblastoma
Primary Tissue|Adrenal Gland|N/A|None	Oth@ Adrenal Glands
Primary Tissue|Ovary|N/A|iron deficiency, bipolar	Gon@ Ovary
LNCAP cell line	Prs@ LNCAP
HKC8 cells|human kidney proximal tubule cells (HKC8 cells)	Kid@ HKC8
R3/R4 Erythroid cells|R3/R4 Erythroid cells	Bld@ Erythroid Cells
Input control|Input control	Unc@ Unclassified
HEK293|HEK293|embryonic kidney, cells contain Adenovirus 5 DNA (PMID: 11967234)|mesoderm	Kid@ 293
Caco-2|Caco-2|colorectal adenocarcinoma. (PMID: 1939345)|endoderm	Dig@ Caco-2
IMR90|IMR90 Human Fetal Lung Fibroblast cell line	Lng@ IMR-90
MCF7-LTED|Long-term estrogen deprived breast cancer cell line	Brs@ MCF-7
Raji-cells|Raji-cells|Burkitt's lymphoma	Bld@ RAJI
Small Cell Lung Carcinoma|H128	Lng@ NCI-H128
MCF-7 breast cancer cells|MCF-7 breast cancer cells	Brs@ MCF-7
FB0167P|Progeria fibroblast|Progeria fibroblast	Oth@ FB0167P
MCF7|breast adenocarcinoma cells|breast adenocarcinoma cells	Brs@ MCF-7
NT2-D1|NT2-D1|malignant pluripotent embryonal carcinoma (Ntera2), The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. - ATCC. (PMID: 6694356)|inner cell mass	PSC@ NT2-D1
hiPS-18a|Cell Line|induced pluripotent cells|presumed normal|undifferentiated	PSC@ iPS cells
hiPS-20b|Cell Line|induced pluripotent cells|presumed normal|undifferentiated	PSC@ iPS cells
hiPS-20b|Cell Line|induced pluripotent cells|none|undifferentiated	PSC@ iPS cells
NH-A|astrocytes (also called Astrocy)|ectoderm	Neu@ NH-A
HCC1954|breast cancer cells|breast cancer cells	Brs@ HCC1954
reduction mammoplasty|epithelial cell|breast|normal|CD24+	Brs@ Breast cells
reduction mammoplasty|epithelial cell|breast|normal|CD44+	Brs@ Breast cells
Homogenized Human Liver|Liver tissue	Liv@ Liver
K562|K562 Cells, 24 hours following induction with TPA	Bld@ K-562
Primary Cell|CD19 Primary Cells|none|CD19+	Bld@ B-cell (CD19+)
HeLa cells|Hela cells	Utr@ HeLa
IMR90|Chromatin IP against pRb	Lng@ IMR-90
NA11894|lymphoblastoid cell	Bld@ NA11894
NA12043|lymphoblastoid cell	Bld@ NA12043
NA12776|lymphoblastoid cell	Bld@ NA12776
NA11830|lymphoblastoid cell	Bld@ NA11830
NA11881|lymphoblastoid cell	Bld@ NA11881
NA11831|lymphoblastoid cell	Bld@ NA11831
NA12813|lymphoblastoid cell	Bld@ NA12813
H1_hESC|human embryonic stem cells	PSC@ hESC H1
CyT49|embryonic stem cell	PSC@ hESC Cyt49
HMVEC|IHEC22|Human Cardiac Microvascular Endothelial Cells|the endothelium of blood vessels|microvascular endothelial cell|dead	CDV@ HMVEC
HPAEC|IHEC21|Human Pulmonary Artery Endothelial Cells|the endothelium of blood vessels|pulmonary artery endothelial cell|dead	CDV@ HPAEC
HCAEC|IHEC20|Human Coronary Artery Endothelial Cells|the endothelium of blood vessels|endothelial cell of coronary artery|dead	CDV@ Coronary artery endothelial cells
HAoEC|IHEC19|Human Aortic Endothelial Cells|the endothelium of blood vessels|aortic endothelial cells|dead	CDV@ HAoEC
HUVEC|IHEC18|Human Umbilical Vein Endothelial Cells|the endothelium of blood vessels|endothelial cell of umbilical vein|pneumonia|alive	CDV@ HUVEC
HUVEC|IHEC17|Human Umbilical Vein Endothelial Cells|the endothelium of blood vessels|endothelial cell of umbilical vein|pneumonia|alive	CDV@ HUVEC
HCAEC|IHEC16|Human Coronary Artery Endothelial Cells|the endothelium of blood vessels|endothelial cell of coronary artery|dead	CDV@ Coronary artery endothelial cells
HCAEC|IHEC15|Human Coronary Artery Endothelial Cells|the endothelium of blood vessels|endothelial cell of coronary artery|pneumonia|dead	CDV@ Coronary artery endothelial cells
HPAEC|IHEC14|Human Pulmonary Artery Endothelial Cells|the endothelium of blood vessels|pulmonary artery endothelial cell|pneumonia|dead	CDV@ HPAEC
HAoEC|IHEC13|Human Aortic Endothelial Cells|the endothelium of blood vessels|aortic endothelial cells|pneumonia|dead	CDV@ HAoEC
HAoEC|IHEC12|Human Aortic Endothelial Cells|the endothelium of blood vessels|aortic endothelial cells|dead	CDV@ HAoEC
Primary Tissue|Pancreas|N/A|None	Pan@ Pancreas
NHEK|NHEK|epidermal keratinocytes|ectoderm	Epd@ NHEK
HUVEC	CDV@ HUVEC
SEM|SEM	Bld@ SEM
testes|adult	Gon@ Testis
ZR75-1|breast cancer	Brs@ ZR-75-1
PC3|PC3	Prs@ PC-3
KOPT-K1|KOPT-K1 persister cells|T-cell acute lymphoblastic leukemia	Bld@ KOPT-K1
MDAMB231|MDAMB231	Brs@ MDA-MB-231
Edom-iPS-2|hiPSC	PSC@ iPS cells
MM1.S	Bld@ MM.1S
LCL	Bld@ Lymphoblastoid cell line
NH-A	Neu@ NH-A
Blood|Bcell|Blood|Adult	Bld@ B-Lymphocytes
Primary Tissue|Right Atrium|N/A|None	CDV@ Atrium
H54|glioblastoma|glioblastoma	Neu@ D54
MDAMB453|breast|epithelial	Brs@ MDA-MB-453
Human Embryonic kidney cell line	Kid@ 293
Calu-3|Lung adenocarcinoma cells|Lung adenocarcinoma	Lng@ Calu-3
SHSY5Y|low_MYCN-Neuroblastoma cell line|Neuroblastoma cell line	Neu@ SH-SY5Y
HEK293 cells|cultured cell line	Kid@ 293
U937|U937 cell line	Bld@ U-937
ICN12 cells|primary pre-B acute lymphomablastic leukemia	Bld@ ICN12
Embryonic stem cells	PSC@ Embryonic Stem Cells
DU145|DU145 Prostate cancer cell line	Prs@ DU 145
HCT116|HCT116 cells|colon cancer	Dig@ HCT 116
SA121|Human embryonic stem cells|Human embryonic stem cells	PSC@ hESC SA121
Human patient-derived xenograft cells	Unc@ Unclassified
HeLa|HeLa|IP with Ab  anti-INTS11 rabbit polyclonal (Bethyl, A301-274A)	Utr@ HeLa
ependymomas_PFA_H3K27me3 ChIP|Primary Ependymoma Tumour	Neu@ Ependymoma
Cultured fibroblasts	Oth@ Fibroblasts
LNCaP cells|prostate adenocarcinoma	Prs@ LNCAP
CyT49|Definitive endoderm|hESC derived definitive endoderm	PSC@ hESC derived mesendodermal cells
Human Embryonal Kidney Cells HEK-293|Isogenic HEK293 Cells	Kid@ 293
T47D-MTVL|Breast cancer cell line	Brs@ T-47D
Human primary endothelial colony-forming cells|ECFCs derived from human umbilical cord blood	CDV@ Primary endothelial cells
IMR90|IMR90 human fiboblasts	Lng@ IMR-90
BGO1|hES Cells|hES Cells	PSC@ hESC BG01
Primary Tissue|Esophagus|N/A|iron deficiency, bipolar	Dig@ Esophagus
DLD1|Cultured cells	Dig@ DLD-1
Primary Tissue|Lung|N/A|iron deficiency, bipolar	Lng@ Lung
MCF-7|MCF-7 cells|breast cancer	Brs@ MCF-7
T47D-MTVL|breast cancer ductal carcinoma	Brs@ T-47D
Jurkat|Jurkat cell line	Bld@ Jurkat
MCF-7 breast cancer cell line|MCF-7 breast cancer cell line	Brs@ MCF-7
RKO|human colon carcinoma	Dig@ RKO
Bronchial Epithelial Cells|Bronchial Epithelial Cells	Lng@ Tracheal epithelial cells
CD4+ T cells activated by IL-2+aCD3+aCD28|CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
Blood monocytes|Blood monocytes	Bld@ Monocytes
NT2-D1|NT2-D1|malignant pluripotent embryonal carcinoma (NTera-2), The NTERA-2 cl.D1 cell line is a pluripotent human testicular embryonal carcinoma cell line derived by cloning the NTERA-2 cell line. - ATCC. (PMID: 6694356)|inner cell mass	PSC@ NT2-D1
Monocytes-CD14+_RO01746|Monocytes-CD14+_RO01746|Monocytes-CD14+ are CD14-positive cells from human leukapheresis production, from donor RO 01746 (draw 1 ID is RO 01746, draw 2 ID is RO 01826), Monocytes-CD14+_RO01746 and Monocytes-CD14+_RO01826 are being used as replicates, newly promoted to tier 2: not in 2011 analysis|mesoderm	Bld@ Monocytes-CD14+
LHCN-M2|LHCN-M2|skeletal myoblasts derived from satellite cells from the pectoralis major muscle of a 41 year old caucasian heart transplant donor, immortalized with lox-hygro-hTERT (LH), and Cdk4-neo (CN), Zhu et al. (2007) in Aging Cell, vol. 6, pp 515-523, newly promoted to tier 2: not in 2011 analysis.|mesoderm	Myo@ LHCN-M2
CD20+_RO01778|CD20+_RO01778|B cells, caucasian, draw number 1, newly promoted to tier 2: not in 2011 analysis|mesoderm	Bld@ CD20+
SK-N-MC|SK-N-MC|neuroepithelioma cell line derived from a metastatic supra-orbital human brain tumor, SK-N-MC was isolated in September of l971 and was found to have moderate dopamine - beta - hydroxylase activity as well as formaldehyde induced fluorescence indicative of intracellular catecholamines. - ATCC. (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)|ectoderm	Neu@ SK-N-MC
AG04450|AG04450|fetal lung fibroblast|endoderm	Lng@ AG04450
PANC-1|pancreatic carcinoma, (PMID: 1140870) PANC-1 was established from a pancreatic carcinoma, which was extracted via pancreatico-duodenectomy specimen from a 56-year-old Caucasian individual. Malignancy of this cell line was verified via in vitro and in vivo assays.|endoderm	Pan@ PANC-1
PFSK-1|neuroectodermal cell line derived from a cerebral brain tumor, (PMID: 1316433)|ectoderm	Neu@ PFSK-1
AoAF|AoAF|aortic adventitial fibroblast cells|mesoderm	CDV@ AoAF
CD8+ T cells|CD8+ T cells	Bld@ CD8-Positive T-Lymphocytes
CD14dimCD16+ non-classical blood monocytes|CD14dimCD16+ non-classical blood monocytes	Bld@ Monocytes-CD14+
patient colon tumor|Patient Tumor	Dig@ Colon cancer
patient breast tumor|Patient Tumor	Brs@ Breast cancer cells
BPE cells|Immortalized mammary epithelial cells	Brs@ BPE
MCF10A CELLS|Immortalized mammary epithelial cells	Brs@ MCF 10A
Primary Cell|CD25- IL17- Th stim MACS|presumed normal|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
Primary Cell|CD25- IL17+ Th17 stim|presumed normal|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
Primary Cell|CD25int CD127+ Tmem|presumed normal|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
Primary Cell Culture|hN (ES H9 derived Neurons)|none|&gt;90% beta III tubulin(+) and &gt;60% MAP2(+)	PSC@ hESC derived neural cells
Primary Cell Culture|hNP (ES H9 derived Nuronal Progenitors)|none|&gt;90% nestin(+) and &lt;5% Oct-4(+)	PSC@ hESC derived neural cells
HeLa cells|HeLa cells	Utr@ HeLa
MCF-7|mammary gland, adenocarcinoma. (PMID: 4357757), newly promoted to tier 2: not in 2011 analysis	Brs@ MCF-7
GM12892|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed	Bld@ GM12892
IB4|IB4 cells|EBV immotalized lymphocyte	Bld@ IB4
Primary Cell|CD15 Primary Cells|none|CD15+	Bld@ CD15 Granulocytes
Primary Cell|CD25- CD45RA+ naive|presumed normal|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
Primary Cell|CD25- CD45RO+ mem|presumed normal|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
hES I3 TESR|Cell Line|embrionic stem cell|none|undifferentiated	PSC@ hESC I3
hiPS-15b|Cell Line|induced pluripotent cells|none|undifferentiated	PSC@ iPS cells
H3K9/K14ac_ChIPSeq|primary Human Aortic Endothelial cells (HAEC)	CDV@ HAEC
HeLa cell line|HeLa cell line	Utr@ HeLa
Megakaryocytes|megakaryocytes cultured from cord blood CD34-positive cells	Bld@ CD34+
NEC|Neuroectodermal sphere cells (NEC) derived from H9 ESC	PSC@ hESC derived neural cells
hES-I3|Cell Line|embrionic stem cell|none|undifferentiated	PSC@ hESC I3
T98G|Human glioblastoma T98G cells	Neu@ T98G
HeLa S3|HeLa S3 cell line	Utr@ HeLa
APL cells _pz164	Bld@ Leukemia, Myeloid
H1 (WA01)|Cell Line|NA|None|undifferentiated	PSC@ hESC H1
memory CD8 T cells	Bld@ CD8-Positive T-Lymphocytes
NA11840|lymphoblastoid cell	Bld@ NA11840
LoVo|epithelial|colon; derived from metastatic site: left supraclavicular region	Dig@ LoVo
Primary Tissue|fetal heart|UW|None	CDV@ Heart
Ls174T|Ls174T cells	Dig@ LS-174T
LNCaP|LNCaP cells	Prs@ LNCAP
THP-1|THP-1 cells	Bld@ THP-1
hepatocytes|liver	Liv@ Hepatocytes
HMEC|HMEC	Brs@ HMEC
CyT49|hESC|Undifferentiated hESCs	PSC@ hESC Cyt49
MRC-iPS-25	PSC@ iPS cells
Primary Tissue|Small Intestine|N/A|iron deficiency, bipolar	Dig@ Intestine, Small
Primary Tissue|Thymus|N/A|None	Oth@ Thymus
NHDF-Ad	Epd@ NHDF
A549|A549 cells|lung carcinoma	Lng@ A549
Primary Tissue|Esophagus|N/A|None	Dig@ Esophagus
Primary Tissue|Aorta|N/A|None	CDV@ Aorta
Primary Tissue|Fetal Brain|UW|None	Neu@ Fetal brain
SAOS	Bon@ Saos-2
ZR-75-1|breast|epithelial	Brs@ ZR-75-1
SW480|Human colorectal cancer cell line	Dig@ SW 480
Retinal pigment cells|Sciencell #6540	Oth@ HRPEpiC
HEK 293T|HEK 293T cells	Kid@ 293
whole cell|SF7761 cell line	Neu@ SF7761
whole cell|neural stem cell (NSC)	Neu@ Neural Stem Cells
human control NPCs|iPSC (GM8330-8)-derived NPC	PSC@ iPS derived neural cells
T47D|T47D breast cancer cells	Brs@ T-47D
LP1|Peripheral blood	Bld@ LP-1
HBL1|Peripheral blood	Bld@ HBL-1
HCT116|HCT116 WT|human colon cancer cells	Dig@ HCT 116
HCT116|HCT116 FBXW7 KO|human colon cancer cells	Dig@ HCT 116
OCI-LY10|ABC DLBCL|Diffuse large B-cell lymphoma (DLBCL)	Bld@ OCI-LY-10
U2932 lymphoma cell line|U2932 human lymphoma cell line	Bld@ U-2932
Human primary adult proerythroblasts (ProEs)|CD34+ HSPC-derived proerythroblasts|bone marrow|adult	Bld@ CD34+
hESC derived anterior foregut (AFG)|hESC derived anterior foregut (AFG)	PSC@ hESC derived mesendodermal cells
hESC derived definitive endoderm cells|hESC derived definitive endoderm cells	PSC@ hESC derived mesendodermal cells
hESC derived anterior primitive streak (APS)|hESC derived anterior primitive streak (APS)	PSC@ hESC derived mesendodermal cells
H7-Embryonic stem cell|H7 - Embryonic stem cell	PSC@ hESC H7
Primary Tissue|Aorta|N/A|iron deficiency, bipolar	CDV@ Aorta
HCT116 colorectal cancer cells DNMT1KO/DNMT3BKO	Dig@ HCT 116
Primary Tissue|Liver|N/A|coronary artery disease	Liv@ Liver
GM19239|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ GM19239
GM19238|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ GM19238
GM19204|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ Lymphoblastoid cell lines
GM19193|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ GM19193
GM19141|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ Lymphoblastoid cell lines
GM18522|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ GM18526
GM18516|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ Lymphoblastoid cell lines
GM18508|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ Lymphoblastoid cell lines
GM18507|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ GM18507
GM18505|lymphoblastoid cell line|lymphoblastoid cell line	Bld@ GM18526
IMR90 cells|IMR90 cells	Lng@ IMR-90
primary HUVEC cells	CDV@ HUVEC
LNCaP cells|prostate cancer	Prs@ LNCAP
Tonsillar Germinal Center B cells|Tonsillar Germinal Center B cells	Bld@ B-Lymphocytes
Tonsillar Nave B cells|Tonsillar Nave B cells	Bld@ B-Lymphocytes
SUM159PT|breast cancer cells|breast cancer cells	Brs@ SUM 159PT
H295R adrenocortical tumor cell line|H295R/TR SF-1 cells	Oth@ NCI-H295R
Primary Cell Culture|Keratinocyte|None|NA	Epd@ Keratinocytes
Primary Cell Culture|Melanocyte|None|NA	Epd@ Melanocytes
HCM|HCM|cardiac myocytes|mesoderm	CDV@ HCM
NHDF-neo|NHDF-neo|neonatal dermal fibroblasts|mesoderm	Epd@ NHDF
HFF-Myc|HFF-Myc|foreskin fibroblast cells expressing canine cMyc|fibroblast	Epd@ HFF
RPTEC|RPTEC|renal proximal tubule epithelial cells	Kid@ RPTEC
BE2_C|BE2_C|neuroblastoma, BE-C is a clone of the SK-N-BE neuroblastoma cell line (see ATCC CRL-2271) that was established in November of 1972 from a bone marrow biopsy taken from a 2-year-old individual with disseminated neuroblastoma after repeated courses of chemotherapy and radiotherapy.|ectoderm	Neu@ BE(2)-C
HFF|HFF|foreskin fibroblast	Epd@ HFF
NHLF|NHLF|lung fibroblasts|endoderm	Lng@ NHLF
HVMF|HVMF|villous mesenchymal fibroblast cells	Plc@ HVMF
SGBS cell line undergoing differentiation for 10 days|adipocyte	Adp@ SGBS
T47D-MTVL|T47D-MTVL breast cancer cell line	Brs@ T-47D
HUVEC|umbilical vein endothelial cells|mesoderm	CDV@ HUVEC
SAEC|SAEC|small airway epithelial cells|endoderm	Lng@ SAEC
Jurkat|Jurkat|T lymphoblastoid derived from an acute T cell leukemia, The Jurkat cell line was established from the peripheral blood of a 14 year old boy by Schneider et al., and was originally designated JM. - ATCC. (PMID: 68013)|mesoderm	Bld@ Jurkat
AG04449|AG04449|fetal buttock/thigh fibroblast	Epd@ AG04449
CD4+CD25-CD45 RA+ naive conventional T cells|CD4+CD25-CD45 RA+ naive conventional T cells	Bld@ CD4-Positive T-Lymphocytes
CD56+ Natural Killer cells|CD56+ Natural Killer cells	Bld@ CD56+
CD19+ B cells|CD19+ B cells	Bld@ B-cell (CD19+)
MCF-7|GATA3_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|GATA3_estrogen|breast cancer cells	Brs@ MCF-7
VCaP|VCaP|Prostate epithelial cells derived from vertebral bone metastasis from patient with hormone refractory cancer.	Prs@ VCaP
HME cells|Immortalized mammary epithelial cells	Brs@ HMEC
Primary Cell Culture|Fibroblast|None|NA	Oth@ Fibroblasts
OCI-LY1|Human DLBCL cel line	Bld@ OCI-LY1
TEX|TEX cells	Bld@ TEX
SK-N-SH_RA|neuroblastoma cell line, treatment: differentiated with retinoic acid, (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)	Neu@ SK-N-SH
FB8470|Normal child fibroblasts|Normal child fibroblasts	Oth@ FB8470
U937|Input ChIP-Seq U937 BIO	Bld@ U-937
PBMC|PBMC|Peripheral blood mononuclear cells|mesoderm	Bld@ PBMC
T-47D|T-47D breast cancer cell line|Breast	Brs@ T-47D
Primary Cell|CD25+ CD127- Treg|presumed normal|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
Lymphoblastoid cell-line|GM12878|lymphoblastoid cell-line derived from NA12878	Bld@ GM12878
SAEC|SAEC|Small Airway Epithelial Cells	Lng@ SAEC
HRE|HRE|Human Renal Epithelial cells (normal)|mesoderm	Kid@ HRE
GM12865|GM12865|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12865
HCPEpiC|HCPEpiC|Human Choroid Plexus Epithelial Cells	Neu@ HCPEpiC
HPF|HPF|Human Pulmonary Fibroblasts isolated from lung tissue	Lng@ HPF
WERI-Rb-1|WERI-Rb-1|retinoblastoma (PMID: 844036)	Oth@ WERI-Rb-1
HMF|HMF|human mammary fibroblasts	Brs@ HMF
HPAF|HPAF|Human Pulmonary Artery Fibroblasts	CDV@ HPAF
HBMEC|HBMEC|Human Brain Microvascular Endothelial Cells	CDV@ HBMEC
GM06990|GM06990|Lymphoblastoid, International HapMap Project, CEPH/Utah, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM06990
HEEpiC|HEEpiC|Human Esophageal Epithelial Cells|endoderm	Dig@ HEEpiC
SK-N-SH_RA|SK-N-SH_RA|neuroblastoma cell line, treatment: differentiated with retinoic acid. (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)|ectoderm	Neu@ SK-N-SH
SKNO-1 (leukemic)|hematopoietic cell|leukemic	Bld@ SKNO-1
HeLa-S3|cervical carcinoma	Utr@ HeLa
Fully differentiated|Adipocytes|Mesenchymal stem cells-derived adipocytes	Adp@ Adipocytes
AML pz229 (leukemic)|hematopoietic cell|leukemic	Bld@ Leukemia, Myeloid
AML pz186 (leukemic)|hematopoietic cell|leukemic	Bld@ Leukemia, Myeloid
Primary Cell|CD34 Cultured Cells|none|CD34+	Bld@ CD34+
hiPS-18c|Cell Line|induced pluripotent cells|none|undifferentiated	PSC@ iPS cells
MCF-7 cells	Brs@ MCF-7
Embyonic stem cells	PSC@ Embryonic Stem Cells
LY2|epithelial cell	Brs@ LY2
HEK293T	Kid@ 293
HAc|HAc|astrocytes-cerebellar|ectoderm	Neu@ HAc
NHEK	Epd@ NHEK
Hela|CCL-2	Utr@ HeLa
p50p50	Unc@ Unclassified
HUES64|hES HUES64	PSC@ hESC HUES64
Primary Tissue|Lung|N/A|None	Lng@ Lung
HL-60|promyelocytic leukemia cells, (PMID: 276884)|mesoderm	Bld@ HL-60
Osteobl	Bon@ Osteobl
HL-60|HL-60 cells	Bld@ HL-60
HCT116|HCT116	Dig@ HCT 116
CD34	Bld@ CD34+
HEK 293T	Kid@ 293
LNCaP|prostate	Prs@ LNCAP
81.3|lymphoblastoid	Bld@ 81.3
MCF7|breast|epithelial	Brs@ MCF-7
T74-D|breast cancer	Brs@ T-47D
HeLa|Human cervical cancer cell line	Utr@ HeLa
HEK293T|Human embryonic kidney cell line	Kid@ 293
ZR751|Human Breast Cancer Cells|Luminal	Brs@ ZR-75-1
MDAMB436|Human Breast Cancer Cells|Basal-Like Carcinoma	Brs@ MDA-MB-436
SKBR3|Human Breast Cancer Cells|HER2+	Brs@ SK-BR-3
WI38|Human Embryonic Lung Fibroblasts|Normal Cells	Lng@ WI-38
HMEC|Human Mammary Epithelial Cells|Normal Cells	Brs@ HMEC
CD14++ CD16- monocytes from patient 2|septic disease	Bld@ Monocytes-CD14+
CD14++ CD16- monocytes from patient 1|septic disease	Bld@ Monocytes-CD14+
Jurkat|Jurkat cell line|Acute T Cell Leukemia T lymphocyte	Bld@ Jurkat
CD19+ B cells|peripheral blood B cells|peripheral blood	Bld@ B-Lymphocytes
prostate cancer cell line|R1-D567	Prs@ R1-D567
H1|human embryonic stem cells	PSC@ hESC H1
293T-Rex mock control cells|15-20	Kid@ 293
T-ALL cell line|Jurkat	Bld@ Jurkat
Fibroblasts|Fibroblast primary cell line	Oth@ Fibroblasts
Dendritic cells|Monocyte-derived denditric cells	Bld@ Dendritic Cells
TFH T cell|Human tonsil|CD4+CD45RA-TCRb+PD-1hiCXCR5hiPSGL-1lo	Bld@ CD4-Positive T-Lymphocytes
TEFF T cell|Human tonsil|CD4+CD45RA-TCRb+PD-1loCXCR5loPSGL-1hi	Bld@ CD4-Positive T-Lymphocytes
22Rv1|prostate cancer cell|prostate cancer	Prs@ 22Rv1
HCC2157|breast cancer cells|breast cancer cells	Brs@ HCC2157
H1-embryonic stem cells|H1-embryonic stem cells	PSC@ hESC H1
H1-embryonic stem cells (p75)|H1-embryonic stem cells	PSC@ hESC H1
human epidermal keratinocytes|human epidermal keratinocytes|primary human epidermal keratinocytes isolate from foreskin	Epd@ Keratinocytes
NTKO|Multiple myeloma|Multiple myeloma	Bld@ Multiple Myeloma
primary human hepatocytes|Liver	Liv@ Hepatocytes
H929|Multiple myeloma|Multiple myeloma	Bld@ NCI-H929
ependymomas_PFB_H3K27me3 ChIP|Primary Ependymoma Tumour	Neu@ Ependymoma
HeLa|HeLa cells|HeLa	Utr@ HeLa
A549|human alveolar basal epithelial cells|epithelial cells|alveolar adenocarcinoma|alveolar basal epithelial cells	Lng@ A549
293FT|embryonal kidney cells|embryonal kidney cells	Kid@ 293
CD14++ CD16- monocytes from blood donor 4|CD14++ CD16- monocytes|control participant	Bld@ Monocytes-CD14+
CD14++ CD16- monocytes from blood donor 3|CD14++ CD16- monocytes|control participant	Bld@ Monocytes-CD14+
CD14++ CD16- monocytes from blood donor 2|CD14++ CD16- monocytes|control participant	Bld@ Monocytes-CD14+
CD14++ CD16- monocytes from blood donor 1|CD14++ CD16- monocytes|control participant	Bld@ Monocytes-CD14+
hESC derived anterior foregut (MHG)|hESC derived anterior foregut (MHG)	PSC@ hESC derived mesendodermal cells
hESC derived anterior foregut (PFG)|hESC derived anterior foregut (PFG)	PSC@ hESC derived mesendodermal cells
human erythroid progenitor (HEP)|human erythroid progenitor (HEP)	Bld@ Erythroblasts
pancreatic islets, input|pancreatic islets	Pan@ Pancreatic islets
Granta-519|MCL Cell line	Bld@ GRANTA-519
HeLa cervical cancer cells|HeLa cell	Utr@ HeLa
T47D|T47D breast cancer cell line	Brs@ T-47D
MCF7|MCF7 breast cancer cell line	Brs@ MCF-7
Mll4set HCT116|Colon cancer cell line|human colon cancer cell with MLL4set	Dig@ HCT 116
MDA-MB-134|Mammary epithelial cells|invasive lobular carcinoma cells	Brs@ MDA-MB-134-VI
K562 erythroleukemia cells	Bld@ K-562
Primary Tissue|Adrenal Gland|N/A|iron deficiency, bipolar	Oth@ Adrenal Glands
T47D|T47D cell line	Brs@ T-47D
IMR90|Proliferating H3K27me3 ChIP|proliferating cells	Lng@ IMR-90
CD56+ ectoderm|Cell Line|ectoderm|presumed normal|intermediate	PSC@ hESC derived mesendodermal cells
L428-PAX5|Hodgkin lymphoma cell line	Bld@ L-428
Namalwa|Burkitt lymphoma cell line	Bld@ NAMALWA
Raji|Burkitt lymphoma cell line	Bld@ RAJI
HCT116 cells|HCT116 cells|colorectal carcinoma	Dig@ HCT 116
CD4+CD25-CD45RA- expanded memory conventional T cells|CD4+CD25-CD45RA- expanded memory conventional T cells	Bld@ CD4-Positive T-Lymphocytes
CD4+CD25+CD45RA- expanded memory regulatory T cells|CD4+CD25+CD45RA- expanded memory regulatory T cells	Bld@ CD4-Positive T-Lymphocytes
CD4+CD25-CD45RA+ expanded naive conventional T cells|CD4+CD25-CD45RA+ expanded naive conventional T cells	Bld@ CD4-Positive T-Lymphocytes
HEK293T|Epithelial cells|Embryonic epithelial kidney cell	Kid@ 293
IMR90|IMR90 Human Fetal Lung Fibroblast cell line|Human Fetal Lung Fibroblast cell line	Lng@ IMR-90
Erythroid cells|Erythroid cells	Bld@ Erythroid Cells
MCF-7|MCF-7 Breast Cancer Cells	Brs@ MCF-7
T-47D|T-47D|epithelial cell line derived from a mammary ductal carcinoma.	Brs@ T-47D
HGADFN167|patient forearm skin biopsy, input|fibroblasts|forearm skin biopsy	Epd@ Dermal fibroblast
HGFDFN168|normal forearm skin biopsy, input|fibroblasts|forearm skin biopsy	Epd@ Dermal fibroblast
LNCaP|LNCaP|prostate adenocarcinoma, LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old caucasian male (blood type B+) with confirmed diagnosis of metastatic prostate carcinoma. - ATCC. (Horoszewicz et al. LNCaP Model of Human Prostatic Carcinoma. Cancer Research 43, 1809-1818, April 1983.)|endoderm	Prs@ LNCAP
HA-sp|HA-sp|astrocytes spinal cord|ectoderm	Neu@ HA-sp
CD20+_RO01794|CD20+_RO01794|B cells, African American, draw number 1, newly promoted to tier 2: not in 2011 analysis|mesoderm	Bld@ CD20+
GM12865|GM12865|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12865
HMEC|HMEC|mammary epithelial cells|ectoderm	Brs@ HMEC
H1-neurons|neurons derived from H1 embryonic stem cells, newly promoted to tier 2: not in 2011 analysis|ectoderm	PSC@ hESC derived neural cells
SK-N-SH_RA|SK-N-SH_RA|neuroblastoma cell line, treatment: differentiated with retinoic acid, (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)|ectoderm	Neu@ SK-N-SH
HRE|HRE|renal epithelial cells|mesoderm	Kid@ HRE
GM06990|GM06990|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM06990
BJ|BJ|skin fibroblast, The line was established from skin taken from normal foreskin. - ATCC.  (PMID: 9916803)	Epd@ BJ
MCF-7|MCF-7 breast adenocarcinoma cells, thiostrepton, FOXM1 ChIP|ER-positive breast adenocarcinoma cells	Brs@ MCF-7
MCF-7|MCF-7 breast adenocarcinoma cells, control, FOXM1 ChIP|ER-positive breast adenocarcinoma cells	Brs@ MCF-7
CD14+CD16- classical blood monocytes|CD14+CD16- classical blood monocytes	Bld@ Monocytes-CD14+
Human primary adult proerythroblasts (ProEs)|CD34+ HSPC-derived proerythroblasts|adult bone marrow	Bld@ CD34+
LNCaP prostate cancer cells|prostate cancer cells	Prs@ LNCAP
HuH7 cells, mitotic block and release|HuH7	Liv@ HuH-7
HuH7 cells, asynchronously cycling|HuH7	Liv@ HuH-7
Raji|Human Raji WT|Burkitt's lymphoma	Bld@ RAJI
stimulated PBMCs_STAT4 ChIP-Seq|peripheral blood mononuclear cells (PBMCs)	Bld@ PBMC
stimulated PBMCs_IRF5 ChIP-Seq|peripheral blood mononuclear cells (PBMCs)	Bld@ PBMC
non-stimulated PBMCs_IRF5 ChIP-Seq|peripheral blood mononuclear cells (PBMCs)	Bld@ PBMC
GM12892|GM12892|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12892
GM10847|GM10847|lymphoblastoid, International HapMap Project, CEPH/Utah, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM10847
GM18951|GM18951|lymphoblastoid, International HapMap Project, Japanese in Tokyo, Japan, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM18951
GM15510|GM15510|lymphoblastoid NIGMS Human Genetic Cell Repository, DNA Polymorphism Discovery Resource Collection, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM15510
GM12891|GM12891|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12891
GM18526|GM18526|lymphoblastoid, International HapMap Project, Han Chinese in Beijing, China, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM18526
GM18505|GM18505|lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM18526
GM19099|GM19099|lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM19099
GM19193|GM19193|lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM19193
WI-38|WI-38|Embryonic Lung Fibroblast Cells, hTERT immortalized, includes Raf1 construct|Fibroblast	Lng@ WI-38
non-tumorigenic epithelial cell line MCF 10A|MCF10A	Brs@ MCF 10A
Germinal center B cells|Primary cells	Bld@ B-Lymphocytes
Colon cancer_H3K27ac_ChIPSeq|Colon Cancer	Dig@ Colon cancer
BCBL1|BCBL1 Pleural Effusion Lymphoma (PEL)cell line	Bld@ BCBL1
Kasumi-1 transfection with RUNX1/ETO siRNA|Kasumi-1	Bld@ Kasumi-1
Kasumi-1 transfection with mismatch siRNA|Kasumi-1	Bld@ Kasumi-1
IMR90|human IMR90 fibroblasts|fetal lung fibroblast	Lng@ IMR-90
Primary Tissue|Fetal Renal Cortex, Left|UW|None	Kid@ Kidney Cortex
Primary Tissue|Fetal Renal Pelvis, Left|UW|None	Kid@ Kidney Pelvis
Primary Tissue|Fetal Renal Pelvis, Right|UW|None	Kid@ Kidney Pelvis
erythroblasts|primary human PBMC derived erythroblasts	Bld@ PBMC
H9 hESCs|H9 hESCs	PSC@ hESC H9
HUVEC|Primary endothelial cells	CDV@ HUVEC
Hela S3 cells	Utr@ HeLa
Cell line derived from Burkitt's lymphoma|B cells	Bld@ Lymphoma, B-Cell
AB32|AB32 PR positive transformed normal breast cell line|Breast	Brs@ MCF 10A
Primary Cell|CD25- Th|presumed normal|CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
HL-60|HL-60|Human promyelocytic leukemia cells. (PMID: 276884)	Bld@ HL-60
HRPEpiC|HRPEpiC|Human Retinal Pigment Epithelial Cells|ectoderm	Oth@ HRPEpiC
GM12864|GM12864|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12864
HCFaa|HCFaa|Human Cardiac Fibroblasts-Adult Atrial	CDV@ HCFaa
HMEC|HMEC|Human Mammary Epithelial Cells	Brs@ HMEC
HA-sp|HA-sp|Human astrocytes spinal cord|Astrocytic	Neu@ HA-sp
HEK293|Untransformed embryonic kidney cell line	Kid@ 293
K562 (leukemic)|hematopoietic cell|leukemic	Bld@ K-562
Primary Cell|cultured CD34|none|CD34+	Bld@ CD34+
MCF7, tamoxifen resistance|Tamoxifen resistance MCF7 cell line|Breast cancer cell	Brs@ MCF-7
HelaS3|cervical carcinoma	Utr@ HeLa
MCF-7 breast cancer cell line|MCF-7 breast cancer cells	Brs@ MCF-7
LCL|lymphoblastoid cell line	Bld@ Lymphoblastoid cell line
HeLa S3 cells (ATCC/National Cell Culture Center)|cervix; adenocarcinoma; epithelial	Utr@ HeLa
Kasumi-1 (leukemic)|hematopoietic cell|leukemic	Bld@ Kasumi-1
Caco-2|differentiated Caco-2 cells|human intestinal cell line	Dig@ Caco-2
Embyonic stem cells|H9	PSC@ hESC H9
IMR90|Chromatin IP against p130	Lng@ IMR-90
HEK293T|kidney cell	Kid@ 293
SKMC|SKMC|skeletal muscle cells|mesoderm	Myo@ SKMC
TKO|Multiple myeloma|Multiple myeloma	Bld@ Multiple Myeloma
HeLa S3 (ATCC/Snyder Lab)	Utr@ HeLa
kidney|adult	Kid@ Kidney
T-ALL|MOLT3	Bld@ T-ALL
Monocytes|monocyte	Bld@ Monocytes
UtE-iPS-7|hiPSC	PSC@ iPS cells
UtE-iPS-6|hiPSC	PSC@ iPS cells
UtE-iPS-4|hiPSC	PSC@ iPS cells
UtE-iPS-11|hiPSC	PSC@ iPS cells
MRC-iPS-25|hiPSC	PSC@ iPS cells
AM-iPS-8|hiPSC	PSC@ iPS cells
AM-iPS-6|hiPSC	PSC@ iPS cells
ketatinocytes	Epd@ Keratinocytes
LNCaP|LNCaP cells|Prostate adenocarcinoma	Prs@ LNCAP
Primary Tissue|Bladder|N/A|None	Oth@ Urinary Bladder
NHLF	Lng@ NHLF
HMEC	Brs@ HMEC
293T cells|293T	Kid@ 293
MCF-7|Breast cancer cells	Brs@ MCF-7
Hela	Utr@ HeLa
WA-7|Cell Line|embrionic stem cell|none|undifferentiated	PSC@ hESC WA-7
HeLa|HeLa, ChIP_Seq	Utr@ HeLa
MR4 cells	Bld@ MR4
Hs68	Epd@ Hs 68
HEK293-T	Kid@ 293
kidney|normal	Kid@ Kidney
ZR-75-1|epithelial	Brs@ ZR-75-1
LNCaP|epithelial	Prs@ LNCAP
LNCAP|prostate|epithelial	Prs@ LNCAP
TAM_R|breast cancer	Brs@ MCF-7
HEK293|HEK293 Cells|embryonic kidney	Kid@ 293
high-MYCN-Neuroblastoma patient cells|Neuroblastoma patient cells	Neu@ Neuroblastoma
MPNST cell line 90-8TL|MPNST cells 90-8TL_PDJQ	Neu@ 90-8TL
MPNST cell line 90-8TL|MPNST cells 90-8TL_DMSO	Neu@ 90-8TL
HUES64|dME_shGATA4_3|dME shGATA4	PSC@ hESC derived mesendodermal cells
HUES64|dME_shGATA4_2|dME shGATA4	PSC@ hESC derived mesendodermal cells
HUES64|dME_shGATA4_1|dME shGATA4	PSC@ hESC derived mesendodermal cells
HUES64|dEN_shGATA4_3|dEN shGATA4	PSC@ hESC derived mesendodermal cells
HUES64|dEN_shGATA4_2|dEN shGATA4	PSC@ hESC derived mesendodermal cells
HUES64|dEN_shGATA4_1|dEN shGATA4	PSC@ hESC derived mesendodermal cells
embryonic stem cells, KAP1 ChIP	PSC@ Embryonic Stem Cells
embryonic stem cells, input	PSC@ Embryonic Stem Cells
Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
Induced pluripotent stem cells|Induced pluripotent stem cells	PSC@ iPS cells
Human dermal fibroblast|OCT3/4, SOX2 and KLF4-overexpressed Human dermal fibroblast	Epd@ Dermal fibroblast
LEC-219|Dermal lymphatic endothelium|Dermal lymphatic endothelial cells	Oth@ LEC
LEC|Dermal lymphatic endothelium|Dermal lymphatic endothelial cells	Oth@ LEC
iSLK|Kidney epithelium|Kidney epithelial cells	Kid@ iSLK
BCBL-1|Primary effusion lymphoma|Primary effusion lymphoma B cells	Bld@ BCBL1
Lymphoblastoid cell line|Lymphoblastoid|blood, peripheral vein	Bld@ Lymphoblastoid cell line
HAEC H3K9Me3 SAHA|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
HAEC H3K9Me3 control|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
HAEC H3K9/14ac SAHA|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
HAEC H3K9/14ac control|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
HAEC H3K4Me3 SAHA|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
HAEC H3K4Me3 control|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
--|normal primary dermal fibroblasts|normal primary dermal fibroblasts	Epd@ Dermal fibroblast
MCF-7|mammary gland, adenocarcinoma	Brs@ MCF-7
T47D|breast cancer cells|ER positive breast cancer cells	Brs@ T-47D
androgen-dependent prostate cancer derived cell line LNCaP|prostate cell line	Prs@ LNCAP
MCF-7|Breast cancer cell line MCF-7	Brs@ MCF-7
Human breast cancer cell line|TAMR	Brs@ MCF-7
Human breast cancer cell line|BT474	Brs@ BT-474
Human breast cancer cell line|T47D	Brs@ T-47D
Human breast cancer cell line|ZR75	Brs@ ZR-75-1
Human tumour tissue|BT81585	Oth@ Tumour tissues
Human tumour tissue|NT2350	Oth@ Tumour tissues
Human tumour tissue|NT2304	Oth@ Tumour tissues
MM1.S|MM1S_BRD3|Multiple myeloma	Bld@ MM.1S
MM1.S|MM1S_BRD2|Multiple myeloma	Bld@ MM.1S
Mock-treated K562 erythroleukemia cells	Bld@ K-562
Primary Cell Culture|Fibroblasts, Fetal Skin, Quadriceps, Right|None|NA	Epd@ Fetal skin
Primary Cell Culture|Fibroblasts, Fetal Skin, Biceps, Right|None|NA	Epd@ Fetal skin
Primary Cell Culture|Fibroblasts, Fetal Skin, Upper Back|None|NA	Epd@ Fetal skin
Primary Cell Culture|Fibroblasts, Fetal Skin, Abdomen|None|NA	Epd@ Fetal skin
Primary Cell Culture|Fibroblasts, Fetal Skin, Scalp|None|NA	Epd@ Fetal skin
Primary Cell Culture|Fibroblasts, Fetal Skin, Back|None|NA	Epd@ Fetal skin
ReN-VM|differentiating neural culture	Neu@ ReN-VM
LS174T|LS174T, GATA6 ChIP|colorectal carcinoma	Dig@ LS-174T
SH-SY5Y|FBio-CHD5 expressing SH-SY5Y cells|neuroblastoma cell line	Neu@ SH-SY5Y
LNCaP-pcDNA3.1|pcDNA3.1 cell line	Prs@ LNCAP
LNCaP-ARhi|ARhi cell line	Prs@ LNCAP
LNCaP-ARmo|ARmo cell line	Prs@ LNCAP
HCT116|colorectal carcinoma	Dig@ HCT 116
T47D-MTVL breast cancer cell line|T47D-MTVL breast cancer cell line	Brs@ T-47D
Mutu III|Mutu III Burkitt's Lymphoma cell-line|B-cell line derived from a tumour biopsy	Bld@ Mutu
Human Mammary Epithelial Cells|Mammary epithelial cells	Brs@ Breast cells
SUM185PE|breast cancer cells|breast cancer cells	Brs@ SUM 185PE
U937CM|U937CM cell line (leukemic)|leukemic cell line	Bld@ U-937
Primary Tissue|Spleen|N/A|iron deficiency, bipolar	Oth@ Spleen
HUES64 derived CD184+|Cell Line|endoderm|presumed normal|differentiated	PSC@ hESC derived mesendodermal cells
Primary Cell|CD3 Primary Cells|None|CD3	Bld@ CD3+
CD4+ T cells activated by IL-2|CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
Prostate cancer cell line|VCaP cell line	Prs@ VCaP
CAL-1|CAL-1 cell line	Bld@ CAL1
APL bone marrow blasts|Primary diagnosis	Bld@ Leukemia, Myeloid
M059J|M059J|malignant glioblastoma, glioma, lack DNA-dependent protein kinase activity, deficient in repair of DNA double strand breaks, the cells are negative for glial fibrillary acidic protein (GFAP), tumor specimen taken from a 33 year old|ectoderm	Neu@ M059J
RPMI-7951|RPMI-7951|Human Skin Malignant Melanoma Cells, This is a hyperdiploid human cell line with the modal chromosome number of 49, occurring in 24% of cells. Polyploid cells occurred at 22%, which is high.|ectoderm	Epd@ RPMI-7951
Primary Cell Culture|Variant Human Mammary Epithelial Cells|None|NA	Brs@ Breast cells
HRPEpiC|HRPEpiC|retinal pigment epithelial cells|ectoderm	Oth@ HRPEpiC
GM12864|GM12864|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12864
HCF|HCF|cardiac fibroblasts|mesoderm	CDV@ HCF
AG10803|AG10803|abdominal skin fibroblasts from apparently heathly 22 year old, 8% of the cells examined showing random chromosome loss, 2% showing random chromosome gain, and 2% showing 69,XYY -Coriell	Epd@ AG10803
HCFaa|HCFaa|cardiac fibroblasts- adult atrial|mesoderm	CDV@ HCFaa
HCPEpiC|HCPEpiC|choroid plexus epithelial cells|ectoderm	Neu@ HCPEpiC
HMF|HMF|mammary fibroblasts	Brs@ HMF
HPF|HPF|pulmonary fibroblasts isolated from lung tissue	Lng@ HPF
H9 hESC|RA-mediated differentiating hESC	PSC@ hESC derived neural cells
H9 hESC|Pluripotent hESC	PSC@ hESC H9
H1|Embryonic stem cells	PSC@ hESC H1
H2171|Small Cell Lung Carcinoma	Lng@ NCI-H2171
H128|Small Cell Lung Carcinoma	Lng@ NCI-H128
Alveolar Epithelial type 2 (AT2 cell)|in vitro diffrentiated AT1 cells	Lng@ AT2
Alveolar Epithelial type 2 (AT2 cell)|Primary isolated AT2 cells	Lng@ AT2
MCF-7|siNT_ER_estrogen|breast cancer cells	Brs@ MCF-7
22RV1|prostate cancer cells	Prs@ 22Rv1
Human primary fetal proerythroblasts (ProEs)|CD34+ HSPC-derived proerythroblasts|2-trimester fetal liver	Bld@ CD34+
HPB-ALL|T-cell acute lymphoblastic leukemia cells	Bld@ T-ALL
BT20 cells|breast cancer cell line	Brs@ BT-20
NCIH838 cells|lung cancer cell line	Lng@ NCI-H838
SKBR3 cells|breast cancer cell line	Brs@ SK-BR-3
NCIH441 cells|lung cancer cell line	Lng@ NCI-H441
MCF7 cells|breast cancer cell line	Brs@ MCF-7
HT29 cells|colon cancer cell line	Dig@ HT-29
HCT15 cells|colon cancer cell line	Dig@ HCT-15
SW620 cells|colon cancer cell line	Dig@ SW 620
ZR751 cells|breast cancer cell line	Brs@ ZR-75-1
NCI1703 cells|lung cancer cell line	Lng@ NCI-H1703
non-stimulated PBMCs_STAT4 ChIP-Seq|peripheral blood mononuclear cells (PBMCs)	Bld@ PBMC
Lymphoblastoid cells|HLS554P	Bld@ Lymphoblastoid cells
Acute lymphoblastic leukemia cells with MLL/AF4 translocation, input|RS4;11 ALL cells	Bld@ RS4-11
PBDE|PBDE|peripheral blood-derived erythroblasts|mesoderm	Bld@ PBDE
SH-SY5Y|SH-SY5Y|neuroblastoma clonal subline of the neuroepithelioma cell line SK-N-SH from the 1970 bone marrow biopsy of a 4-year-old girl with metastatic neuroblastoma, trisomy of 1q|ectoderm	Neu@ SK-N-SH
U2OS|U2OS|osteosarcoma from the tibia of a 15 year old, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972, (PMID: 6081590)|mesoderm	Bon@ U2OS
HAEC|HAEC_H3K9Me3_500nM TSA_12h|Primary Human Aortic Endothelial Cells	CDV@ HAEC
HAEC|HAEC_H3K4Me3_500nM TSA_12h|Primary Human Aortic Endothelial Cells	CDV@ HAEC
HAEC|HAEC_H3K9/14ac_500nM TSA_12h|Primary Human Aortic Endothelial Cells	CDV@ HAEC
HAEC|HAEC_H3K9Me3_control|Primary Human Aortic Endothelial Cells	CDV@ HAEC
HAEC|HAEC_H3K4Me3_control|Primary Human Aortic Endothelial Cells	CDV@ HAEC
HAEC|HAEC_H3K9/14ac_control|Primary Human Aortic Endothelial Cells	CDV@ HAEC
Primary Tissue|Fetal Brain|Brain|presumed normal	Neu@ Fetal brain
U87MG|U87MG cell line, 2 million EGFRvIII|glioblastoma	Neu@ U-87 MG
Normal Colon Crypt_H3K4me3_ChIPSeq|Normal Colon Crypt	Dig@ Crypt
Colon cancer_H3K4me3_ChIPSeq|Colon Cancer	Dig@ Colon cancer
Normal Colon Crypt_H3K27ac_ChIPSeq|Normal Colon Crypt	Dig@ Crypt
Normal Colon Crypt_input DNA|Normal Colon Crypt	Dig@ Crypt
Normal Colon Crypt_H3K4me1_ChIPSeq|Normal Colon Crypt	Dig@ Crypt
embryonic carcinoma NCCIT|pluripotent cells	PSC@ NCCIT
LNCap|Prostate Cancer Cell Line	Prs@ LNCAP
K562-WCE|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-RBBP5 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
786-O clear cell renal carcinoma cells|786-O clear cell renal carcinoma cells	Kid@ 786-O
A549|Lung cancer cell line	Lng@ A549
melanoma cell line LOXIMVI|melanoma cell line LOXIMVI|malignant melanoma, lymph node metastasis	Epd@ LOX-IMVI
melanoma cell line SK-MEL-28|melanoma cell line SK-MEL-28|malignant melanoma, noncutaneous metastasis	Epd@ SK-MEL-28
Human Epidermal Melanocytes, adult, lightly pigmented donor (HEMa-LP)|HEMa melanocytes|normal skin	Epd@ Melanocytes
Human Epidermal Melanocytes, neonatal, lightly pigmented donor (HEMn-LP)|HEMn melanocytes|normal skin	Epd@ Melanocytes
MelJuSo|MelJuSo cells|Human skin melanoma cell line	Epd@ MEL-JUSO
keratinocytes|neonatal keratinocytes	Epd@ Keratinocytes
MDA-231|MDA-231_HOTAIR|MDA-231 cell line overexpressing human HOTAIR	Brs@ MDA-MB-231
HeLa|HeLa_Terc|HeLa S3 cells overexpressing human telomerase and TERC	Utr@ HeLa
HeLa S3 cells|Human epithelial carcinoma cell line	Utr@ HeLa
Primary Tissue|Fetal Renal Cortex, Right|UW|None	Kid@ Kidney Cortex
GM12878|lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus|mesoderm	Bld@ GM12878
GM12892|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12892
IMR90|fetal lung fibroblast IMR90 cell line|fetal lung fibroblast	Lng@ IMR-90
Input ChIP-seq CD34+ progenitors BIO|Hematopoietic Stem &amp; Progenitor Cells	Bld@ CD34 Hematopoietic stem cells
Input ChIP-Seq CD34 erythroid BIO|Pro-erythroblasts	Bld@ CD34+
U2OS|U2OS|Osteosarcoma from the tibia of a 15 year old human female, J. Ponten and E. Saksela derived this line (originally 2T) in 1964 from a moderately differentiated sarcoma, viruses were not detected during co-cultivation with WI-38 cells or in CF tests against SV40, RSV or adenoviruses, mycoplasma contamination was detected and eliminated in 1972. (PMID: 6081590)|mesoderm	Bon@ U2OS
Pluripotent hESC (H9)|H9 hESC	PSC@ hESC H9
BJ|BJ|skin fibroblast, The line was established from skin taken from normal foreskin. - ATCC.  (PMID: 9916803)|ectoderm	Epd@ BJ
HEK293|HEK293|embryonic kidney. (PMID: 11967234)|endoderm	Kid@ 293
GM12872|GM12872|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12872
GM12875|GM12875|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12875
MCF-7|MCF-7|mammary gland, adenocarcinoma. (PMID: 4357757)	Brs@ MCF-7
AG10803|AG10803|abdominal skin fibroblasts from apparently heathly 22 year old|mesoderm	Epd@ AG10803
GM12874|GM12874|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12874
AG09309|AG09309|adult toe fibroblast from apparently healthy 21 year old|mesoderm	Epd@ AG09309
HCM|HCM|Human Cardiac Myocytes|mesoderm	CDV@ HCM
GM12873|GM12873|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12873
AG09319|AG09319|gum tissue fibroblasts from apparently heathly 24 year old|mesoderm	Oth@ AG09319
NHDF-neo|NHDF-neo|Neonatal Human Dermal Fibroblasts|mesoderm	Epd@ NHDF
NB4|NB4|acute promyelocytic leukemia cell line. (PMID: 1995093)	Bld@ NB-4
HCF|HCF|Human Cardiac Fibroblasts|mesoderm	CDV@ HCF
GM12878|GM12878|lymphoblastoid, International HapMap Project - CEPH/Utah - European Caucasion, Epstein-Barr Virus|mesoderm	Bld@ GM12878
HVMF|HVMF|Human Villous Mesenchymal Fibroblast Cells	Plc@ HVMF
K562|K562_cMYC|chronic myeloid leukemia	Bld@ K-562
HepG2|HepG2_PolII|liver carcinoma cells	Liv@ Hep G2
HepG2|HepG2_cMYC|liver carcinoma cells	Liv@ Hep G2
HepG2|liver carcinoma cells|carcinoma cells|liver	Liv@ Hep G2
HepG2|liver carcinoma cells|liver carcinoma cells	Liv@ Hep G2
NB4|NB4 cells (leukemic), untreated, HpaII NA-Seq|leukemic cells	Bld@ NB-4
NB4|NB4 cells (leukemic), untreated, NlaIII NA-Seq|leukemic cells	Bld@ NB-4
K562|K562|leukemia|The continuous cell line K-562 was established by Lozzio and Lozzio from the pleural effusion of a 53-year-old female with chronic myelogenous leukemia in terminal blast crises. - ATCC	Bld@ K-562
chronic myeloid leukemia cell line|K562 cell line	Bld@ K-562
Primary Tissue|Fetal Lung|Lung|presumed normal	Lng@ Fetal lung
breast adenocarcinoma cell line|MCF7 cell line stably expressing HA ER E2F1C mutant	Brs@ MCF-7
T47D breast cancer cells|T47D breast cancer cells, non-treated	Brs@ T-47D
T47D breast cancer cells|T47D breast cancer cells, E2 treated	Brs@ T-47D
MCF-7 breast cancer cells|MCF-7 breast cancer cells, non-treated	Brs@ MCF-7
MCF-7 breast cancer cells|MCF-7 breast cancer cells, E2 treated	Brs@ MCF-7
Hematopoietic Stem &amp; Progenitor Cells, MEIS1 ChIP|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
aTconv cells from PBMC, normal|aTconv cells	Bld@ PBMC
Human Adipocytes|Simpson Golabi Behmel Syndrome (SGBS) human adi- pocytes	Adp@ SGBS
blood cells|Jurkat cells	Bld@ Jurkat
blood cells|CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
CMK|CMK Cells	Bld@ CMK
Embyonic stem cells|BGO3 (feeder free)	PSC@ hESC BG03
T47D breast cancer cells|T47D breast cancer cells	Brs@ T-47D
ECC1 breast cancer cells|ECC1 breast cancer cells	Utr@ ECC-1
Ishikawa breast cancer cells|Ishikawa breast cancer cells	Utr@ Ishikawa
Caco-2|proliferating Caco-2 cells|human intestinal cell line	Dig@ Caco-2
neuroblastoma cell line SH-SY5Y|neuroblastoma cell line	Neu@ SH-SY5Y
H1|embryonic stem cells|embryonic stem cell	PSC@ hESC H1
pancreatic islet cells|Purified pancreatic islets	Pan@ Pancreatic islets
H1 (WA01)|Cell Line|n/a|None|undifferentiated	PSC@ hESC H1
MCF7|human breast cancer cell	Brs@ MCF-7
MCF-7|epithelial cell	Brs@ MCF-7
OCIAML3|myelomonocyte|blood|acute myeloid leukemia	Bld@ OCI-AML3
HCCA|IHEC38|Human Common Carotid Artery|Human Common Carotid Artery (HCCA) from 68 years old Japanese female donor (cause of death Alive,sample from CEA operation) provided by Brain Attack Center, Ota Memorial Hospital (Hiroshima, Japan) (Lot. CRIF2C)|aortic endothelial cells|the endothelium of blood vessels|carotid stenosis	CDV@ Carotid Arteries
HEEpiC|HEEpiC|esophageal epithelial cells|endoderm	Dig@ HEEpiC
HPAF|HPAF|pulmonary artery fibroblasts|mesoderm	CDV@ HPAF
LNCaP	Prs@ LNCAP
501Mel|501Mel|melanoma	Epd@ 501A
T98G|Brain|Glioblastoma|Brain	Neu@ T98G
451Lu|451Lu|melanoma	Epd@ 451Lu
prefrontal cortex	Neu@ Prefrontal Cortex
LCL|LCL	Bld@ Lymphoblastoid cell line
SKBr3|SKBr3|breast cancer epithelial cells	Brs@ SK-BR-3
HT29|Colon Carcinoma|Colon Carcinoma	Dig@ HT-29
flag-Anp32e-HeLa	Utr@ HeLa
HeLa|Hela_TFAM_20G2C12	Utr@ HeLa
HeLa|Hela_Input_20G2C12	Utr@ HeLa
IMR90|IMR90_MeCP2	Lng@ IMR-90
Fibrobl_GM03348|Fibrobl_GM03348|skin fibroblast	Epd@ Fibrobl GM03348
HSMMtube	Myo@ HSMM
CD20+	Bld@ CD20+
CD20+_RO01794	Bld@ CD20+
REH|REH	Bld@ REH
K562|K562	Bld@ K-562
Melanomas|WM262	Epd@ WM262
HCT-116	Dig@ HCT 116
K562-C/EBPA|K562-C/EBPA|K562-C/EBPA	Bld@ K-562
Th1 cells|Th1	Bld@ Th1 Cells
GM12878|lymphoblastoid cells|lymphoblastoid cells	Bld@ GM12878
COLO-320|colorectal cancer cells	Dig@ COLO 320
Primary Tissue|Fetal lung|lung|none	Lng@ Fetal lung
primary cells|primary keratinocyte|keratinocytes|epidermis	Epd@ Keratinocytes
HL60|Blood|N/A|N/A|Cancer	Bld@ HL-60
K562|Blood|N/A|N/A|Cancer	Bld@ K-562
MUTZ-3|myeloblast	Bld@ MUTZ-3
N/A|N/A|N/A|N/A|N/A	Unc@ Unclassified
MCF-10a|breast|epithelial	Brs@ MCF 10A
T-47D|breast cancer	Brs@ T-47D
Day 8 differentiated cells|Day 8 differentiated cells	PSC@ hESC derived neural cells
undifferentiated hESCs|undifferentiated hESCs	PSC@ Embryonic Stem Cells
A673|A673|muscle|Ewing sarcoma	Myo@ A-673
RJ2.2.5 cells|RJ2.2.5 cells	Bld@ RAJI
ZR-75-1|Breast Cancer|Breast	Brs@ ZR-75-1
BT-549|Breast Cancer|Breast	Brs@ BT-549
MDA-MB-468|Breast Cancer|Breast	Brs@ MDA-MB-468
GIST48|GIST48 Cells|GIST cell line	Dig@ GIST-48
Vertebral Cancer of Prostate (VCaP)|VCaP_SUMO2/3_R1881|bone metastasis of prostate cancer	Prs@ VCaP
Vertebral Cancer of Prostate (VCaP)|VCaP_SUMO2/3_EtOH|bone metastasis of prostate cancer	Prs@ VCaP
CyT49|Hepatic endoderm|gut tube derived hepatic endoderm	PSC@ hESC derived mesendodermal cells
CyT49|Definitive Endoderm|hESC derived definitive endoderm	PSC@ hESC derived mesendodermal cells
Hematopoietic progenitor cells|CD34+ cells	Bld@ CD34 Hematopoietic stem cells
MCF-7|ChIP-seq_Input_siFOXA1_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_ER_siCTRL_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_Input_siCTRL_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_FoxA1_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_FoxA1_TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_FoxA1_E2|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_FoxA1_Vehicle|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_p65_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_p65_TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_p65_E2|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_p65_Vehicle|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_ER_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_ER_TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_ER_E2|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_ER_Vehicle|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_Input_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_Input_TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_Input_E2|ER Positive Breast Cancer Cells	Brs@ MCF-7
MCF-7|ChIP-seq_Input_Vehicle|ER Positive Breast Cancer Cells	Brs@ MCF-7
low-MYCN-Neuroblastoma patient cells|Neuroblastoma patient cells	Neu@ Neuroblastoma
Small Cell Lung Carcinoma|NCI-H82	Lng@ NCI-H82
Small Cell Lung Carcinoma|NCI-H69	Lng@ NCI-H69
Small Cell Lung Carcinoma|GLC16	Lng@ GLC16
GBM1B|DNA from glioblastoma stem cells|glioblastoma stem cell line	Neu@ GBM1-HAM
GBM1A|DNA from glioblastoma stem cells|glioblastoma stem cell line	Neu@ GBM1-HAM
tonsil B cell (nave)|tonsil	Bld@ B-Lymphocytes
tonsil B cell (GC)|tonsil	Bld@ B-Lymphocytes
Ewing sarcoma cell line A673|A673 after 48 hrs shFLI1	Myo@ A-673
Ewing sarcoma cell line A673|A673 after 48 hrs shGFP	Myo@ A-673
Ewing sarcoma cell line SKMNC|SKMNC after 48 hrs shFLI1	Bon@ SKMNC
Ewing sarcoma cell line SKMNC|SKMNC after 48 hrs shGFP	Bon@ SKMNC
HEK 293T|dCas9-noED +VEGFA TS3 gRNA|kidney	Kid@ 293
CD4+ T cells|Primary CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
SKMEL5|melanoma cell line|melanoma cell line	Epd@ SK-MEL-5
Diffuse Large B-Cell Lymphoma|TOLEDO	Bld@ Toledo
Diffuse Large B-Cell Lymphoma|LY4	Bld@ OCI-LY4
Diffuse Large B-Cell Lymphoma|LY3	Bld@ OCI-LY-3
Diffuse Large B-Cell Lymphoma|HBL1	Bld@ HBL-1
Diffuse Large B-Cell Lymphoma|DHL6	Bld@ SU-DHL-6
liver|Alcoholic steatohepatitsis (ASH)	Liv@ Liver
adipocyte_RNAPII ChIP-seq TNF|SGBS adipocyte D10	Adp@ Adipocytes
adipocyte_RNAPII ChIP-seq Vehicle|SGBS adipocyte D10	Adp@ Adipocytes
SW480|SW480R|Epithelial tumor cells isolated from human colorectal adenocarcinoma	Dig@ SW 480
embryonic stem cells, ZNF486 ChIP	PSC@ Embryonic Stem Cells
embryonic stem cells, H3K4me3 ChIP	PSC@ Embryonic Stem Cells
HUVEC cells (ATCC, CRL1730)|HUVEC Cells	CDV@ HUVEC
HCT116|DKO1 RNA polymerase II ChIP-seq|human colorectal cancer cell line	Dig@ HCT 116
HCT116|DKO1 H3K4me3 ChIP-seq|human colorectal cancer cell line	Dig@ HCT 116
HCT116|DKO1 H3K27ac ChIP-seq|human colorectal cancer cell line	Dig@ HCT 116
immortalized primary fetal human epididymis cells|SV-40 transformed primary human fetal epididymis cells	Gon@ Epididymis
Hematopoietic Stem &amp; Progenitor Cells|CD133+ expanded UCB	Bld@ Hematopoietic Stem Cells
SF8628|Pediatric, K27M mutated DIPG cells treated with DMSO for 72h, H3K27me3 ChIP|pons	Neu@ SF8628
SF8628|Pediatric, K27M mutated DIPG cells treated with DMSO for 24h, H3K27me3 ChIP|pons	Neu@ SF8628
SF8628|Pediatric, K27M mutated DIPG cells treated with DMSO for 24h, input|pons	Neu@ SF8628
SF8628|Pediatric, K27M mutated DIPG cells treated with GSKJ4 for 72h, H3K27me3 ChIP|pons	Neu@ SF8628
SF8628|Pediatric, K27M mutated DIPG cells treated with GSKJ4 for 24h, H3K27me3 ChIP|pons	Neu@ SF8628
Human primary fetal liver proerythroblasts (ProEs), EZH2 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), EZH1 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
PANC1|PANC1 Pancreatic cancer cell line	Pan@ PANC-1
GM19147|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19114|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
hESCs differentiated into pancreatic lineage|hESCs differentiated into pancreatic lineage	PSC@ hESC derived mesendodermal cells
NTERA2 pluripotent stem cell line|NTERA2	PSC@ NTERA-2
LNCaP|Pol II ChIP-seq (TBBz)|Prostate Carcinoma Cells	Prs@ LNCAP
HEK293T|HEK293T_egfa-t1 sgRNA	Kid@ 293
HCT116|HCT116 colon cancer cell line	Dig@ HCT 116
MCF-7|MCF-7, untreated, ChIP input|mammary adenocarcinoma cell line	Brs@ MCF-7
MCF-7|MCF-7, untreated, PSF ChIP|mammary adenocarcinoma cell line	Brs@ MCF-7
CS1AN|CSB_N20|Transformed Skin fibroblasts	Epd@ CS1AN
CS1AN|CSB_GFP|Transformed Skin fibroblasts	Epd@ CS1AN
CS1AN|CSB_input|Transformed Skin fibroblasts	Epd@ CS1AN
CS1AN|CS1AN_N20|Transformed Skin fibroblasts	Epd@ CS1AN
CS1AN|CS1AN_GFP|Transformed Skin fibroblasts	Epd@ CS1AN
CS1AN|CS1AN_input|Transformed Skin fibroblasts	Epd@ CS1AN
NCHA2|NCHA2|HIV-1 latency T cell line	Bld@ NCHA
NCHA1|NCHA1|HIV-1 latency T cell line	Bld@ NCHA
ACH2|ACH2|HIV-1 latency T cell line	Bld@ ACH-2
A3.01|A3.01|CD4+ T cell line	Bld@ CD4-Positive T-Lymphocytes
Akata|Akata BL cell line_with_acyclovir|B lymphocytes	Bld@ Akata
Akata|Akata BL cell line|B lymphocytes	Bld@ Akata
H1-embryonic stem cells (p69)|H1-embryonic stem cells	PSC@ hESC H1
C-FA-iPSC#1|Induced pluripotent stem cells from human fibroblasts from patients with FA disease	PSC@ iPS cells
FA-iPSC#8|Induced pluripotent stem cells from human fibroblasts from patients with FA disease	PSC@ iPS cells
FA-iPSC#5|Induced pluripotent stem cells from human fibroblasts from patients with FA disease	PSC@ iPS cells
C-FA-iPSC#2|Induced pluripotent stem cells from human fibroblasts from patients with FA disease	PSC@ iPS cells
human Neural Stem Cells|human Neural Stem Cells (hNSCs)	Neu@ Neural Stem Cells
CUTLL1|ChIP-SEQ_JMJD3 CUTLL1|human T cell leukemia cells	Bld@ CUTLL1
CUTLL1|ChIP-SEQ_Input CUTLL1|human T cell leukemia cells	Bld@ CUTLL1
CUTLL1|ChIP-SEQ_H3K27me3_CUTLL1_GSKJ4|human T cell leukemia cells	Bld@ CUTLL1
CUTLL1|ChIP-SEQ_H3K27me3_CUTLL1_shRENILLA|human T cell leukemia cells	Bld@ CUTLL1
CUTLL1|ChIP-SEQ_H3K27me3_CUTLL1_shJMJD3|human T cell leukemia cells	Bld@ CUTLL1
Human dermal fibroblast|OCT3/4, SOX2-overexpressed Human dermal fibroblast	Epd@ Dermal fibroblast
NT2|human embryonic carcinoma cells|human embryonic carcinoma cells	PSC@ NT2-D1
Vertebral Cancer of Prostate (VCaP)|VCaP_FOXA1_R1881|bone metastasis of prostate cancer	Prs@ VCaP
Vertebral Cancer of Prostate (VCaP)|VCaP_FOXA1_EtOH|bone metastasis of prostate cancer	Prs@ VCaP
Vertebral Cancer of Prostate (VCaP)|VCaP_PIAS1_R1881|bone metastasis of prostate cancer	Prs@ VCaP
Vertebral Cancer of Prostate (VCaP)|VCaP_PIAS1_EtOH|bone metastasis of prostate cancer	Prs@ VCaP
Vertebral Cancer of Prostate (VCaP)|VCaP_AR_R1881|bone metastasis of prostate cancer	Prs@ VCaP
HeLa|HeLa cells|C-terminal FLAG-tagged H3.3 stably expressing HeLa	Utr@ HeLa
fetal livers cells|fetal liver derived erythroid cells|Fetal (50100-day gestation)	Liv@ Liver
twin 2_euploid_fetal primary fibroblasts_DNaseI|Fetal primary fibroblasts|Euploid	Oth@ Fibroblasts
twin 1_T21_fetal primary fibroblasts_DNaseI|Fetal primary fibroblasts|Trisomy 21	Oth@ Fibroblasts
keratinocytes_overexpressing SNAI2_differentiation medium_SNAI2-ChIPseq|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_overexpressing SNAI2_growth medium_SNAI2-ChIPseq|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_overexpressing LACZ_growth medium_SNAI2-ChIPseq|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_SNAI2 knockdown_growth medium_SNAI2-ChIPseq|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_control shRNA_growth medium_SNAI2-ChIPseq|Human keratinocytes	Epd@ Keratinocytes
RD|RD human cell line	Myo@ RD
CAL-1 plasmacytoid dendritic cells|plasmacytoid dendritic cell	Bld@ CAL1
Skin fibroblast cells|Primary Dermal Fibroblast|skin, unspecified	Epd@ Dermal fibroblast
hASC_anti_EBF1|Adipose stromal cell (ASC) adipocyte	Adp@ Adipose stromal cell
hASC_Control_IgG|Adipose stromal cell (ASC) adipocyte	Adp@ Adipose stromal cell
IMR90|IMR90_input|human primary lung fibroblasts	Lng@ IMR-90
IMR90|IMR90_macroH2A1 ChIP|human primary lung fibroblasts	Lng@ IMR-90
CyT49|Hepatic endoderm|hESC derived hepatic endoderm	PSC@ hESC derived mesendodermal cells
IIDP/donor 790|Islet|Cadaveric Islet	Pan@ Pancreatic islets
Lonza CC-2511|normal dermal fibroblasts|normal dermal fibroblasts	Epd@ Dermal fibroblast
SW480|SW480|Colon cancer	Dig@ SW 480
Colo741|Colon Carcinoma|Colon Carcinoma	Dig@ COLO 741
TB40-E HCMV strain infected CD34+ cells|Human hematopoietic stem cells CD34+ freshly purified|5 days of HCMV infection	Bld@ CD34 Hematopoietic stem cells
THP-1|THP-1 cells polarized towards M1-macrophages using LPS	Bld@ Macrophages
HMLE_Twist3D_H3K4me3|human mammary epithelial cells	Brs@ HMLE
HMLE_Twist3D_H3K27me3|human mammary epithelial cells	Brs@ HMLE
HMLE_Parental_H3K27me3|human mammary epithelial cells	Brs@ HMLE
Prostate cancer cell line LNCaP|LNCaP	Prs@ LNCAP
MCF7|MCF7_WT_input|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_WT_BAF155_ChIP|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_mut_input|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_mut_BAF155_ChIP|breast cancer cells	Brs@ MCF-7
U937|U937 cells containing empty expression vector, grown for 48 hours before harvest|Established cell culture from histiocytic lymphoma|histiocytic lymphoma	Bld@ U-937
HS578T|breast cancer cells|triple negative breast cancer cells	Brs@ Hs 578T
MDA-MB-231|breast cancer cells|triple negative breast cancer cells	Brs@ MDA-MB-231
human aortic endothelial cells|human aortic endothelial cells	CDV@ HAoEC
Lymphoblast Cell Lines|EBV-infected B Lymphocytes	Bld@ B-Lymphocytes
ChIP-Seq Analysis of NF-kB p65 in KB Cells	Utr@ KB
ChIP-Seq Analysis of H3K9me3 in KB Cells	Utr@ KB
ChIP-Seq Analysis of H3K9Ac in KB Cells	Utr@ KB
ChIP-Seq Analysis of RNA Pol II in KB Cells	Utr@ KB
ChIP-Seq Analysis of CDK6 in KB Cells	Utr@ KB
pancreatic islets, H3K36me3 ChIP|pancreatic islets	Pan@ Pancreatic islets
pancreatic islets, H3K27ac ChIP|pancreatic islets	Pan@ Pancreatic islets
Human tracheal epithelial cells|epithelia|trachea|adult	Lng@ Tracheal epithelial cells
HeLa S3|HeLa S3_FOXM1 ChIP|epithelial	Utr@ HeLa
Endometrial stromal cells|Primary endometrial stromal cells	Utr@ Endometrial stromal cells
Human tumour tissue|NT2079	Oth@ Tumour tissues
Human tumour tissue|NT2229	Oth@ Tumour tissues
Human tumour tissue|Met_T4	Oth@ Tumour tissues
Human tumour tissue|Met_T3	Oth@ Tumour tissues
Human tumour tissue|Met_T1	Oth@ Tumour tissues
Human tumour tissue|BT81583	Oth@ Tumour tissues
Human tumour tissue|NT2171	Oth@ Tumour tissues
Human tumour tissue|NT2138	Oth@ Tumour tissues
Human tumour tissue|NT2289	Oth@ Tumour tissues
Human tumour tissue|NT2360	Oth@ Tumour tissues
Human tumour tissue|NT2433	Oth@ Tumour tissues
Human tumour tissue|CX627219_T4	Oth@ Tumour tissues
Human tumour tissue|BT82590	Oth@ Tumour tissues
Human tumour tissue|BT82597	Oth@ Tumour tissues
Diffuse Large B-Cell Lymphoma|primary normal tonsil	Bld@ Lymphoma, B-Cell
Diffuse Large B-Cell Lymphoma|primary normal lymph node	Bld@ Lymphoma, B-Cell
GM12878|lymphoblastoid cells	Bld@ GM12878
AC16|Pol II_ChIP-seq_TNF|cardiomyocytes	CDV@ AC16
AC16|Pol II_ChIP-seq_Vehicle|cardiomyocytes	CDV@ AC16
T47D|T47D cells|breast cancer cell line	Brs@ T-47D
U-2932|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ U-2932
SU-DHL6|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ SU-DHL-6
SU-DHL4|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ SU-DHL-4
SU-DHL2|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ SU-DHL-2
SU-DHL10|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ SU-DHL-10
OCI-Ly7|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ OCI-LY-7
OCI-Ly3|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ OCI-LY-3
OCI-Ly19|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ OCI-LY-19
OCI-Ly10|B cells|diffuse large B cell lymphoma (DLBCL)	Bld@ OCI-LY-10
5-aza-2-deoxycytidine-treated K562 erythroleukemia cells	Bld@ K-562
human myotube|myotube	Myo@ Myotube
HEK293T17 cell culture	Kid@ 293
IB4 LCL|Lymphoblastoid Cell Lines (IB4 LCL)	Bld@ IB4
H295R/TR SF-1 cells|input DNA|adrenocortical tumor	Oth@ NCI-H295R
IMR90|IMR90, Nup98 ChIP|lung fibroblasts	Lng@ IMR-90
C57BL/6|human epidermal keratinocytes|human epidermal keratinocytes	Epd@ Keratinocytes
C57BL/6|human dermal fibroblasts|human dermal fibroblasts	Epd@ Dermal fibroblast
K562|K562_TALE-3XFlag_ChIP|erythrocytic leukaemia cells	Bld@ K-562
Bone marrow|Cell line|Chronic myelogenous leukemia (CML)	Bld@ K-562
Primary cells	Unc@ Unclassified
C4-12/Flag.ER|Genomic DNA	Brs@ MCF-7
C4-12/Flag.ER|ChIP'ed DNA	Brs@ MCF-7
HEK293|Human Embryonic Kidney cells	Kid@ 293
PaTu8988S|PaTu8988S|pancreatic ductal adenocarcinoma	Pan@ PA-TU-8988S
CD4+CD25highCD127low/- Treg cells|CD4+CD25highCD127low/- Treg|expanded human FOXP3-losing Treg cells|Peripheral blood mononuclear cells (PBMC)	Bld@ CD4-Positive T-Lymphocytes
CD4+CD25highCD127low/- Treg cells|CD4+CD25highCD127low/- Treg|expanded human FOXP3+ Treg cells|Peripheral blood mononuclear cells (PBMC)	Bld@ CD4-Positive T-Lymphocytes
lymphoblastoid cells|IR treated lymphoblastoid cells	Bld@ Lymphoblastoid cells
lymphoblastoid cells|nutlin-3 treated lymphoblastoid cells	Bld@ Lymphoblastoid cells
IMR90|Senescent H3K27me3 ChIP|senescent cells	Lng@ IMR-90
IMR90|Senescent Histone 3 ChIP|senescent cells	Lng@ IMR-90
IMR90|Proliferating Histone 3 ChIP|proliferating cells	Lng@ IMR-90
in vitro derived endoderm|HUES64 derived day 5 endoderm	PSC@ hESC derived mesendodermal cells
MDA-MB-231|breast cancer cells|breast cancer cells	Brs@ MDA-MB-231
T-47D|breast cancer cells|breast cancer cells	Brs@ T-47D
--|Patient AML cells|Patient AML cells	Bld@ Leukemia, Myeloid
U2OS_A477T|Human osteosarcoma cell line	Bon@ U2OS
U2OS_GRalpha|Human osteosarcoma cell line	Bon@ U2OS
DAOY|DAOY cells|medulloblastoma cell line	Neu@ Daoy
SNU216|SNU216|gastric cancer cell	Dig@ SNU-216
HeLa cells transfected with INO80 siRNA|HeLa-S3 cells	Utr@ HeLa
Prostate cancer patient b	Prs@ Prostate cancer
Prostate cancer patient a	Prs@ Prostate cancer
Prostate cancer patient d	Prs@ Prostate cancer
Prostate cancer patient c	Prs@ Prostate cancer
Prostate cancer patient b|non-malignant adjacent tissues	Prs@ Prostate cancer
Prostate cancer patient a|non-malignant adjacent tissues	Prs@ Prostate cancer
H1|H1 embryonic stem cells|Embryonic stem cells	PSC@ hESC H1
IMR90|IMR90 fibroblasts|Primary lung fibroblasts	Lng@ IMR-90
EBV-Transformed peripheral blood B lymphocytes|EBV-Transformed B lymphocytes|whole blood	Bld@ B-Lymphocytes
eCenH3 HeLa S3|eCenH3 ChIP|Cervical cancer	Utr@ HeLa
eCenH3 HeLa S3|eCenH3 MNase input|Cervical cancer	Utr@ HeLa
HeLa S3|WT CenH3 ChIP|Cervical cancer	Utr@ HeLa
HeLa S3|WT MNase input|Cervical cancer	Utr@ HeLa
SKOV-3 cells|SKOV-3 cells|ovarian carcinoma cell line	Gon@ SK-OV-3
WI38|ras_SUMO1_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_SUMO1_ChIPSeq|primary fibroblasts	Lng@ WI-38
Acute lymphoblastic leukemia cells with MLL/AF4 translocation|SEM	Bld@ SEM
Th2|Th2|primary Th2 T cells|mesoderm	Bld@ Th2 Cells
Th17|Th17|T helper cells expressing IL-17, primary pheresis of single normal subject|mesoderm	Bld@ Th17 Cells
CD4+_Naive_Wb11970640|CD4+_Naive_Wb11970640|CD4+ naive sorted cells, donor is Caucasian, male 26 year old, primary pheresis of single normal subject|mesoderm	Bld@ CD4+
NHBE_RA|NHBE_RA|bronchial epithelial cells with retinoic acid	CDV@ NHBE
GM04503|GM04503|adult twin pair fibroblasts, monozygotic twin of GM04504	Epd@ GM04503
GM04504|GM04504|adult twin pair fibroblasts, monozygotic twin of GM04503, 13% of the cells examined show random chromosome loss	Epd@ GM04504
bone_marrow_MSC|bone_marrow_MSC|These cells are primary fibroblastoid cells obtained from human bone marrow of normal donors as described in Roecklein and Torok-Storb, 1995 Blood 85:997-1005.	Oth@ Mesenchymal stem cells
Th1_Wb54553204|Th1_Wb54553204|Th1 cells in vivo isolation, donor is Caucasian, male 33 year old, primary pheresis of single normal subject|mesoderm	Bld@ Th1 Cells
Th1_Wb33676984|Th1_Wb33676984|Th1 cells in vivo isolation|mesoderm	Bld@ Th1 Cells
HMVEC-dAd|HMVEC-dAd|adult dermal microvascular endothelial cells.	CDV@ HMVEC
Treg_Wb78495824|Treg_Wb78495824|T regulatory cells in vivo isolation|mesoderm	Bld@ T-Lymphocytes, Regulatory
PrEC|PrEC|prostate epithelial cell line|epithelial	Prs@ PrEC
Th2_Wb54553204|Th2_Wb54553204|Th2 cells in vivo isolation, donor is Caucasian, male 33 year old, primary pheresis of single normal subject|mesoderm	Bld@ Th2 Cells
HGADFN167|patient forearm skin biopsy, lamin ChIP|fibroblasts|forearm skin biopsy	Epd@ Forearm skin
HGFDFN168|normal forearm skin biopsy, lamin ChIP|fibroblasts|forearm skin biopsy	Epd@ Forearm skin
HGADFN167|patient forearm skin biopsy, H3K27me3 ChIP|fibroblasts|forearm skin biopsy	Epd@ Forearm skin
HGFDFN168|normal forearm skin biopsy, H3K27me3 ChIP|fibroblasts|forearm skin biopsy	Epd@ Forearm skin
MDA-MB-231|MDA-MB-231 breast cancer cells|breast cancer cells	Brs@ MDA-MB-231
SK-N-MC|neuroepithelioma cell line derived from a metastatic supra-orbital human brain tumor, SK-N-MC was isolated in September of l971 and was found to have moderate dopamine - beta - hydroxylase activity as well as formaldehyde induced fluorescence indicative of intracellular catecholamines. - ATCC. (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)|ectoderm	Neu@ SK-N-MC
WERI-Rb-1|WERI-Rb-1|retinoblastoma (PMID: 844036)|ectoderm	Oth@ WERI-Rb-1
HBMEC|HBMEC|brain microvascular endothelial cells|mesoderm	CDV@ HBMEC
GM12875|GM12875|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12875
HL-60|HL-60|promyelocytic leukemia cells, (PMID: 276884)|mesoderm	Bld@ HL-60
GM12866|GM12866|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed.|mesoderm	Bld@ GM12866
AG09319|AG09319|gum tissue fibroblasts from apparently heathly 24 year old	Oth@ AG09319
AG09309|AG09309|adult toe fibroblast from apparently healthy 21 year old, 7% of the cells examined showing random chromosome loss/gain -Coriell	Epd@ AG09309
Urothelia|Urothelia|primary ureter cell culture of urothelial cells derived from a 12 year-old girl and immortalized by transfection with a temperature-sensitive SV-40 large T antigen gene	Oth@ Urothelia
ECC-1|ECC-1|epithelial cell line derived from an endometrium adenocarcinoma, fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes|endoderm	Utr@ ECC-1
Ishikawa|Ishikawa|endometrial adenocarcinoma	Utr@ Ishikawa
GM13976|GM13976|lymphoblastoid cell line, clinically normal; monozygotic twin sister with Cornelia De Lange syndrome is GM13977|mesoderm	Bld@ GM13976
GM10266|GM10266|lymphoblastoid cell line, De Lange phenotype; developmental delay; profound retardation; seizures; 3 cousins are also affected; 46,XY,-22,+der (22)t(3;22)(q25.3;p12)|mesoderm	Bld@ GM10266
GM10248|GM10248|lymphoblastoid cell line, Clinically normal; 4 paternal cousins have Cornelia de Lange syndrome; 46,XY, t(3;22)(q25.3;p12)|mesoderm	Bld@ GM10248
GM20000|GM20000|lymphoblastoid cell line, De Lange phenotype; developmental delay; profound retardation|mesoderm	Bld@ GM20000
Heart_OC|Heart_OC|Primary frozen heart tissue from NICHD donor IDs 1104 (Rep B1 DNase), 602 (Rep B2 DNase), 1442 (Rep B3 DNase), 1863 (Rep B1 FAIRE), 4548 (Rep B2 FAIRE)	CDV@ Heart
GM13977|GM13977|lymphoblastoid cell line, Clinically affected; microcephaly; low frontal hairline; synophris; penciled arched eyebrows; short nose; crescent shaped mouth; hirsutism; micromelia; short thumbs; mental retardation; clinically normal monozygotic twin sister is GM13976|mesoderm	Bld@ GM13977
WI-38|WI-38 cell culture|WI-38 primary human lung fibroblasts	Lng@ WI-38
U2OS|U2OS_KD_SIRT3|human osteosarcoma cells	Bon@ U2OS
MDA-MB-231|MDA-MB-231 breast adenocarcinoma cells, thiostrepton, FOXM1 ChIP|ER-negative breast adenocarcinoma cells	Brs@ MDA-MB-231
MDA-MB-231|MDA-MB-231 breast adenocarcinoma cells, control, FOXM1 ChIP|ER-negative breast adenocarcinoma cells	Brs@ MDA-MB-231
Germinal center B cells|Germinal center B cells	Bld@ B-Lymphocytes
MCF-7|siGATA_ER_estrogen|breast cancer cells	Brs@ MCF-7
BCBL1|BCBL1 pleural effusion lymphoma, IgG ChIP|KSHV-infected pleural effusion lymphoma cells	Bld@ BCBL1
FLP143HA|derived from HEK293, human embryonic kidney cells	Kid@ 293
HeLa S3|immortalized cervical cancer derived cell line	Utr@ HeLa
RPMI-8402|T-ALL cell line, TAL1 ChIP|T-cell acute lymphoblastic leukemia (T-ALL) cells	Bld@ RPMI 8402
RPMI-8402|T-ALL cell line, HEB ChIP|T-cell acute lymphoblastic leukemia (T-ALL) cells	Bld@ RPMI 8402
RPMI-8402|T-ALL cell line, GATA3 ChIP|T-cell acute lymphoblastic leukemia (T-ALL) cells	Bld@ RPMI 8402
RPMI-8402|T-ALL cell line, E2A ChIP|T-cell acute lymphoblastic leukemia (T-ALL) cells	Bld@ RPMI 8402
HCT116 with homozygous deletion of DNMT3b and DNMT1 (Rhee et al Nature 2002)	Dig@ HCT 116
BPLER cells|Transformed mammary epithelial cells	Brs@ BPLER
HMLER cells|Transformed mammary epithelial cells	Brs@ HMLE
HCT116|Human colorectal cancer cell-line HCT116	Dig@ HCT 116
UM-SCC-74A cell line|Base of tongue	Oth@ SCC-4
UM-SCC-4 cell line|Base of tongue	Oth@ SCC-4
CaSki (ATCC) cell line|Cervix	Utr@ Ca Ski
UM-SCC-47 cell line|Base of tongue	Oth@ SCC-4
GM08714|GM08714|lymphoblastoid cell line, Instability of heterochromatin of chromosomes 1, 9, and 16 with variable combined immunodeficiency; dysmorphic facial features, developmental delay, malabsorption, and recurrent infections; see GM08747 Fibroblast; donor subject is a compound heterozygote: one allele has a G&gt;A transition at nucleotide 1807 (1807G&gt;A) of the DNMT3B gene resulting in an Ala to Thr substitution at codon 603 Ala603Thr (A603T), the mutation occurring in a region between motifs I and IV within the catalytic domain of DNMT3B; the second allele has a G&gt;A transition within intron 22 located 11 nucleotides 5-prime of the normal splice acceptor site IVS22AS,G&gt;A,-11 resulting in the generation of a novel splice acceptor site and a 9-bp insertion in the processed RNA. This results in the insertion of 3 amino acids (serine, threonine, and proline) at codon 744 (744ins3). The insertion was within the conserved region of the catalytic domain, which is likely to be disrupted by the insertion of a proline residue. This mutation was de novo.|mesoderm	Bld@ GM08714
HEK293-T-REx|HEK293-T-REx|embryonic kidney cells transformed with Adenovirus 5 DNA stably expressing tetracycline repressor, HEK293 (ATCC number CRL-1573) is the parental cell line, hypotriploid, XXX|mesoderm	Kid@ 293
Raji|Raji|B lymphocyte, The Raji line of lymphoblast-like cells was established by R.J.V. Pulvertaft in 1963 from a Burkitt's lymphoma of the left maxilla of an 11-year-old Black male. - ATCC. (PMID: 14086209)|mesoderm	Bld@ RAJI
PBDEFetal|PBDEFetal|peripheral blood-derived erythroblasts from 16-19 week human fetal liver|mesoderm	Bld@ PBDEFetal
IMR90hTert|IMR90hTert_SNAP45|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
IMR90hTert|IMR90hTert_RPC4|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
HCT116|colorectal cancer cells, hypoxia, CDK8 ChIP	Dig@ HCT 116
Umbilical cord blood|Megakaryocytes	Bld@ Umbilical cord blood
Umbilical cord blood|Erythroblasts	Bld@ Umbilical cord blood
Cell culture|CHRF-288-11	Bld@ CHRF-288-11
UVSS1KO Cells|SV40 Immortalized Fibroblast	Oth@ UVSS1
HAEC|HAEC_input_control|Primary Human Aortic Endothelial Cells	CDV@ HAEC
MCF7|Breast Cancer Cell Line	Brs@ MCF-7
U87MG|U87MG cell line, kinase dead EGFRvIII|glioblastoma	Neu@ U-87 MG
MDAH087 fibroblast cell line|Fibroblast cells from Li Fraumeni patient	Epd@ MDAH087
MCF-7 cells|Immortalized breast cancer cells	Brs@ MCF-7
BGO3 (feeder free)|Endodermal Diff of BG03 cells, Activin A t|embryonic stem cells	PSC@ hESC derived mesendodermal cells
TC-797|TC-797|NUT Midline Carcinoma cell line	Oth@ TC-797
HeLa|HeLa, TTF2 ChIP	Utr@ HeLa
MCF-7|MCF-7|human breast adenocarcinoma	Brs@ MCF-7
Colon cancer_DNase I ChIPSeq|Colon Cancer	Dig@ Colon cancer
embryonic carcinoma NCCIT|SNF5 overexpressed cells	PSC@ NCCIT
Primary Cell Culture|Fibroblasts, Fetal Skin, Quadriceps, Left|None|NA	Epd@ Fetal skin
Primary Cell Culture|Fibroblasts, Fetal Skin, Biceps, Left|None|NA	Epd@ Fetal skin
human mobilized peripheral blood derived erythroblasts|human erythroblasts	Bld@ Erythroblasts
human fetal liver derived erythroblasts|human erythroblasts	Bld@ Erythroblasts
hESC-H1|hESC-H1 line-derived erythroblasts|human erythroblasts	PSC@ hESC derived mesendodermal cells
hESC-H1|hESCs-H1 line|human embryonic stem cells	PSC@ hESC H1
K562|Input control	Bld@ K-562
HeLa-S3|HeLa_Input DNA|HELA cell culture	Utr@ HeLa
HeLa-S3|HeLa_HA-flag-Vezf1 ChIP-Seq|HELA cell culture	Utr@ HeLa
H1 hESCs-WCE|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-RBBP5 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-JARID1A ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-CHD1 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
K562-SAP30 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-PLU1 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-PHF8 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-HDAC6 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-HDAC2 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-HDAC1 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-CHD1 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
HeLa|Hela cells knockdown Med23	Utr@ HeLa
HeLa|Hela cells knockdown control	Utr@ HeLa
H3396|ERa e2 2M|breast cancer cells	Brs@ H3396
H3396|ERa e2 5k LinDA|breast cancer cells	Brs@ H3396
H3396|ERa e2 10k LinDA|breast cancer cells	Brs@ H3396
H3396|ERa e2 100k LinDA|breast cancer cells	Brs@ H3396
H3396|H3K4me3 e2 1k LinDA|breast cancer cells	Brs@ H3396
H3396|H3K4me3 e2 1M|breast cancer cells	Brs@ H3396
H3396|H3K4me3 e2 10k LinDA|breast cancer cells	Brs@ H3396
GM07006|EBV transformed mononuclear cells from perypherial blood|Lymphoblastoid cells	Bld@ Lymphoblastoid cell lines
AUBLA|EBV transformed mononuclear cells from perypherial blood|Lymphoblastoid cells	Bld@ Lymphoblastoid cells
GM13472|EBV transformed mononuclear cells from perypherial blood|Lymphoblastoid cells	Bld@ Lymphoblastoid cell lines
GM18319|EBV transformed mononuclear cells from perypherial blood|Lymphoblastoid cells	Bld@ Lymphoblastoid cell lines
SE160|EBV transformed mononuclear cells from perypherial blood|Lymphoblastoid cells	Bld@ Lymphoblastoid cells
MCF-7|breast cancer cells|breast cancer cells	Brs@ MCF-7
Gliobla|glioblastoma, these cells (aka H54 and D54) come from a surgical resection from a patient with glioblastoma multiforme (WHO Grade IV). D54 is a commonly studied glioblastoma cell line (Bao et al., 2006) that has been thoroughly described by S Bigner (1981). (PMID: 7252524)|ectoderm	Neu@ D54
HeLa|HeLa|HeLa S3 cells	Utr@ HeLa
K562|TCF7L2 ChIP-seq K562 BIO	Bld@ K-562
T-47D|T-47D is a human epithelial cell line derived from an mammary ductal carcinoma.	Brs@ T-47D
MCF-7|mammary gland, adenocarcinoma. (PMID: 4357757)|ectoderm	Brs@ MCF-7
HepG2|liver carcinoma|endoderm	Liv@ Hep G2
GM12891|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12891
HeLa-S3|cervical carcinoma|ectoderm	Utr@ HeLa
LNCaP|prostate adenocarcinoma, LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old caucasian male (blood type B+) with confirmed diagnosis of metastatic prostate carcinoma. - ATCC. (Horoszewicz et al. LNCaP Model of Human Prostatic Carcinoma. Cancer Research 43, 1809-1818, April 1983.)|endoderm	Prs@ LNCAP
U87|U87|glioblastoma, astrocytoma, (PMID: 4332744)|ectoderm	Neu@ U-87 MG
PFSK-1|neuroectodermal cell line derived from a cerebral brain tumor, (PMID: 1316433)	Neu@ PFSK-1
SMAD1 ChIP-seq CD34 ertyhroid BMP|Pro-erythroblasts	Bld@ CD34+
human leukemic blasts|diagnostic sample (pre-treatment)	Bld@ Leukemic blast cell
p63_IP|Human neonatal foreskin keratinocytes	Epd@ Keratinocytes
Input|Human neonatal foreskin keratinocytes	Epd@ Keratinocytes
Input ChIP-Seq CD34 erythroid BMP|Pro-erythroblasts	Bld@ CD34+
TCF7L2 ChIP-seq CD34 progenitors BIO|Hematopoietic Stem &amp; Progenitor Cells	Bld@ CD34 Hematopoietic stem cells
SMAD1 ChIP-seq CD34+ progenitors BMP|Hematopoietic Stem &amp; Progenitor Cells	Bld@ CD34 Hematopoietic stem cells
GATA1 ChIP-seq CD34 erythroid BMP|Pro-erythroblasts	Bld@ CD34+
GATA1 ChIP-seq CD34 erythroid BIO|Pro-erythroblasts	Bld@ CD34+
B-cell  lymphoma cell line|Ramos|B-cell	Bld@ RAMOS
B-cell  lymphoma cell line|BL41|B-cell	Bld@ BL-41
B-cell  lymphoma cell line|Blue1|B-cell	Bld@ BLUE-1
B-cell  lymphoma cell line|CA46|B-cell	Bld@ CA46
B-cell  lymphoma cell line|Raji|B-cell	Bld@ RAJI
IMR90|normal human lung fibroblasts	Lng@ IMR-90
Primary Cell|CD34 Primary Cells|None|CD34	Bld@ CD34+
Primary Cell|Mobilized CD3 Primary Cells|None|CD3+	Bld@ CD3+
Primary Tissue|Fetal Heart|Heart|presumed normal	CDV@ Heart
NHU|Normal urothelium cells|normal bladder	Oth@ NHU
EJ|Urinary bladder cancer cell line|bladder cancer	Oth@ EJ-1
RT112|Urinary bladder cancer cell line|bladder cancer	Oth@ RT-112
Ntera2 cells|Ntera2	PSC@ NTERA-2
Jurkat|Jurkat-Tat T cells	Bld@ Jurkat
Endoderm progenitor|endoderm progenitor derived from H9 hESC	PSC@ hESC derived mesendodermal cells
LNCaP-1F5|FoxA1_ChIP-seq_siFoxA1|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|FoxA1_ChIP-seq|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|AR_ChIP-seq_siFoxA1|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|AR_ChIP-seq|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
AG04450|AG04450|fetal lung fibroblast|mesoderm	Lng@ AG04450
GM12801|GM12801|B-Lymphocyte, Lymphoblastoid, International HapMap Project, CEPH/Utah, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12801
K562|K562_PolII|chronic myeloid leukemia	Bld@ K-562
HUVEC|HUVEC_PolII|umbilical vein endothelial cells	CDV@ HUVEC
HepG2|HepG2_CTCF|liver carcinoma cells	Liv@ Hep G2
NHEK|normal human epidermal keratinocytes|normal human epidermal keratinocytes	Epd@ NHEK
K562|chronic myeloid leukemia|chronic myeloid leukemia	Bld@ K-562
HUVEC|umbilical vein endothelial cells|umbilical vein endothelial cells	CDV@ HUVEC
HelaS3|cervical carcinoma|cervical carcinoma	Utr@ HeLa
H1_ES|human embryonic stem cells|human embryonic stem cells	PSC@ hESC H1
NB4|NB4 cells (leukemic), ATRA, HpaII NA-Seq|leukemic cells	Bld@ NB-4
NB4|NB4 cells (leukemic), ATRA, NlaIII NA-Seq|leukemic cells	Bld@ NB-4
CUTLL1|CUTLL1: input|T lymphocyte|T lymphoblastic leukemia/lymphoma	Bld@ CUTLL1
CUTLL1|CUTLL1: RBPJ Chromatin IP|T lymphocyte|T lymphoblastic leukemia/lymphoma	Bld@ CUTLL1
CUTLL1|CUTLL1: Notch1 Chromatin IP|T lymphocyte|T lymphoblastic leukemia/lymphoma	Bld@ CUTLL1
Chromatin IP against GATA2|umbilical vein endothelial cells	CDV@ HUVEC
H7-hESC|H7-hESC|Undifferentiated human embryonic stem cells	PSC@ hESC H7
AG10803|AG10803|Adult human abdominal skin fibroblasts|mesoderm	Epd@ AG10803
HPdLF|HPdLF|Normal Human Periodontal Ligament Fibroblasts	Oth@ HPdLF
HAEpiC|HAEpiC|Human Amniotic Epithelial Cells	Oth@ HAEpiC
HMVEC-LLy|HMVEC-LLy|Normal Human Lymphatic Microvascular Endothelial Cells, Lung-Derived	CDV@ HMVEC
HMVEC-dNeo|HMVEC-dNeo|Normal Neonatal Human Microvascular Endothelial Cells (single Donnor), Dermal-Derived	CDV@ HMVEC
BE2_C|BE2_C|Human neuroblastoma|ectoderm	Neu@ BE(2)-C
HNPCEpiC|HNPCEpiC|Human Non-Pigment Ciliary Epithelial Cells	Oth@ HNPCEpiC
GM12878|GM12878|lymphoblastoid|International HapMap Project - CEPH/Utah - European Caucasion; Epstein-Barr Virus	Bld@ GM12878
AG09319|AG09319|Adult human gum tissue fibroblasts|mesoderm	Oth@ AG09319
HRGEC|HRGEC|Human Renal Glomerular Endothelial Cells|Endothelial	Kid@ HRGEC
AG09309|AG09309|Adult human toe fibroblast|mesoderm	Epd@ AG09309
HIPEpiC|HIPEpiC|Human Iris Pigment Epithelial Cells|ectoderm	Oth@ HIPEpiC
NHLF|NHLF|Normal Human Lung Fibroblasts	Lng@ NHLF
HMVEC-dBl-Ad|HMVEC-dBl-Ad|Normal Adult Human Blood Microvascular Endothelial Cells, Dermal-Derived	CDV@ HMVEC
HFF-Myc|HFF-Myc|Human Foreskin Fibroblast Cells Expressing Canine cMyc|Fibroblast	Epd@ HFF
LNCaP|LNCaP|prostate adenocarcinoma, LNCaP clone FGC was isolated in 1977 by J.S. Horoszewicz, et al., from a needle aspiration biopsy of the left supraclavicular lymph node of a 50-year-old Caucasian male (blood type B+) with confirmed diagnosis of metastatic prostate carcinoma. - ATCC. (Horoszewicz et al. LNCaP Model of Human Prostatic Carcinoma. Cancer Research 43, 1809-1818, April 1983.)|endoderm	Prs@ LNCAP
HFF|HFF|Human Foreskin Fibroblast|Fibroblast	Epd@ HFF
HMVEC-dLy-Ad|HMVEC-dLy-Ad|Normal Adult Human Blood Microvascular Endothelial Cells, Dermal-Derived	CDV@ HMVEC
BJ|BJ|Skin fibroblast The line was established from skin taken from normal foreskin. - ATCC.  (PMID: 9916803)|mesoderm	Epd@ BJ
HA-h|HA-h|Human Astrocytes-hippocampal|Astrocytic	Neu@ HA-h
SKMC|SKMC|Human Skeletal Muscle Cells|mesoderm	Myo@ SKMC
Caco-2|Caco-2|colorectal adenocarcinoma. (PMID: 1939345)	Dig@ Caco-2
HAc|HAc|Human Astrocytes-cerebellar|Astrocytic	Neu@ HAc
NH-A|NH-A|normal human astrocytes	Neu@ NH-A
AoAF|AoAF|Normal Human Aortic Adventitial Fibroblast Cells	CDV@ AoAF
A549|A549|epithelial cell line This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old Caucasian male. - ATCC, derived from a lung carcinoma tissue. (PMID: 175022)|endoderm	Lng@ A549
HGF|HGF|Human Gingival Fibroblasts	Oth@ HGF
HMVEC-dLy-Neo|HMVEC-dLy-Neo|Normal Neonatal Human Lymphatic Microvascular Endothelial Cells, Dermal-Derived	CDV@ HMVEC
HUVEC|HUVEC|Human Umbilical Vein Endothelial Cell|mesoderm	CDV@ HUVEC
HMVEC-dBl-Neo|HMVEC-dBl-Neo|Normal Neonatal Human Blood Microvascular Endothelial Cells, Dermal-Derived	CDV@ HMVEC
NHDF-Ad|NHDF-Ad|Adult Normal Human Dermal Fibroblasts	Epd@ NHDF
AG04450|AG04450|Fetal lung fibroblast|mesoderm	Lng@ AG04450
HSMM|HSMM|Normal Human Skeletal Muscle Myoblasts|mesoderm	Myo@ HSMM
HRCEpiC|HRCEpiC|Human Renal Cortical Epithelial cells (normal)|mesoderm	Kid@ HRCEpiC
NHEK|NHEK|Normal Human Epidermal Keratinocytes|ectoderm	Epd@ NHEK
HConF|HConF|Human Conjunctival Fibroblast	Oth@ HConF
RPTEC|RPTEC|Renal Proximal Tubule Epithelial Cells	Kid@ RPTEC
HMVEC-LBl|HMVEC-LBl|Normal Human Blood Microvascular Endothelial Cells, Lung-Derived	CDV@ HMVEC
U2OS|Osteosarcome cell line	Bon@ U2OS
U2OS|Osteosarcoma cell line	Bon@ U2OS
CD34+ cells from human patient with t(8:21)|AML patient bone marrow CD34+	Bld@ CD34+
LNCaP prostate cancer cells|androgen-dependent prostate cancer cells	Prs@ LNCAP
Primary Cell|Mobilized CD4 Primary Cells|None|CD4+	Bld@ CD4+
breast adenocarcinoma cell line|MCF7 cell line stably expressing HA ER E2F1 DNA binding domain mutant	Brs@ MCF-7
breast adenocarcinoma cell line|MCF7 cell line stably expressing HA ER E2F1 wild type	Brs@ MCF-7
H1|embryonic stem cells, control ChIP-seq|embryonic stem cell	PSC@ hESC H1
IMR90|IMR90 human lung fibroblasts	Lng@ IMR-90
H1|H1 human embryonic stem cells	PSC@ hESC H1
Hematopoietic Stem &amp; Progenitor Cells, RNA Pol II ChIP|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
Hematopoietic Stem &amp; Progenitor Cells, Ikaros ChIP|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
Hematopoietic Stem &amp; Progenitor Cells, Pu.1 ChIP|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
Hematopoietic Stem &amp; Progenitor Cells, TAL1 ChIP|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
NCCIT|NCCIT|embryonic carcinoma cell line	PSC@ NCCIT
Treg cells from PBMC, normal|Treg cells	Bld@ PBMC
NHEK|normal human epidermal keratinocytes	Epd@ NHEK
K562|chronic myeloid leukemia	Bld@ K-562
Leukemic T-cell line originally derived from a T-ALL patient|Leukemic T-cell	Bld@ T-ALL
CD34+CD133+ hematopoietic progenitor cells (HPCs)|CD34+CD133+ hematopoietic progenitor cells (HPCs)	Bld@ CD34 Hematopoietic stem cells
K562|K562 Cells	Bld@ K-562
GM12878|lymphoblastoid cell line	Bld@ GM12878
AML pz12 (leukemic)|hematopoietic cell|leukemic	Bld@ Leukemia, Myeloid
hiPS line PDB2lox_21|hiPS line PDB2lox_21	PSC@ iPS cells
hiPS line PDB1lox_21puro_26|hiPS line PDB1lox_21puro_26	PSC@ iPS cells
hiPS line PDB2lox_17|hiPS line PDB2lox_17	PSC@ iPS cells
hiPS line PDB1lox_17puro_5|hiPS line PDB1lox_17puro_5	PSC@ iPS cells
hiPS line 4|hiPS line 4	PSC@ iPS cells
hiPS line C1|hiPS line C1	PSC@ iPS cells
hiPS line A6|hiPS line A6	PSC@ iPS cells
hiPS line A1|hiPS line A1	PSC@ iPS cells
hES line WIBR7|hES line WIBR7	PSC@ hESC WIBR7
hES line WIBR3|hES line WIBR3	PSC@ hESC WIBR3
hES line WIBR2|hES line WIBR2	PSC@ hESC WIBR2
hES line WIBR1|hES line WIBR1	PSC@ hESC WIBR1
hES line BG03|hES line BG03	PSC@ hESC BG03
hES line BG01|hES line BG01	PSC@ hESC BG01
human fibroblast line GM|human fibroblast line GM	Bld@ Lymphoblastoid cell lines
Embyonic stem cells|pluripotent and self-renewing cells	PSC@ Embryonic Stem Cells
MCF7|MCF7 cells|human breast cancer cell	Brs@ MCF-7
GM10861|lymphoblastoid, GM10861, vitamin D|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM10861|lymphoblastoid, GM10861, unstimulated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM10855|lymphoblastoid, GM10855, vitamin D|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM10855|lymphoblastoid, GM10855, unstimulated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
Human Cultured Primary Erythroblasts|Human Cultured Primary Erythroblasts	Bld@ Erythroblasts
LnCaP - R1881 - Chromatin IP against H3K4me3	Prs@ LNCAP
LnCaP - Ethanol - Chromatin IP against H3K4me3	Prs@ LNCAP
U2OS|Chromatin IP against p53-pS46|osteosarcoma	Bon@ U2OS
U2OS|Chromatin IP against p53-pS15|osteosarcoma	Bon@ U2OS
U2OS|Chromatin IP against p53|osteosarcoma	Bon@ U2OS
U2OS|U2OS cells, ERb vector transfected with Doxycycline added and E2 treatment	Bon@ U2OS
U2OS|U2OS cells, ERb vector transfected with Doxycycline added	Bon@ U2OS
GM06990|Peripheral vein|Epstein-Barr Virus transformed lymphoblastoid	Bld@ GM06990
MCF-7 breast cancer cell line|ATCC MCF-7 cells	Brs@ MCF-7
mammosphere-derived epithelial cells from #68 patient|mammosphere-derived epithelial cells (MDECs)	Brs@ Mammosphere
mammosphere-derived epithelial cells from #67 patient|mammosphere-derived epithelial cells (MDECs)	Brs@ Mammosphere
Shef 4 cells|ES cells|ES cells	PSC@ Embryonic Stem Cells
MCF-7|breast carcinoma cell line|breast carcinoma cell line	Brs@ MCF-7
hES cell line WIBR3|hES line WIBR3 20% O2	PSC@ hESC WIBR3
hES cell line WIBR2|hES line WIBR2 20% O2	PSC@ hESC WIBR2
hES cell line WIBR1|hES line WIBR1 20% O2	PSC@ hESC WIBR1
hES cell line WIBR3|hES line WIBR3 5% O2	PSC@ hESC WIBR3
hES cell line WIBR2|hES line WIBR2 5% O2	PSC@ hESC WIBR2
hES cell line WIBR1|hES line WIBR1 5% O2	PSC@ hESC WIBR1
Rh4|Rh4, pFM2 IP|rhabdomyosarcoma	Myo@ Rh-4
CD4+ T cells|CD4+ T cells, ChIP_Seq	Bld@ CD4-Positive T-Lymphocytes
T24 bladder cancer cells|G0/G1 T24 Cells	Oth@ T24
T24 bladder cancer cells|Mitotic T24 Cells	Oth@ T24
Saos-2|p53 Saos-2 cell line|osteosarcoma	Bon@ Saos-2
Saos-2|TAp73beta Saos-2 cell line|osteosarcoma	Bon@ Saos-2
Saos-2|TAp73alpha Saos-2 cell line|osteosarcoma	Bon@ Saos-2
MCF7|MCF7|estrogen-responsive breast cancer	Brs@ MCF-7
APL cells _pz74	Bld@ Leukemia, Myeloid
MDA-MB-231|Human breast adenocarcinoma cell line	Brs@ MDA-MB-231
primary CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
CC-2538 (product number)|normal osteoblast|not applicable	Bon@ CC-2538
MCF-7|MCF-7 culture cells	Brs@ MCF-7
T47D|Breast Cancer|Breast	Brs@ T-47D
HeLa|Cervix|Adenocarcinoma|Cervix	Utr@ HeLa
MCF-7|ChIP-seq_ER_siFOXA1_E2+TNF|ER Positive Breast Cancer Cells	Brs@ MCF-7
HEK293T|HEK293T_emx1 sgRNA	Kid@ 293
HEK293T|HEK293T_none (control)	Kid@ 293
coilin-LAP HeLa|HeLa Kyoto	Utr@ HeLa
H3K27ac_ChIPseq_Human|sperm	Gon@ Sperm
H3K4me1_ChIPseq_Human|sperm	Gon@ Sperm
keratinocytes_overexpressing LACZ_differentiation medium_SNAI2-ChIPseq|Human keratinocytes	Epd@ Keratinocytes
SW480|Colon Carcinoma|Colon Carcinoma	Dig@ SW 480
AC16|p65_ChIP-seq_TNF|cardiomyocytes	CDV@ AC16
AC16|p65_ChIP-seq_Vehicle|cardiomyocytes	CDV@ AC16
HEK293T|HEK_BRD4_ChIP-seq	Kid@ 293
HEK293T|HEK_IgG_ChIP-seq	Kid@ 293
HEK293T|HEK293T|kidney	Kid@ 293
HCT116|HCT116_Input	Dig@ HCT 116
HCT116|HCT116_MeCP2	Dig@ HCT 116
IMR90|IMR90_Input	Lng@ IMR-90
Melanoma	Epd@ Melanoma
MV4;11	Bld@ MV-4-11
HuRef|Lymphoblast	Bld@ HuRef
MS4221|Lymphoblast	Bld@ MS4221
IMS13q|Lymphoblast	Bld@ IMS13q
PDNC4|Fibroblast	Oth@ PDNC-4
MKN28|MKN28|gastric cancer cell	Dig@ MKN-28
H293T|H293T	Kid@ 293
HBVSMC|HBVSMC|brain vascular smooth muscle cells.|mesoderm	Myo@ HBVSMC
MCF7|GREB1_ICI_ChIP	Brs@ MCF-7
MCF7|GREB1_ChIP	Brs@ MCF-7
MCF7|ER_ChIP	Brs@ MCF-7
WSU-DLCL2|WSU-DLCL2	Bld@ WSU-DLCL2
KARPAS-422|KARPAS-422	Bld@ KARPAS-422
Pfeiffer|Pfeiffer	Bld@ Pfeiffer
HepG2	Liv@ Hep G2
LNCaP|Human prostate cancer cells	Prs@ LNCAP
Blood|CD36|Blood|Adult	Bld@ CD36+
Blood|HSC|Blood|Adult	Bld@ Hematopoietic Stem Cells
HeLa|HeLa|epithelial	Utr@ HeLa
HCT116	Dig@ HCT 116
liver|Human Liver	Liv@ Liver
U2OS|U2OS_FOXM1_ChIP-seq|Osteosarcoma	Bon@ U2OS
Melanomas|Wm451-lu	Epd@ WM451
Peripheral blood|Monocytes	Bld@ Monocytes
IMR90|Lung fibroblast|Lung fibroblast	Lng@ IMR-90
Primary Tissue|Fetal Testes|UW|None	Gon@ Testis
UAE(leukemic)	Bld@ U-937
BE(2)-C/Tet-Off/Myc-HOXC9|BE2C/Tet-Off/HOXC9_Doxy-_6d_HOXC9_ChIP|Sympathetic nervous system|Neuroblastoma	Neu@ BE(2)-C
C4-2B|C4-2B	Bld@ C4-2
Gliobla	Neu@ Glioblastoma
U87	Neu@ U-87 MG
K562|H3K4me1_K562	Bld@ K-562
K562|K562|K562	Bld@ K-562
K562|Input ChIP-Seq K562	Bld@ K-562
Th2 cells|Th2	Bld@ Th2 Cells
HelaS3|HelaS3_PolII|cervical carcinoma	Utr@ HeLa
HelaS3|HelaS3_cMYC|cervical carcinoma	Utr@ HeLa
GM12878|GM12878_PolII|lymphoblastoid cells	Bld@ GM12878
GM12878|GM12878_cMYC|lymphoblastoid cells	Bld@ GM12878
Chromatin IP against cFOS|umbilical vein endothelial cells	CDV@ HUVEC
AG04449|AG04449|Fetal buttock/thigh fibroblast|mesoderm	Epd@ AG04449
PANC-1|PANC-1|pancreatic carcinoma. (PMID: 1140870)	Pan@ PANC-1
MCF7 (cancer)|hematopoietic cell|cancer	Brs@ MCF-7
Primary Tissue|Fetal Lung|UW|None	Lng@ Fetal lung
GM12878|lymphoblast cells	Bld@ GM12878
Rh4|Rh4, input|rhabdomyosarcoma	Myo@ Rh-4
RD|RD, pFM2 IP|rhabdomyosarcoma	Myo@ RD
K562|K562 cells|myelogenous leukaemia	Bld@ K-562
islet	Pan@ Pancreatic islets
IMR-90	Lng@ IMR-90
MDA-MB-231|epithelial	Brs@ MDA-MB-231
GM12878|lymphoblastoid	Bld@ GM12878
HEK293	Kid@ 293
androgen-dependent prostate cancer derived cell line LNCaP|prostate cell line|androgen dependent	Prs@ LNCAP
HcoEpiC|Human normal colon cell line	Dig@ Colon
501Mel-Cl8|501Mel|melanoma	Epd@ 501A
LNCaP|ChIP-seq, background control for TOP1	Prs@ LNCAP
LNCaP|ChIP-seq with BLRP-tagged TOP1, 30min treatment with 100 nM DHT	Prs@ LNCAP
LNCaP|ChIP-seq with BLRP-tagged TOP1, 30min treatment with vehicle	Prs@ LNCAP
LNCaP|ChIP-seq with MRE11, 15min treatment with 100 nM DHT	Prs@ LNCAP
LNCaP|ChIP-seq with MRE11, 0min	Prs@ LNCAP
LNCaP|ChIP-seq with AR, 1h treatment with 100 nM DHT	Prs@ LNCAP
GM12878|Lymphoblast Cell Line|EBV-infected B Lymphocytes	Bld@ GM12878
HEK 293T|HEK 293T cells_IP_treatment|non-malignant cell line	Kid@ 293
HEK 293T|HEK 293T cells_IP_control|non-malignant cell line	Kid@ 293
HEK 293T|HEK 293T cells_input_treatment|non-malignant cell line	Kid@ 293
HEK 293T|HEK 293T cells_input_control|non-malignant cell line	Kid@ 293
MCF-7|Breast adenocarcinoma	Brs@ MCF-7
MDA-MB-231|Breast adenocarcinoma	Brs@ MDA-MB-231
neural precursor cell: neuroepithelial|embryonic stem cells	PSC@ hESC derived neural cells
Ewing sarcoma cell line A673|A673 after 96 hrs shFLI1	Myo@ A-673
Ewing sarcoma cell line A673|A673 after 96 hrs shGFP	Myo@ A-673
MCF7|H3K27me3 hypoxia 24 hours	Brs@ MCF-7
MCF7|H3K27me3 hypoxia 8 hours	Brs@ MCF-7
MCF7|H3K27me3 normoxia	Brs@ MCF-7
AoSMC-Aortic Smooth Mus Cells|Aorta	CDV@ AoSMC
HG fibroblasts_INPUT|HGPS dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-HGPS1)|HGPS patient 2 (TRS-HGPS)	Epd@ Dermal fibroblast
HG fibroblasts_INPUT|HGPS dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-HGPS1)|HGPS patient 1 (TRS-HGPS)	Epd@ Dermal fibroblast
WT fibroblasts_INPUT|WT dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-WT1)|age-matched control wild-type individual 2 (TRS-WT)	Epd@ Dermal fibroblast
WT fibroblasts_INPUT|WT dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-WT1)|age-matched control wild-type individual 1 (TRS-WT)	Epd@ Dermal fibroblast
HG fibroblasts_BRD4_ChIPSeq|HGPS dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-HGPS1)|HGPS patient 2 (TRS-HGPS)	Epd@ Dermal fibroblast
HG fibroblasts_BRD4_ChIPSeq|HGPS dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-HGPS1)|HGPS patient 1 (TRS-HGPS)	Epd@ Dermal fibroblast
WT fibroblasts_BRD4_ChIPSeq|WT dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-WT1)|age-matched control wild-type individual 2 (TRS-WT)	Epd@ Dermal fibroblast
WT fibroblasts_BRD4_ChIPSeq|WT dermal fibroblasts transformed by retroviral introduction of TERT, HRAS and SV40 T antigens (TRS-WT1)|age-matched control wild-type individual 1 (TRS-WT)	Epd@ Dermal fibroblast
PU.1 after RUNX1/ETO knockdown from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
PU.1 from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
LMO2 after RUNX1/ETO knockdown from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
LMO2 from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
CEBPA after RUNX1/ETO knockdown from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
CEBPA from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
ATCC HTB-22|cultured MCF7 cells (ATCC HTB-22)|MCF7	Brs@ MCF-7
ATCC CCL-243|cultured K562 cells (ATCC CCL-243)|K562	Bld@ K-562
HEK 293T|Input|kidney	Kid@ 293
HEK 293T|dCas9-noED + control gRNA|kidney	Kid@ 293
VCaP|VCaP prostate cancer cells, R1881, ASH2 ChIP|vertebral metastatic lesion-derived prostate cancer cell line	Prs@ VCaP
VCaP|VCaP prostate cancer cells, vehicle, ASH2 ChIP|vertebral metastatic lesion-derived prostate cancer cell line	Prs@ VCaP
293T-Rex cells expressing FLAG/HA-tagged AUTS2|15-20	Kid@ 293
lymphoblastoid|lymphoblastoid cell line	Bld@ Lymphoblastoid cell line
recombinant protein|histidine	Unc@ Unclassified
EP300 after RUNX1/ETO knockdown from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
EP300 from Kasumi1 cells|Kasumi-1	Bld@ Kasumi-1
RUNX1 CD34+ AML blast J282 apheresis|AML blast	Bld@ CD34+
HCT116|HCT116 RNA polymerase II ChIP-seq|human colorectal cancer cell line	Dig@ HCT 116
Spinal cord astrocytes, Sciencell|Sciencell #1820	Neu@ Astrocytes
Skeletal myoblast|Skeletal myoblast	Myo@ Myoblasts
Retinal pigment cells, science cell|Sciencell #6540	Oth@ HRPEpiC
SW1353|SW1353 cells|Human chodrogenic cells	Bon@ SW 1353
HeLa|input from BIX treated RNaseH1 overexpressing cells	Utr@ HeLa
HeLa|PolIIS2ph ChIP in BIX treated RNaseH1 overexpressing cells	Utr@ HeLa
HeLa|input from untreated cells	Utr@ HeLa
HeLa|PolIIS2ph ChIP in untreated cells	Utr@ HeLa
HEK293|HEK293 Cels|embryonic kidney	Kid@ 293
RPMI-8402|T-ALL cell line	Bld@ RPMI 8402
T-ALL cancer sample_H3K27me3|Lymphocytes	Bld@ T-ALL
T-ALL cancer sample_input|Lymphocytes	Bld@ T-ALL
Jurkat|Jurkat culture cells_H3K27me3	Bld@ Jurkat
Jurkat|Jurkat culture cells_H3K27ac_sodium_butirate	Bld@ Jurkat
Jurkat|Jurkat culture cells_H3K27ac	Bld@ Jurkat
Jurkat|Jurkat culture cells_input	Bld@ Jurkat
Human primary fetal liver proerythroblasts (ProEs), TAL1 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), NFE2 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), EZH2_shEZH2 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), EZH2_shNT ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), EZH1_shEZH2 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), EZH1_shNT ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), SUZ12 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), EED ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), H3K4me3 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), H3K27me3 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
Human primary fetal liver proerythroblasts (ProEs), H3K27me1 ChIP|CD34+ HSPC-derived proerythroblasts|fetal liver	Bld@ Erythroblasts
293T-Rex	Kid@ 293
Female Brain: gyrus rectus|Female Brain: gyrus rectus	Neu@ Adult brains
Female Brain: cerebellum|Female Brain: cerebellum	Neu@ Adult brains
Female Brain: putamen|Female Brain: putamen	Neu@ Adult brains
Female Brain: central medial thalamic nuclei (contains nucleus medialis dorsalis fasciculosis, commissural nucleus, paraventricular thalamic nucleus, reuniens thalamic nucleus, cucullaris nucleus, paratenial thalamic nucleus)|Female Brain: central medial thalamic nuclei (contains nucleus medialis dorsalis fasciculosis, commissural nucleus, paraventricular thalamic nucleus, reuniens thalamic nucleus, cucullaris nucleus, paratenial thalamic nucleus)	Neu@ Adult brains
Female Brain: medial superior temporal gyrus (secondary auditory cortex)|Female Brain: medial superior temporal gyrus (secondary auditory cortex)	Neu@ Adult brains
Female Brain: white matter|Female Brain: white matter	Neu@ Adult brains
Female Brain: internal globus pallidus|Female Brain: internal globus pallidus	Neu@ Adult brains
Female Brain: occipital pole, Internal calcarine sulcus, (primary visual cortex V1)|Female Brain: occipital pole, Internal calcarine sulcus, (primary visual cortex V1)	Neu@ Adult brains
Female Brain: posterior precentral gyrus (primary motor cortex)|Female Brain: posterior precentral gyrus (primary motor cortex)	Neu@ Adult brains
GM18916|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18909|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18520|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18511|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18510|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18498|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18486|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19119|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19201|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19171|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19138|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19137|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19101|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19222|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19160|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19159|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18913|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18912|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18855|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18853|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18852|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18523|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18522|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18517|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18516|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18519|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18499|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19239|Lymphoblastoid cell lines	Bld@ GM19239
GM19193|Lymphoblastoid cell lines	Bld@ GM19193
GM19099|Lymphoblastoid cell lines	Bld@ GM19099
GM19098|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19143|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19152|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19153|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19144|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19127|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19128|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19130|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19131|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19140|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19116|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19209|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19200|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19172|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19102|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19210|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM19093|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18870|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18862|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18861|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18856|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18508|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18507|Lymphoblastoid cell lines	Bld@ GM18507
GM18504|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
GM18502|Lymphoblastoid cell lines	Bld@ Lymphoblastoid cell lines
HCT116|Input DNA|colorectal cancer cell	Dig@ HCT 116
HCT116|p53 ChIP-seq|colorectal cancer cell	Dig@ HCT 116
HEK293|Human embryonic kidney cells	Kid@ 293
LNCaP|CK2 ChIP-seq|Prostate Carcinoma Cells	Prs@ LNCAP
HeLaS3|HeLaS3_egfa-t1 sgRNA	Utr@ HeLa
HeLaS3|HeLaS3_emx1 sgRNA	Utr@ HeLa
HeLaS3|HeLaS3_none (control)	Utr@ HeLa
the human primary mammary epithelial cell line (HMEC) immortalised by expressing hTERT, the catalytical subunit of telomerase|HMET|epithelial|Mammary epithelial Cells	Brs@ HMEC
HeLa|HeLa|IP with Ab   rabbit IgG (Santa Cruz, sc-2027)	Utr@ HeLa
H3_ChIPSeq_Human|sperm	Gon@ Sperm
HEK 293|HEK 293 cells	Kid@ 293
LS174T|LS174T, H3K4me1 ChIP|colorectal carcinoma	Dig@ LS-174T
LS174T|LS174T, H3K4me3 ChIP|colorectal carcinoma	Dig@ LS-174T
LS174T|LS174T, H3K27ac ChIP|colorectal carcinoma	Dig@ LS-174T
LEC-219|Kidney epithelium|Kidney epithelial cells	Oth@ LEC
BJAB-219|Human Burkitt lymphoma|Human Burkitt lymphoma B cells	Bld@ BJAB
BJAB|Human Burkitt lymphoma|Human Burkitt lymphoma B cells	Bld@ BJAB
BEC-219|Dermal blood endothelium|Dermal blood endothelial cells	CDV@ BEC
BEC|Dermal blood endothelium|Dermal blood endothelial cells	CDV@ BEC
Vertebral Cancer of Prostate (VCaP)|VCaP_H3K4me2_R1881|bone metastasis of prostate cancer	Prs@ VCaP
Vertebral Cancer of Prostate (VCaP)|VCaP_IgG|bone metastasis of prostate cancer	Prs@ VCaP
BJ|BJ_untreated_IgG|Human diploid foreskin fibroblasts (BJ) immortalized with hTERT	Epd@ BJ
BJ|BJ_DNA damage_p53|Human diploid foreskin fibroblasts (BJ) immortalized with hTERT	Epd@ BJ
BJ|BJ_untreated_p53|Human diploid foreskin fibroblasts (BJ) immortalized with hTERT	Epd@ BJ
BJ|BJ_DNA damage_JMJD3|Human diploid foreskin fibroblasts (BJ) immortalized with hTERT	Epd@ BJ
BJ|BJ_untreated_JMJD3|Human diploid foreskin fibroblasts (BJ) immortalized with hTERT	Epd@ BJ
K562 cells|TBP ChIP-seq (Human K562 cells) Rep 1	Bld@ K-562
MCF10A|MCF10A	Brs@ MCF 10A
C4-2|C4-2_p300 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
prostate tissue_ARRB1 ChIP|human prostate tissue	Prs@ Prostate
prostate tissue_H3K4me3 ChIP|human prostate tissue	Prs@ Prostate
prostate tissue_H3K4me1 ChIP|human prostate tissue	Prs@ Prostate
C4-2|C4-2_H3K4me3 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|C4-2_H3K4me1 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|C4-2_RNAPolII ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|nucARRB1_H3K4me3 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|nucARRB1_H3K4me1 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|nucARRB1_RNAPolII ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|nucARRB1_p300 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|nucARRB1_ARRB1 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
C4-2|C4-2_ARRB1 ChIP|immortalised prostate epithelial cells	Bld@ C4-2
Hela|cervical cancer cells	Utr@ HeLa
twin 2_euploid_fetal primary fibroblasts_ChIP|Fetal primary fibroblasts|Euploid	Oth@ Fibroblasts
twin 1_T21_fetal primary fibroblasts_ChIP|Fetal primary fibroblasts|Trisomy 21	Oth@ Fibroblasts
Transformed human primary mammary epithelial cell line (HMEC) immortalised by expressing hTERT, the catalytical subunit of telomerase|epithelial|Epithelial|transformed epithelial cell line	Brs@ HMEC
the human primary mammary epithelial cell line (HMEC) immortalised by expressing hTERT, the catalytical subunit of telomerase|epithelial|Mammary epithelial Cells	Brs@ HMEC
keratinocytes_overexpressing SNAI2_differentiation medium_Input|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_overexpressing LACZ_differentiation medium_Input|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_overexpressing SNAI2_growth medium_Input|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_overexpressing LACZ_growth medium_Input|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_SNAI2 knockdown_growth medium_Input|Human keratinocytes	Epd@ Keratinocytes
keratinocytes_control shRNA_growth medium_Input|Human keratinocytes	Epd@ Keratinocytes
THP-1|THP-1 WCE ChIPseq|monocytic cell	Bld@ THP-1
THP-1|THP-1 RAD21 ChIPseq|monocytic cell	Bld@ THP-1
THP-1|THP-1 CTCF ChIPseq|monocytic cell	Bld@ THP-1
Skin fibroblast cells|Primary Dermal Fibroblast|skin, upper arm	Epd@ Dermal fibroblast
Endothelial cells|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
HAEC input SAHA|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
HAEC input control|Primary Human Aortic Endothelial Cells (HAECs)	CDV@ HAEC
BC-3|pleural effusion	Bld@ BC-3
pleural effusion	Lng@ Pleural Effusion
D14-erythroid cells, input|erythroid cells|polychromatic ~ orthochromatic erythroblast	Bld@ Erythroblasts
D11-erythroid cells, input|erythroid cells|basophilic ~ polychromatic erythroblast	Bld@ Erythroblasts
D8-erythroid cells, input|erythroid cells|proerythroblast	Bld@ Erythroblasts
D14-erythroid cells, TR4 ChIP|erythroid cells|polychromatic ~ orthochromatic erythroblast	Bld@ Erythroblasts
D11-erythroid cells, TR4 ChIP|erythroid cells|basophilic ~ polychromatic erythroblast	Bld@ Erythroblasts
D8-erythroid cells, TR4 ChIP|erythroid cells|proerythroblast	Bld@ Erythroblasts
HeLa-siAnp32e	Utr@ HeLa
AD04DF_LMNA|Dermal fibroblast|Skin|Skin, arm|Adult	Epd@ Dermal fibroblast
Lonza, CC-2511|LDF_LMNA|Dermal fibroblast|Skin|Adult	Epd@ Dermal fibroblast
LY2|Ly2 Input_control|breast cancer	Brs@ LY2
LY2|Ly2 HoxC11_Untreated|breast cancer	Brs@ LY2
LY2|Ly2 HoxC11_Tamoxifen|breast cancer	Brs@ LY2
KYSE150|KYSE150_shCtrl_H3K4me3	Dig@ KYSE-150
KYSE150|KYSE150_shJMJD2C_H3K9me3	Dig@ KYSE-150
KYSE150|KYSE150_shCtrl_H3K9me3	Dig@ KYSE-150
KYSE150|KYSE150_shJMJD2C_H3K36me3	Dig@ KYSE-150
KYSE150|KYSE150_shCtrl_H3K36me3	Dig@ KYSE-150
KYSE150|KYSE150_IgG	Dig@ KYSE-150
KYSE150|KYSE150_shJMJD2C_JMJD2C	Dig@ KYSE-150
KYSE150|KYSE150_shCtrl_JMJD2C	Dig@ KYSE-150
HMLE_Twist3D_H3|human mammary epithelial cells	Brs@ HMLE
HMLE_Twist2D_H3|human mammary epithelial cells	Brs@ HMLE
HMLE_Twist2D_H3K4me3|human mammary epithelial cells	Brs@ HMLE
HMLE_Twist2D_H3K27me3|human mammary epithelial cells	Brs@ HMLE
HMLE_Parental_H3|human mammary epithelial cells	Brs@ HMLE
HMLE_Parental_H3K4me3|human mammary epithelial cells	Brs@ HMLE
Prostate cancer cell line VCaP|VCaP	Prs@ VCaP
human epidermal keratinocytes, MAFB ChIP|primary human epidermal keratinocytes|foreskin	Epd@ Keratinocytes
human epidermal keratinocytes, MAF ChIP|primary human epidermal keratinocytes|foreskin	Epd@ Keratinocytes
U937|U937 clone 2MIXL containing MIXL1 enforced expression vector, grown for 48 hours before harvest|Established cell culture from histiocytic lymphoma|histiocytic lymphoma	Bld@ U-937
U937|U937 clone 1MIXL containing MIXL1 enforced expression vector, grown for 48 hours before harvest|Established cell culture from histiocytic lymphoma|histiocytic lymphoma	Bld@ U-937
hESC derived posterior foregut (MHG)|hESC derived posterior foregut (MHG)	PSC@ hESC derived mesendodermal cells
hESC derived posterior foregut (PFG)|hESC derived posterior foregut (PFG)	PSC@ hESC derived mesendodermal cells
H1 Trophectoderm cells|H1 Trophectoderm cells	PSC@ hESC derived trophoblast cells
H1 Neuronal Progenitor cells|H1 Neuronal Progenitor cells	PSC@ hESC derived neural cells
H1 Mesenchymal stem cells|H1 Mesenchymal stem cells	PSC@ hESC derived mesendodermal cells
H1 Mesendoderm cells|H1 Mesendoderm cells	PSC@ hESC derived mesendodermal cells
H1 embryonic stem cells|H1 embryonic stem cells	PSC@ hESC H1
pancreatic islets, H3K4me3 ChIP|pancreatic islets	Pan@ Pancreatic islets
HuG-1|HUG1N_control|gastric carcinoma	Dig@ HuG1-N
HuG-1|HUG1N_GATA6_ChIP|gastric carcinoma	Dig@ HuG1-N
AGS|AGS_control|gastric carcinoma	Dig@ AGS
AGS|AGS_GATA6_ChIP|gastric carcinoma	Dig@ AGS
Human tumour tissue|CC135745_T2	Oth@ Tumour tissues
Human tumour tissue|CC316812_T1	Oth@ Tumour tissues
Human tumour tissue|CC106585_T3	Oth@ Tumour tissues
HCT116|HCT116 Colon Cancer Cells|Colon Cancer	Dig@ HCT 116
Namalwa|Burkitt's lymphoma cell line	Bld@ NAMALWA
Reh|Pro-B lymphoblastic leukemia cell line	Bld@ REH
L591|Hodgkin's Lymphoma cell line	Bld@ L-591
L428|Hodgkin's Lymphoma cell line	Bld@ L-428
L1236|Hodgkin's Lymphoma cell line	Bld@ L-1236
KATOIII|KATOIII GATA6|gastric cancer	Dig@ KATO III
KATOIII|KATOIII GATA4|gastric cancer	Dig@ KATO III
KATOIII|KATOIII KLF5|gastric cancer	Dig@ KATO III
KATOIII|KATOIII Input|gastric cancer	Dig@ KATO III
AGS|AGS GATA6|gastric cancer	Dig@ AGS
AGS|AGS GATA4|gastric cancer	Dig@ AGS
AGS|AGS KLF5|gastric cancer	Dig@ AGS
AGS|AGS Input|gastric cancer	Dig@ AGS
YCC3|YCC3 GATA6|gastric cancer	Dig@ YCC3
YCC3|YCC3 GATA4|gastric cancer	Dig@ YCC3
YCC3|YCC3 KLF5|gastric cancer	Dig@ YCC3
YCC3|YCC3 Input|gastric cancer	Dig@ YCC3
LN229 glioblastoma cell line|LN229 human glioblastoma cell line with GFP overexpression	Neu@ LN-229
LN229 glioblastoma cell line|LN229 human glioblastoma cell line with SOX4 overexpression	Neu@ LN-229
MM1.S|MM1S_WCE_forBRD3rep1-3|Multiple myeloma	Bld@ MM.1S
MM1.S|MM1S_BRD3_AB367A|Multiple myeloma	Bld@ MM.1S
MM1.S|MM1S_WCE_forBRD2rep1-BRD3AB367A|Multiple myeloma	Bld@ MM.1S
MM1.S|MM1S_WCE_forBRD2rep2-3|Multiple myeloma	Bld@ MM.1S
RPMI-8402|T-ALL cell line|Jurkat T-ALL cell line	Bld@ Jurkat
A549|A549_Smad3	Lng@ A549
A549|A549_input	Lng@ A549
H441|H441_Smad4_siTTF-1	Lng@ NCI-H441
H441|H441_Smad4_siControl	Lng@ NCI-H441
H441|H441_input_2	Lng@ NCI-H441
H441|H441_TTF-1_1p5h	Lng@ NCI-H441
H441|H441_TTF-1_0h	Lng@ NCI-H441
H441|H441_Smad3_siTTF-1	Lng@ NCI-H441
H441|H441_Smad3_siControl	Lng@ NCI-H441
H441|H441_input_1	Lng@ NCI-H441
LREX'|AR Input sample|Prostate Cancer	Prs@ LREX
LREX'|GR Input sample|Prostate Cancer	Prs@ LREX
LREX'|IP:AR with DHT treatment|Prostate Cancer	Prs@ LREX
LREX'|IP:GR with Dex treatment|Prostate Cancer	Prs@ LREX
MCF7|WTCHG01310|Mammary gland|Breast cancer (invasive ductal)|Malignant	Brs@ MCF-7
SaOS2|osteosarcoma cell line	Bon@ Saos-2
LNCaP|Enzalutamide, replicate 2	Prs@ LNCAP
LNCaP|Enzalutamide, replicate 1	Prs@ LNCAP
LNCaP|Bicalutamide, replicate 2	Prs@ LNCAP
LNCaP|Bicalutamide, replicate 1	Prs@ LNCAP
Human epididymal epithelial cells (pool of two individual samples)|epithelia|epididymis|immature	Gon@ Epididymis
Human epididymal epithelial cells|epithelia|epididymis|immature	Gon@ Epididymis
U2OS|U2OS cells, -Dox, input	Bon@ U2OS
U2OS|U2OS cells, +Dox, input	Bon@ U2OS
U2OS|U2OS cells, -Dox, pSer2 Pol II ChIP	Bon@ U2OS
U2OS|U2OS cells, +Dox, pSer2 Pol II ChIP	Bon@ U2OS
U2OS|U2OS cells, -Dox, pSer5 Pol II ChIP	Bon@ U2OS
U2OS|U2OS cells, +Dox, pSer5 Pol II ChIP	Bon@ U2OS
U2OS|U2OS cells, -Dox, total Pol II ChIP	Bon@ U2OS
U2OS|U2OS cells, +Dox, total Pol II ChIP	Bon@ U2OS
U2OS|U2OS cells, -Dox, Miz1 ChIP	Bon@ U2OS
U2OS|U2OS cells, +Dox, Miz1 ChIP	Bon@ U2OS
U2OS|U2OS cells, -Dox, Myc ChIP	Bon@ U2OS
U2OS|U2OS cells, +Dox, Myc ChIP	Bon@ U2OS
COLO829 melanoma cell line|COLO829 human melanoma cell line treated with PLX4032	Dig@ COLO 829
COLO829 melanoma cell line|COLO829 human melanoma cell line treated with DMSO	Dig@ COLO 829
Primary human melanocytes infected with a lentivirus for BRAFV600E|Primary Melanocyte	Epd@ Melanocytes
Primary human melanocytes infected with a lentivirus for RFP (control)|Primary Melanocyte	Epd@ Melanocytes
HCT116 colorectal cancer cells DNMT3BKO	Dig@ HCT 116
HCT116 colorectal cancer cells DNMT1KO	Dig@ HCT 116
Rhabdomyosarcoma|Rhabdomyosarcoma	Myo@ RD
human myoblast|myoblast	Myo@ Myoblasts
CSBN1 input DNA|fibroblast	Oth@ Fibroblasts
CSB input DNA|fibroblast	Oth@ Fibroblasts
CSBN1 CHIP|fibroblast	Oth@ Fibroblasts
CSB CHIP|fibroblast	Oth@ Fibroblasts
Raji|Burkitt's lymphoma	Bld@ RAJI
1	Unc@ Unclassified
HUVEC_acetylated H4_VEGF plus|human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_acetylated H4_minus|human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_NFATc1_VEGF plus|human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_NFATc1_minus|human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_H3K4me3 VEGF plus|human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_H3K4me3 minus|human umbilical vein endothelial cells	CDV@ HUVEC
Empty_Vehicle	Unc@ Unclassified
T47D-MTVLstably overexpressing H1.4-HA|breast cancer ductal carcinoma	Brs@ T-47D
T47D-MTVLstably overexpressing H1.2-HA|breast cancer ductal carcinoma	Brs@ T-47D
T47D-MTVLstably overexpressing H1.0-HA|breast cancer ductal carcinoma	Brs@ T-47D
LS174T|LS174T, input|colorectal carcinoma	Dig@ LS-174T
H295R/TR SF-1 cells|ChIP-seq_NRSF/REST_overexpressed SF-1|adrenocortical tumor	Oth@ NCI-H295R
H295R/TR SF-1 cells|ChIP-seq_NRSF/REST_basal SF-1|adrenocortical tumor	Oth@ NCI-H295R
HEK293|HEK293 cells, RNAPolII.Doxy1.0	Kid@ 293
HEK293|HEK293 cells, RNAPolII.Doxy0.0	Kid@ 293
HEK293|HEK293 cells, IgG.control	Kid@ 293
HEK293|HEK293 cells, IgG.shRECQL5-7	Kid@ 293
HEK293|HEK293 cells, RNAPolII.shRECQL5-7	Kid@ 293
HEK293|HEK293 cells, IgG.shRECQL5-5	Kid@ 293
HEK293|HEK293 cells, RNAPolII.shRECQL5-5	Kid@ 293
HEK293|HEK293 cells, IgG.shCTRL	Kid@ 293
HEK293|HEK293 cells, RNAPolII.shCTRL	Kid@ 293
IMR90|IMR90, IgG ChIP|lung fibroblasts	Lng@ IMR-90
HUES6-derived|Neurons, Nup98 ChIP|neurons	PSC@ hESC derived neural cells
HUES6-derived|Neural progenitor cells, IgG ChIP|neural progenitor cells	PSC@ hESC derived neural cells
HUES6-derived|Neural progenitor cells, Nup98 ChIP|neural progenitor cells	PSC@ hESC derived neural cells
HUES6|HUES6, IgG ChIP|embryonic stem (ES) cells	PSC@ hESC HUES6
HUES6|HUES6, Nup98 ChIP|embryonic stem (ES) cells	PSC@ hESC HUES6
K562|K562_TALE-3XFlag_input|erythrocytic leukaemia cells	Bld@ K-562
MDA-MD-231|MDA-MD-231, input	Brs@ MDA-MB-231
MDA-MD-231|MDA-MD-231, G18 ChIP	Brs@ MDA-MB-231
Umbilical vein|Primary cells	CDV@ Primary umbilical vein endothelial cells
SH-SY5Y|Fbio-Ctrl expressing SH-SY5Y cells|neuroblastoma cell line	Neu@ SH-SY5Y
mixed LuCaPs|Normal rabbit immunoglobulin	Prs@ LNCAP
LuCaP69 xenografted tumor tissue|overexpressed AR xenograft	Prs@ LNCAP
LuCaP73 xenografted tumor tissue|normal AR xenograft	Prs@ LNCAP
mixed LNCaP lines|pcDNA3.1 cell line	Prs@ LNCAP
MCF-7|luminal-A|breast cancer|adult	Brs@ MCF-7
HeLa|Hela_TFAM_20F8A9	Utr@ HeLa
HeLa|Hela_Input_20F8A9	Utr@ HeLa
iPSCs derived from ADSCs|ADS_iPS_Input|ADS_iPS	PSC@ iPS cells
iPSCs derived from ADSCs|ADS_iPS_Rpc155|ADS_iPS	PSC@ iPS cells
Adipose Derived Stem Cells|ADS_Input|ADS	Adp@ Adipose-Derived Mesenchymal Stem Cells
Adipose Derived Stem Cells|ADS_Rpc155|ADS	Adp@ Adipose-Derived Mesenchymal Stem Cells
H1 hESCs|H1_TFIIIC|hESC	PSC@ hESC H1
H1 hESCs|H1_Input|hESC	PSC@ hESC H1
H1 hESCs|H1_Rpc155|hESC	PSC@ hESC H1
hs_HeLa_RXR	Utr@ HeLa
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR G568W+FoxA1	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR G568W	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR Q640X+FoxA1	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR Q640X	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR C562S +FoxA1	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR C562S	Prs@ DU 145
prostate cancer cell line DU145|FOXA1_ChIP-seq_DU145 AR Q640X+FoxA1	Prs@ DU 145
prostate cancer cell line DU145|FOXA1_ChIP-seq_DU145 AR C562S+FoxA1	Prs@ DU 145
prostate cancer cell line DU145|FOXA1_ChIP-seq_DU145 AR + FoxA1 high	Prs@ DU 145
prostate cancer cell line DU145|FOXA1_ChIP-seq_DU145 AR + FoxA1	Prs@ DU 145
prostate cancer cell line DU145|FOXA1_ChIP-seq_DU145 AR	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR + FoxA1 high	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR + FoxA1	Prs@ DU 145
prostate cancer cell line DU145|AR_ChIP-seq_DU145 AR	Prs@ DU 145
prostate cancer cell line DU145|Input_DU145 Empty Vector	Prs@ DU 145
OCI-Ly7_P18|OCI-Ly7 lymphoma cells	Bld@ OCI-LY-7
eCenH3 HeLa S3|Heterotypic CenH3 (CenH3/H3) ChIP-seq|Cervical cancer	Utr@ HeLa
eCenH3 HeLa S3|Homotypic CenH3 (CenH3/CenH3) ChIP-seq|Cervical cancer	Utr@ HeLa
HCT116|HCT116_ser2p	Dig@ HCT 116
HCT116 colorectal cancer cell line|human colorectal cancer cell line	Dig@ HCT 116
E6-1|NELF-E shRNA+TNF stim|T lymphocyte supension|Peripherial Blood	Bld@ Jurkat (Clone E6-1)
E6-1|Control shRNA+TNF stim|T lymphocyte supension|Peripherial Blood	Bld@ Jurkat (Clone E6-1)
E6-1|NELF-E shRNA-unstim|T lymphocyte supension|Peripherial Blood	Bld@ Jurkat (Clone E6-1)
E6-1|Control shRNA-unstim|T lymphocyte supension|Peripherial Blood	Bld@ Jurkat (Clone E6-1)
MCF7|MCF7_Nutlin stimulated_ChIP|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_Input|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_H2A.Zac_ChIP|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_H2A.Z_ChIP|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_H3K27ac_ChIP|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_H3K122Ac_ChIP|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_Nutlin stimulated_input|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_unstimulated_input|breast cancer cells	Brs@ MCF-7
MCF-7|MCF-7_RNAPII_ChIP-seq|breast adenocarcinoma cells	Brs@ MCF-7
MCF-7|MCF-7_Med12_ChIP-seq|breast adenocarcinoma cells	Brs@ MCF-7
MCF-7|MCF-7_LRH1_ChIP-seq|breast adenocarcinoma cells	Brs@ MCF-7
DLD-1|Colorectal cancer cells	Dig@ DLD-1
293T|FANCD2_IP_UV treated|human cell lines (kidney, embryonic)	Kid@ 293
293T|FANCD2_IP_UV untreated|human cell lines (kidney, embryonic)	Kid@ 293
H9|H9_SOX2_AF2018	PSC@ hESC H9
H9|H9_input	PSC@ hESC H9
HCC95|HCC95_p63_4A4	Lng@ HCC95
HCC95|HCC95_SOX2_AF2018	Lng@ HCC95
HCC95|HCC95_input	Lng@ HCC95
TT|TT_p63_4A4	Dig@ T.T
TT|TT_SOX2_AF2018	Dig@ T.T
TT|TT_input	Dig@ T.T
KYSE70|KYSE70_p63_4A4	Dig@ KYSE-70
KYSE70|KYSE70_SOX2_AF2018	Dig@ KYSE-70
KYSE70|KYSE70_input	Dig@ KYSE-70
Blood lymphocytes	Bld@ Lymphocytes
IMR90|OIS Ras-Induced H3K4me3|Ras-induced cells	Lng@ IMR-90
IMR90|Control H3K4me3|control cells	Lng@ IMR-90
IMR90|OIS Ras-Induced H3|Ras-induced cells	Lng@ IMR-90
IMR90|Control H3|control cells	Lng@ IMR-90
Pfeiffer cell line|Pfeiffer cell line	Bld@ Pfeiffer
WSUDLCL2 cell line|WSUDLCL2 cell line	Bld@ WSU-DLCL2
SUDHL6 cell line|SUDHL6 cell line	Bld@ SU-DHL-6
OCI-Ly1 cell line|OCI-Ly1 cell line	Bld@ OCI-LY1
SUDHL5 cell line|SUDHL5 cell line	Bld@ SU-DHL-5
Farage cell line|Farage cell line	Bld@ Farage
OCI-Ly7 cell line|OCI-Ly7 cell line	Bld@ OCI-LY-7
Primary Tissue|Left Ventricle|N/A|coronary artery disease	CDV@ Heart Ventricles
HeLa|HeLa 1.2.11 ALT (-) cells, HMBOX1 ChIP	Utr@ HeLa
HeLa|HeLa 1.2.11 ALT (-) cells, NR2C2 ChIP	Utr@ HeLa
HeLa|HeLa 1.2.11 ALT (-) cells, NR2F2 ChIP	Utr@ HeLa
HeLa|HeLa 1.2.11 ALT (-) cells, TRF2 ChIP	Utr@ HeLa
WI-38|WI-38 VA13 ALT (+) cells, HMBOX1 ChIP	Lng@ WI-38
WI-38|WI-38 VA13 ALT (+) cells, NR2C2 ChIP	Lng@ WI-38
WI-38|WI-38 VA13 ALT (+) cells, NR2F2 ChIP	Lng@ WI-38
WI-38|WI-38 VA13 ALT (+) cells, TRF2 ChIP	Lng@ WI-38
HeLa|HeLa 1.2.11 ALT (-) cells, HeLa input DNA	Utr@ HeLa
WI-38|WI-38 VA13 ALT (+) cells, VA13 input DNA	Lng@ WI-38
T32, 3rd pair, 2nd individual|CD14 cells	Bld@ Monocytes-CD14+
T31, 3rd pair, 1st individual|CD14 cells	Bld@ Monocytes-CD14+
T22, 2nd pair, 2nd individual|CD14 cells	Bld@ Monocytes-CD14+
T21, 2nd pair, 1st individual|CD14 cells	Bld@ Monocytes-CD14+
T11, 1st pair, 1st individual|CD14 cells	Bld@ Monocytes-CD14+
BT549|BT549 breast cancer cells, input|triple negative breast cancer cells	Brs@ BT-549
BT549|BT549 breast cancer cells, IgG ChIP|triple negative breast cancer cells	Brs@ BT-549
BT549|BT549 breast cancer cells, cJun ChIP|triple negative breast cancer cells	Brs@ BT-549
BT549|BT549 breast cancer cells, Fra1 ChIP|triple negative breast cancer cells	Brs@ BT-549
CD56+ ectoderm|Cell Line|ectoderm|presumed normal|NA	PSC@ hESC derived mesendodermal cells
NFkappaB ChIP-seq, EtOH|LCL	Bld@ Lymphoblastoid cell line
U2OS_E773R|Human osteosarcoma cell line	Bon@ U2OS
U2OS_30iiB|Human osteosarcoma cell line	Bon@ U2OS
MDA-MB-453|MDA-MB-453 chromatin input-seq|breast cancer	Brs@ MDA-MB-453
MDA-MB-453|TCF7L2 ChIP-seq vehicle treatment|breast cancer	Brs@ MDA-MB-453
MDA-MB-453|TCF7L2 ChIP-seq, 16h DHT treatment|breast cancer	Brs@ MDA-MB-453
MDA-MB-453|FOXA1 ChIP-seq, 16h DHT treatment|breast cancer	Brs@ MDA-MB-453
MDA-MB-453|AR ChIP-seq, 16h DHT treatment|breast cancer	Brs@ MDA-MB-453
MDA-MB-453|MYC ChIP-seq, 6h DHT treatment|breast cancer	Brs@ MDA-MB-453
UBN1 ChIP|HeLa	Utr@ HeLa
input DNA|HeLa	Utr@ HeLa
HIRA ChIP|HeLa	Utr@ HeLa
ASF1a ChIP|HeLa	Utr@ HeLa
HA.H3.3.input|HeLa	Utr@ HeLa
HA.H3.3.faire|HeLa	Utr@ HeLa
HA.H3.3 ChIP|HeLa	Utr@ HeLa
HT1080|HT1080_Input_DNA|Fibrosarcoma cells	Bon@ HT-1080
HT1080|HT1080_XPD_ChIP_Seq|Fibrosarcoma cells	Bon@ HT-1080
HT1080|HT1080_XPB_ChIP_Seq|Fibrosarcoma cells	Bon@ HT-1080
MDA231|MDA231_H3K4_me3	Brs@ MDA-MB-231
MDA231|MDA231_H3K4_input	Brs@ MDA-MB-231
MDA231|MDA231_MBD3	Brs@ MDA-MB-231
MDA231|MDA231_MBD3_input	Brs@ MDA-MB-231
MCF-7|MCF-7_MBD3	Brs@ MCF-7
MCF-7|MCF-7_MBD3_input	Brs@ MCF-7
HeLa|HeLa cells, input	Utr@ HeLa
HeLa|HeLa cells, RNA Pol II ChIP	Utr@ HeLa
HeLa|HeLa cells, Miz1 ChIP	Utr@ HeLa
HeLa|HeLa cells, Myc ChIP	Utr@ HeLa
OCI-Ly7_input|OCI-Ly7 lymphoma cells	Bld@ OCI-LY-7
OCI-Ly7_BCL6|OCI-Ly7 lymphoma cells	Bld@ OCI-LY-7
OCI-Ly7_BACH2|OCI-Ly7 lymphoma cells	Bld@ OCI-LY-7
HeLa cells transfected with empty vector|HeLa-S3 cells	Utr@ HeLa
Kasumi-1 cells|Input DNA for LMO2 ChIP-seq|Hematopoietic|Acute myeloid leukemia	Bld@ Kasumi-1
Kasumi-1 cells|LMO2 ChIP-seq|Hematopoietic|Acute myeloid leukemia	Bld@ Kasumi-1
Kasumi-1 cells|Input DNA for HEB and E2A ChIP-seq|Hematopoietic|Acute myeloid leukemia	Bld@ Kasumi-1
Kasumi-1 cells|E2A ChIP-seq|Hematopoietic|Acute myeloid leukemia	Bld@ Kasumi-1
Kasumi-1 cells|HEB ChIP-seq|Hematopoietic|Acute myeloid leukemia	Bld@ Kasumi-1
Kasumi-1 cells|Input DNA for AML1-ETO ChIP-seq|Hematopoietic|Acute myeloid leukemia	Bld@ Kasumi-1
Kasumi-1 cells|AML1-ETO ChIP-seq|Hematopoietic|Acute myeloid leukemia	Bld@ Kasumi-1
HEK293T RAD21cv|Input ChIP-seq, RAD21cv HEK293, TEV Treated	Kid@ 293
HEK293T RAD21cv|Smc3 ChIP-seq, RAD21cv HEK293, TEV Treated	Kid@ 293
breast carcinoma cell line MCF-7|MCF-7	Brs@ MCF-7
Prostate cancer cell line|NCI H660 cell line	Prs@ NCI-H660
Prostate cancer cell line overexpressing ERa|VCaP ERa cell line	Prs@ VCaP
IMR90|IMR90 human fetal lung fibroblast cells, Rb shRNA, senescent, H3K4me3 ChIP|human fetal lung fibroblast cell line	Lng@ IMR-90
IMR90|IMR90 human fetal lung fibroblast cells, senescent, H3K4me3 ChIP|human fetal lung fibroblast cell line	Lng@ IMR-90
IMR90|IMR90 human fetal lung fibroblast cells, quiescent, H3K4me3 ChIP|human fetal lung fibroblast cell line	Lng@ IMR-90
IMR90|IMR90 human fetal lung fibroblast cells, growing, H3K4me3 ChIP|human fetal lung fibroblast cell line	Lng@ IMR-90
MCF7|MCF7_p300_ChIP|breast cancer cells	Brs@ MCF-7
MCF7|MCF7_Input_control (for p300)|breast cancer cells	Brs@ MCF-7
RPMI-8402|RPMI-8402_Input|T-lymphoblastic leukemia (T-ALL)	Bld@ RPMI 8402
RPMI-8402|RPMI-8402_ZFX_ChIPSeq|T-lymphoblastic leukemia (T-ALL)	Bld@ RPMI 8402
NOMO-1|NOMO-1_Input|Acute myeloid leukemia (AML)	Bld@ NOMO-1
NOMO-1|NOMO-1_ZFX_ChIPSeq|Acute myeloid leukemia (AML)	Bld@ NOMO-1
EPT1 cells|EPT1 cells|prostate cell model	Prs@ EP156T
EP156T cells|EP156T cells|prostate cell model	Prs@ EP156T
HL60|MLL wildtype human AML	Bld@ HL-60
MOLM-13|MLL-AF9 positive human AML	Bld@ MOLM-13
ML2|MLL-AF6 positive human AML	Bld@ ML-2
human fetal (gestational week 20) cortex|human cortex|fetal (gestational week 20)	Neu@ Fetal brain
Jurkat Trex (Invitrogen)|Jurkat_input	Bld@ Jurkat
Jurkat Trex (Invitrogen)|Jurkat_RUNX1_ChIP	Bld@ Jurkat
WI38|ras_PIASy_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_PIASy_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|ras_H3K9me3_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|ras_H3K27me3_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|ras_H3K4me3_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|ras_PolII_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|ras_Ubc9_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|ras_SUMO2_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|ras_input_DNA|primary fibroblasts	Lng@ WI-38
WI38|prolif_H3K9me3_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_H3K27me3_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_H3K4me3_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_PolII_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_Ubc9_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_SUMO2_ChIPSeq|primary fibroblasts	Lng@ WI-38
WI38|prolif_input_DNA|primary fibroblasts	Lng@ WI-38
Human neonatal epidermis_Wdr5_ChIP|human differentited primary keratinocytes (NHEK)	Epd@ NHEK
Human neonatal epidermis_input|human differentited primary keratinocytes (NHEK)	Epd@ NHEK
Human neonatal epidermis_Grhl3 ChIP|human differentited primary keratinocytes (NHEK)	Epd@ NHEK
Chromatin IP against RNAPII in MM.1S (500 nM JQ1) for 12022011_B0A1WABXX*|Plasma cell	Bld@ Plasma Cells
Whole cell extract from MM.1S cells (500 nM JQ1) for 12022011_B0A1WABXX*|Plasma cell	Bld@ Plasma Cells
Whole cell extract from MM.1S cells (500 nM JQ1)|Plasma cell	Bld@ Plasma Cells
Chromatin IP against Med1 in MM1S Rep2|Plasma cell	Bld@ MM.1S
Chromatin IP against Med1 in MM.1S (500 nM JQ1)|Plasma cell	Bld@ Plasma Cells
Chromatin IP against Max in MM.1S (500 nM JQ1) for 12022011_B0A1WABXX*|Plasma cell	Bld@ Plasma Cells
Chromatin IP against H3K4me3 in MM.1S (500 nM JQ1) for 12022011_B0A1WABXX*|Plasma cell	Bld@ Plasma Cells
Chromatin IP against H3K27ac in MM.1S (500 nM JQ1) for 12022011_B0A1WABXX*|Plasma cell	Bld@ Plasma Cells
Chromatin IP against CDK9 in MM.1S (DMSO) for 12022011_B0A1WABXX*|Plasma cell	Bld@ Plasma Cells
Chromatin IP against CDK9 in MM.1S (500 nM JQ1) for 12022011_B0A1WABXX*|Plasma cell	Bld@ Plasma Cells
Chromatin IP against c-Myc in MM.1S (500 nM JQ1)|Plasma cell	Bld@ Plasma Cells
Chromatin IP against Brd4 in MM.1S (DMSO)|Plasma cell	Bld@ Plasma Cells
Chromatin IP against Brd4 in MM.1S (500 nM JQ1)|Plasma cell	Bld@ Plasma Cells
Primary Tissue|Heart|Washington University, St. Louis|None	CDV@ Heart
Primary Tissue|Fetal Ovary|UW|None	Gon@ Ovary
HSMMtube|HSMMtube|skeletal muscle myotubes differentiated from the HSMM cell line|mesoderm	Myo@ HSMM
bone_marrow_HS27a|bone_marrow_HS27a|HS27a Human Marrow Stromal Cells are fibroblastoid cells immortalized with HPV16 E6/E7 genes as described in Roecklein and Torok-Storb, 1995 Blood 85:997-1005, insert DNA is LXSN-16 E6E7 packaged in PA31.	Bon@ HS-27A
CD4+_Naive_Wb78495824|CD4+_Naive_Wb78495824|CD4+ naive sorted cells, donor is Causasian, female 35 year old, primary pheresis of single normal subject|mesoderm	Bld@ CD4+
CD34+_Mobilized|CD34+_Mobilized|hematopoietic progenitor cells- mobilized, from donor RO01679.	Bld@ CD34 Hematopoietic stem cells
HPAEC|HPAEC|pulmonary artery endothelial cells.|mesoderm	CDV@ HPAEC
Th1|Th1|primary Th1 T cells|mesoderm	Bld@ Th1 Cells
HBVP|HBVP|brain vascular pericytes|mesoderm	CDV@ HBVP
bone_marrow_HS5|bone_marrow_HS5|HS5 Human Marrow Stromal Cells are fibroblastoid cells immortalized with HPV16 E6/E7 genes as described in Roecklein and Torok-Storb, 1995 Blood 85:997-1005, insert DNA is LXSN-16 E6E7 packaged in PA31.	Oth@ HS-5
Treg_Wb83319432|Treg_Wb83319432|T regulatory cells in vivo isolation, donor is Caucasian, male 28 year old, primary pheresis of single normal subject|mesoderm	Bld@ T-Lymphocytes, Regulatory
Th2_Wb33676984|Th2_Wb33676984|Th2 cells in vivo isolation, donor is Asian, female 26 year old, primary pheresis of single normal subject|mesoderm	Bld@ Th2 Cells
AG08470|normal skin biopsy, input|fibroblasts|skin biopsy	Epd@ AG08470
AG08470|normal skin biopsy, H3K27me3 ChIP|fibroblasts|skin biopsy	Epd@ AG08470
GM12872|GM12872|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12872
GM12873|GM12873|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12873
Confluent preadipocyte SGBS cell line|preadipocyte	Adp@ SGBS
MCF7|TLE3_ChIP	Brs@ MCF-7
MCF7|RXRA_ChIP	Brs@ MCF-7
MCF7|IgG_ChIP	Brs@ MCF-7
MCF7|KLF4_ChIP	Brs@ MCF-7
MCF7|COT2_ChIP	Brs@ MCF-7
MCF7|GREB1_XENO_ChIP	Brs@ MCF-7
MCF7|ER_XENO_ChIP	Brs@ MCF-7
MCF7|INPUT	Brs@ MCF-7
MCF7|E2F4_ICI_ChIP	Brs@ MCF-7
MCF7|E2F4_TAM_ChIP	Brs@ MCF-7
HEK293T|Human embryonic kidney cells, pull-down of GST-tagged TET3 CXXC domain protein|embryonic kidney cells	Kid@ 293
HGF|HGF|gingival fibroblasts	Oth@ HGF
HMVEC-dLy-Neo|HMVEC-dLy-Neo|neonatal lymphatic microvascular endothelial cells, dermal-derived|mesoderm	CDV@ HMVEC
HMVEC-dBl-Neo|HMVEC-dBl-Neo|neonatal blood microvascular endothelial cells, dermal-derived|mesoderm	CDV@ HMVEC
HMVEC-LLy|HMVEC-LLy|lymphatic microvascular endothelial cells, lung-derived|mesoderm	CDV@ HMVEC
HIPEpiC|HIPEpiC|iris pigment epithelial cells|ectoderm	Oth@ HIPEpiC
HMVEC-LBl|HMVEC-LBl|blood microvascular endothelial cells, lung-derived|mesoderm	CDV@ HMVEC
HA-h|HA-h|astrocytes-hippocampal|ectoderm	Neu@ HA-h
HSMM|HSMM|skeletal muscle myoblasts|mesoderm	Myo@ HSMM
A549|lung adenocarcinoma cells:A549, the histone was h3k9ac,treated by tgf-beta+sorafenib	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k9me3,treated by tgf-beta+sorafenib	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k4me3,treated by tgf-beta+sorafenib	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k27me3,treated by tgf-beta+sorafenib	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k9ac,treated by tgf-beta	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k9me3,treated by tgf-beta	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k4me3,treated by tgf-beta	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k27me3,treated by tgf-beta	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k9ac,without treated	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k9me3,without treated	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k4me3,without treated	Lng@ A549
A549|lung adenocarcinoma cells:A549, the histone was h3k27me3,without treated	Lng@ A549
Primary Tissue|Psoas Muscle|N/A|iron deficiency, bipolar	Myo@ Muscles
Primary Tissue|Gastric|N/A|iron deficiency, bipolar	Dig@ Gastric primary sample
A375|A375|pigmented melanoma	Epd@ A-375
Adult_CD4_Th1|Adult_CD4_Th1|CD4+ cells isolated from human blood and enriched for Th1 populations|mesoderm	Bld@ CD4-Positive T-Lymphocytes
iPS_NIHi7|iPS_NIHi7|iPS cells derived from AG08395 fibroblast	PSC@ iPS cells
RWPE1|RWPE1|prostate epithelial	Prs@ RWPE-1
Olf_neurosphere|Olf_neurosphere|Human olfactory neurosphere-derived cells from mucosal biopsies	Neu@ Olf neurosphere
Cerebellum_OC|Cerebellum_OC|Primary frozen cerebellum tissue from NICHD donor IDs 1104 (Rep B1), 602 (Rep B2), 1442 (Rep B3), all Caucasian	Neu@ Adult brains
Monocytes-CD14+|Monocytes-CD14+|Monocytes-CD14+ are CD14-positive cells from human leukapheresis production, from donor RO 01746 (draw 1 ID is RO 01746, draw 2 ID is RO 01826), newly promoted to tier 2: not in 2011 analysis|mesoderm	Bld@ Monocytes-CD14+
GC_B_cell|GC_B_cell|Germinal center B cells (CD77+) isolated from de-identified tonsillectomy	Bld@ B-Lymphocytes
Cerebrum_frontal_OC|Cerebrum_frontal_OC|Primary frozen frontal cerebrum tissue from NICHD donor IDs 1104 (Rep B1), 602 (Rep B2), 1442 (Rep B3), all Caucasian	Neu@ Adult brains
Medullo_D341|Medullo_D341|Medulloblastoma cell line of neuron or neuron precurosr origin	Neu@ D341 Med
FibroP_AG08395|FibroP_AG08395|fibroblasts taken from individuals with Parkinson's disease	Epd@ FibroP
HEK293T|HEK293T|embryonic kidney that expresses SV40 large T antigen, HEK293 (ATCC number CRL-1573) is the parental cell line|mesoderm	Kid@ 293
Adult_CD4_Th0|Adult_CD4_Th0|CD4+ cells isolated from human blood and enriched for Th0 populations|mesoderm	Bld@ CD4-Positive T-Lymphocytes
Colo829|Colo829|malignant melanoma	Dig@ COLO 829
iPS_CWRU1|iPS_CWRU1|iPS cells derived from MSC658 fibroblast	PSC@ iPS cells
iPS_NIHi11|iPS_NIHi11|iPS cells derived from AG20443 fibroblast	PSC@ iPS cells
Frontal_cortex_OC|Frontal_cortex_OC|Primary ventromedial prefrontal cortex, from KPBBB donor IDs 673 (Rep B1) and 913 (Rep B2)	Neu@ Prefrontal Cortex
FibroP_AG08396|FibroP_AG08396|fibroblasts taken from individuals with Parkinson's disease	Epd@ FibroP
FibroP_AG20443|FibroP_AG20443|fibroblasts taken from individuals with Parkinson's disease	Epd@ FibroP
Psoas_muscle_OC|Psoas_muscle_OC|Primary frozen psoas muscle tissue from NICHD donor IDs 1104 (Rep B1 DNase), 602 (Rep B2 DNase), 1442 (Rep B3 DNase), 1540 (Rep B1), 1863 (Rep B2 FAIRE)	Myo@ Muscles
Naive_B_cell|Naive_B_cell|Naive B cells (IgD+) isolated from de-identified tonsillectomy	Bld@ B-Lymphocytes
H9 hESC	PSC@ hESC H9
H9 hESC|DOX-damaged induced hESC	PSC@ hESC H9
Medullo	Neu@ Medullo
Medullo|Medullo|medulloblastoma (aka D721), surgical resection from a patient with medulloblastoma as described by Darrell Bigner (1997)|ectoderm	Neu@ Medullo
GM10248	Bld@ GM10248
Colon_OC|Colon_OC|Primary frozen colon tissue from NCTC donor IDs 10-0005A (Rep B1) and 10-0170A (Rep B2), African American and caucasian	Dig@ Colon
Kidney_OC	Kid@ Kidney
GM13976	Bld@ GM13976
Spleen_OC	Oth@ Spleen
Lung_OC	Lng@ Lung
Pancreas_OC	Pan@ Pancreas
Lung_OC|Lung_OC|Primary frozen lung tissue from NICHD donor IDs 1104 (Rep B1 DNase), 602 (Rep B2 DNase), 1442 (Rep B3 DNase) and CF Center donor IDs DD006I (Rep B1 FAIRE) and DD007I (Rep B2 FAIRE)	Lng@ Lung
GM20000	Bld@ GM20000
Spleen_OC|Spleen_OC|Primary frozen spleen tissue from NICHD donor IDs 1863 (Rep B1) and 4548 (Rep B2)	Oth@ Spleen
Pancreas_OC|Pancreas_OC|Primary frozen pancreas tissue from NCTC donor IDs 09-0144A (Rep B1) and 10-0021A (Rep B2)	Pan@ Pancreas
GM10266	Bld@ GM10266
GM13977	Bld@ GM13977
Kidney_OC|Kidney_OC|Primary frozen kidney tissue from NICHD donor IDs 1104 (Rep B1 DNase), 602 (Rep B2 DNase), 1442 (Rep B3 DNase), 1863 (Rep B3 FAIRE) and NCTC donor ID 10-0022A (Rep B1 FAIRE)	Kid@ Kidney
Chromatin IP against 48hr_IgG|H1 embryonic stem cells	PSC@ hESC H1
Chromatin IP against 48hr_H3K4me3|H1 embryonic stem cells	PSC@ hESC H1
Chromatin IP against 48hr_H3K27ac|H1 embryonic stem cells	PSC@ hESC H1
U2OS|U2OS_KD_input|human osteosarcoma cells	Bon@ U2OS
U2OS|U2OS_UV_SIRT3|human osteosarcoma cells	Bon@ U2OS
U2OS|U2OS_UV_input|human osteosarcoma cells	Bon@ U2OS
U2OS|U2OS_NT_SIRT3|human osteosarcoma cells	Bon@ U2OS
U2OS|U2OS_NT_IgG|human osteosarcoma cells	Bon@ U2OS
U2OS|U2OS_NT_input|human osteosarcoma cells	Bon@ U2OS
Dnd41|Dnd41|T cell leukemia with Notch mutation|mesoderm	Bld@ DND-41
HSMM	Myo@ HSMM
CD20+|CD20+|B cells from donors RO01778 and RO01794, newly promoted to tier 2: not in 2011 analysis|mesoderm	Bld@ CD20+
BJ|BJ_c-Myc ChIP-Seq_48hr_mockinduction|foreskin fibroblast cell	Epd@ BJ
BJ|BJ_Oct4 ChIP-Seq_48hr_mockinduction|foreskin fibroblast cell	Epd@ BJ
T47D|T47D cells	Brs@ T-47D
Leiomyoma cells|Leiomyoma cells	Myo@ Leiomyoma
A549|A549 Input|NSCLC	Lng@ A549
A549|A549 Nicotine stimulated|NSCLC	Lng@ A549
A549|A549 Serum starved|NSCLC	Lng@ A549
MCF10A|MCF10A_P-Ser2_ChIP-seq|breast epithelial cells	Brs@ MCF 10A
MCF10A|MCF10A_PALB2_ChIP-seq|breast epithelial cells	Brs@ MCF 10A
MCF10A|MCF10A_BRCA1_ChIP-seq|breast epithelial cells	Brs@ MCF 10A
PC-3|Ago2 IP	Prs@ PC-3
PC-3|Ago1 IP	Prs@ PC-3
PC-3|H3k4me3 IP	Prs@ PC-3
PC-3|Input DNA	Prs@ PC-3
Burkitt lymphoma|IgG_ChIP-Seq|Raji cells	Bld@ RAJI
Burkitt lymphoma|EBV_EBNA1_Raji_ChIP-Seq|Raji cells	Bld@ RAJI
ZR751|ZR751_input|breast cancer cells	Brs@ ZR-75-1
MCF-7|MCF_input|breast cancer cells	Brs@ MCF-7
ZR751|ZR751_siGATA_ER_estrogen|breast cancer cells	Brs@ ZR-75-1
ZR751|ZR751_siNT_ER_estrogen|breast cancer cells	Brs@ ZR-75-1
MCF-7|siGATA_p300_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|siNT_p300_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|siGATA_p300_estrogen|breast cancer cells	Brs@ MCF-7
MCF-7|siNT_p300_estrogen|breast cancer cells	Brs@ MCF-7
MCF-7|siGATA_H3K4me1_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|siNT_H3K4me1_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|siGATA_H3K4me1_estrogen|breast cancer cells	Brs@ MCF-7
MCF-7|siNT_H3K4me1_estrogen|breast cancer cells	Brs@ MCF-7
MCF-7|siGATA_H3K27ac_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|siNT_H3K27ac_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|siGATA_H3K27ac_estrogen|breast cancer cells	Brs@ MCF-7
MCF-7|siNT_H3K27ac_estrogen|breast cancer cells	Brs@ MCF-7
MCF-7|siGATA_FOXA1_Veh|breast cancer cells	Brs@ MCF-7
MCF-7|siNT_FOXA1_Veh|breast cancer cells	Brs@ MCF-7
HeLa|WCE 3mM sodium bicarbonate	Utr@ HeLa
HeLa|WCE 25mM sodium bicarbonate	Utr@ HeLa
HeLa|H4K16ac 3mM sodium bicarbonate	Utr@ HeLa
HeLa|H4K16ac 25mM sodium bicarbonate	Utr@ HeLa
NCI-H3122|H3122_FOXA1_ab23738	Lng@ NCI-H3122
NCI-H3122|H3122_NKX2-1_BL4000_2	Lng@ NCI-H3122
NCI-H3122|H3122_input_2	Lng@ NCI-H3122
NCI-H2087|H2087_NKX2-1_BL4000	Lng@ NCI-H2087
NCI-H2087|H2087_input	Lng@ NCI-H2087
NCI-H1819|H1819_NKX2-1_BL4000	Lng@ HCC1819
NCI-H1819|H1819_input	Lng@ HCC1819
NCI-H3122|H3122_NKX2-1_BL4000	Lng@ NCI-H3122
NCI-H3122|H3122_input	Lng@ NCI-H3122
HEK293|HEK293, control	Kid@ 293
HEK293|HEK293, HP1b ChIP	Kid@ 293
HEK293|HEK293, HP1a ChIP	Kid@ 293
HEK293|HEK293, Brd4 ChIP	Kid@ 293
HEK293|HEK293, Brd3 ChIP	Kid@ 293
HEK293|HEK293, Brd2 ChIP	Kid@ 293
Blood|CD4|Blood|Adult	Bld@ CD4+
LS180 cells|LS180_SMRT_125|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_SMRT_Veh|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_NCoR_125|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_NCoR_Veh|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_MED1_125|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_MED1_Veh|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_CBP_125|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_CBP_Veh|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_SRC1_125|cultured CRC cells	Dig@ LS-180
LS180 cells|LS180_SRC1_Veh|cultured CRC cells	Dig@ LS-180
FLP76|derived from HEK293, human embryonic kidney cells	Kid@ 293
293T-Rex|derived from HEK293, human embryonic kidney cells	Kid@ 293
K562|chronic myelogenous leukemia cells	Bld@ K-562
H2A.Z_hES_ChIPSeq|H1 human embryonic stem cells	PSC@ hESC H1
RPMI-8402|T-ALL cell line, WCE input|T-cell acute lymphoblastic leukemia (T-ALL) cells	Bld@ RPMI 8402
M23F|hiPSC_M23F, H3K27me3 ChIP|human induced pluripotent stem cells (hiPSCs)	PSC@ iPS cells
M23F|hiPSC_M23F, H3K4me3 ChIP|human induced pluripotent stem cells (hiPSCs)	PSC@ iPS cells
H1-hESC (WiCell Research Institute WA01)|human embryonic stem cells|inner cell mass, sex: M	PSC@ hESC H1
H3K4me3 hypoxia ChIP-seq|HUVEC	CDV@ HUVEC
H3K4me3 normoxia ChIP-seq|HUVEC	CDV@ HUVEC
H3K4me1 hypoxia ChIP-seq|HUVEC	CDV@ HUVEC
H3K4me1 normoxia ChIP-seq|HUVEC	CDV@ HUVEC
INPUT under hypoxia ChIP-seq|HUVEC	CDV@ HUVEC
INPUT under normoxia ChIP-seq|HUVEC	CDV@ HUVEC
HIF1 under hypoxia ChIP-seq|HUVEC	CDV@ HUVEC
HIF1 under normoxia ChIP-seq|HUVEC	CDV@ HUVEC
NCCIT|DF-NCCIT_NP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-NCCIT_NP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-H2AK119Ub_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-H3K36me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-H3K27me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-H3K9me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-H3K4me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-DNMT3B_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-DNMT3A_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|DF-DNMT1_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-H2AK119Ub_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-H3K36me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-H3K27me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-H3K9me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-H3K4me3_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-DNMT3B_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-DNMT3A_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|UD-DNMT1_ChIP|embroynic cancer	PSC@ NCCIT
NCCIT|Input-DNA_ChIP|embroynic cancer	PSC@ NCCIT
PrEC	Prs@ PrEC
Combined IP DNA_non-stimulated PBMCs_Control IgG ChIP-Seq|peripheral blood mononuclear cells (PBMCs)	Bld@ PBMC
IMR90|Human Liver	Lng@ IMR-90
BCBL1|BCBL1 pleural effusion lymphoma, SMC1 ChIP|KSHV-infected pleural effusion lymphoma cells	Bld@ BCBL1
BCBL1|BCBL1 pleural effusion lymphoma, CTCF ChIP|KSHV-infected pleural effusion lymphoma cells	Bld@ BCBL1
Acute lymphoblastic leukemia cells with MLL/AF4 translocation, H3K4me3 ChIP|RS4;11 ALL cells	Bld@ RS4-11
Acute lymphoblastic leukemia cells with MLL/AF4 translocation, AF4 ChIP|RS4;11 ALL cells	Bld@ RS4-11
Acute lymphoblastic leukemia cells with MLL/AF4 translocation, MLLN ChIP|RS4;11 ALL cells	Bld@ RS4-11
Acute lymphoblastic leukemia cells with MLL/AF4 translocation, H3K79me2 ChIP|RS4;11 ALL cells	Bld@ RS4-11
HeLa|HeLa_Oct1	Utr@ HeLa
IMR90hTert|IMR90hTert_SNAP190|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
IMR90hTert|IMR90hTert_SNAP19|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
IMR90hTert|IMR90hTert_SNAP43|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
IMR90hTert|IMR90hTert_TF2B|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
IMR90hTert|IMR90hTert_RPB2|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
IMR90hTert|IMR90hTert_Brf2|diploid fibroblast-like cells|fetal female lung	Lng@ IMR-90
HCT116|colorectal cancer cells, normoxia, CDK8 ChIP	Dig@ HCT 116
HCT116|colorectal cancer cells, input	Dig@ HCT 116
BGO3 (feeder free)|BGO3_t0_ChipSeq|Embryonic stem cells	PSC@ hESC BG03
BGO3 (feeder free)|Endodermal Diff of BG03 cells t|Embryonic stem cells	PSC@ hESC derived mesendodermal cells
U2OS|Input_DNA|Osteosarcoma	Bon@ U2OS
HCT116|H2B ChIP-Seq USP49 knockdown|colorectal carcinoma	Dig@ HCT 116
HCT116|H2B ChIP-Seq Control|colorectal carcinoma	Dig@ HCT 116
HCT116|uH2b ChIP-Seq USP49 knockdown|colorectal carcinoma	Dig@ HCT 116
HCT116|uH2B ChIP-Seq Control|colorectal carcinoma	Dig@ HCT 116
RWPE1|RWPE1-ERG prostate epithelial cell line, input|benign prostate epithelial cells	Prs@ RWPE-1
RWPE1|RWPE1-ERG prostate epithelial cell line, ERG ChIP|benign prostate epithelial cells	Prs@ RWPE-1
HeLa S3|cervical cancer cell line (low-density fractions)	Utr@ HeLa
GM12878|input vehicle treated|lymphoblastoid	Bld@ GM12878
GM12878|input SFN treated|lymphoblastoid	Bld@ GM12878
GM06993, GM07000, GM11882, GM11992, GM12763, GM12872|IgG ChIP vehicle treated|lymphoblastoid	Bld@ GM12872
GM06993, GM07000, GM11882, GM11992, GM12763, GM12872|IgG ChIP SFN treated|lymphoblastoid	Bld@ GM12872
GM07000, GM11882|NRF2 ChIP vehicle treated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM06993, GM12872|NRF2 ChIP vehicle treated|lymphoblastoid	Bld@ GM12872
GM11992, GM12763|NRF2 ChIP vehicle treated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM11994|NRF2 ChIP vehicle treated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM07000, GM11882|NRF2 ChIP SFN treated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM06993, GM12872|NRF2 ChIP SFN treated|lymphoblastoid	Bld@ GM12872
GM11992, GM12763|NRF2 ChIP SFN treated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM11994|NRF2 ChIP SFN treated|lymphoblastoid	Bld@ Lymphoblastoid cell lines
HAEC|HAEC_input_500nM TSA_12h|Primary Human Aortic Endothelial Cells	CDV@ HAEC
Primary Cell|CD19|presumed normal|CD19+	Bld@ B-cell (CD19+)
Primary Tissue|Adipose Tissue|N/A|None	Adp@ Adipose Tissue
NCC_TFAP2A|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
H293T|H293T_TET2 kd_H3K4me3	Kid@ 293
H293T|H293T_RNAi control_H3K4me3	Kid@ 293
H293T|H293T_HT OGT	Kid@ 293
H293T|H293T_HT TET3	Kid@ 293
H293T|H293T_HT TET2	Kid@ 293
H293T|H293T_HT Control	Kid@ 293
H293T|H293T_H3K4me3	Kid@ 293
IMR90|Senescent H3K4me3 ChIP|senescent cells	Lng@ IMR-90
IMR90|Proliferating LaminB1 ChIP|proliferating cells	Lng@ IMR-90
IMR90|Proliferating H3K4me3 ChIP|proliferating cells	Lng@ IMR-90
WM262|WM262 WCE|Melanoma	Epd@ WM262
WM853.2|Chromatin IP against SetDB1|Melanoma	Epd@ WM853
Wm451-lu|Wm451-lu WCE|Melanoma	Epd@ WM451
WM853.2|WM853.2 WCE|Melanoma	Epd@ WM853
BGO3 (feeder free)|Smc1 ChipSeq in human ES cells|embryonic stem cells	PSC@ hESC BG03
BGO3 (feeder free)|Smc3 ChipSeq in human ES cells|embryonic stem cells	PSC@ hESC BG03
BGO3 (feeder free)|Endodermal Diff of BG03 cells, Activin A, t|embryonic stem cells	PSC@ hESC derived mesendodermal cells
BGO3 (feeder free)|ChipSeq for Pol2|embryonic stem cells	PSC@ hESC BG03
BGO3 (feeder free)|ChipSeq for IgG|embryonic stem cells	PSC@ hESC BG03
BJ|BJ_DNA Input_control_48hr_postinduction|foreskin fibroblast cell	Epd@ BJ
BJ|BJ_c-Myc ChIP-Seq_48hr_postinduction|foreskin fibroblast cell	Epd@ BJ
BJ|BJ_Klf4 ChIP-Seq_48hr_postinduction|foreskin fibroblast cell	Epd@ BJ
BJ|BJ_Sox2 ChIP-Seq_48hr_postinduction|foreskin fibroblast cell	Epd@ BJ
BJ|BJ_Oct4 ChIP-Seq_48hr_postinduction|foreskin fibroblast cell	Epd@ BJ
Jurkat E6-1|01142010_610A5AAXX_B8	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|06172009_42A7LAAXX_B7	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|03232009_3140UAAXX_B8	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|03232009_3140UAAXX_B6	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|03232009_3140UAAXX_B7	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|10162009_42YHYAAXX_B1	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|10162009_42YHYAAXX_B2	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|06172009_42A7LAAXX_B1	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|10162009_42YHYAAXX_B3	Bld@ Jurkat (Clone E6-1)
Jurkat E6-1|04102009_3139VAAXX_B5	Bld@ Jurkat (Clone E6-1)
HEK293|HEK293, Dcp2 shRNA, RNA pol II ChIP	Kid@ 293
HEK293|HEK293, Dcp1a shRNA, RNA pol II ChIP	Kid@ 293
HEK293|HEK293, Edc3 shRNA, RNA pol II ChIP	Kid@ 293
HEK293|HEK293, TTF2+Xrn2 shRNA, RNA pol II ChIP	Kid@ 293
HEK293|HEK293, Xrn2 shRNA, RNA pol II ChIP	Kid@ 293
HEK293|HEK293, TTF2 shRNA, RNA pol II ChIP	Kid@ 293
HEK293|HEK293, scrambled shRNA, RNA pol II ChIP	Kid@ 293
HEK293|HEK293, RNA pol II ChIP	Kid@ 293
HeLa|HeLa, Dcp1a ChIP	Utr@ HeLa
HeLa|HeLa, Xrn2 ChIP	Utr@ HeLa
HeLa|HeLa, input	Utr@ HeLa
SKBR-3|SKBR-3, TFAP2C ChIP	Brs@ SK-BR-3
MDA-MB-453|MDA-MB-453, TFAP2C ChIP	Brs@ MDA-MB-453
BT-474|BT-474, TFAP2C ChIP	Brs@ BT-474
MCF-7|MCF-7, TFAP2C ChIP	Brs@ MCF-7
human embryonic stem cell (H1)|human embryonic stem cell (H1)	PSC@ hESC H1
HeLa|RNA Pol II WCE	Utr@ HeLa
IMR90|lung fibroblasts|contact-inhibited IMR90	Lng@ IMR-90
H1|H1 human Embryonic stem cell	PSC@ hESC H1
H1|H1 human Embryonic stem cells	PSC@ hESC H1
HepG2.2.15|HepG2.2.15 cells, H3K27me3 ChIP|human hepatocellular liver carcinoma cells	Liv@ Hep G2
HepG2.2.15|HepG2.2.15 cells, H3K4me3 ChIP|human hepatocellular liver carcinoma cells	Liv@ Hep G2
HepG2|HepG2 cells, H3K27me3 ChIP|human hepatocellular liver carcinoma cells	Liv@ Hep G2
HepG2|HepG2 cells, H3K4me3 ChIP|human hepatocellular liver carcinoma cells	Liv@ Hep G2
Human Cerebellum tissue (Cat # TCB-4098, Capital Biosciences USA)|Cebrellum	Neu@ Adult brains
Human Peripheral Blood Lymphocytes|Cebrellum	Bld@ Lymphocytes
Human Peripheral Blood Lymphocytes|Peripheral Blood Lymphocytes	Bld@ Lymphocytes
K562|control knockdown	Bld@ K-562
K562|ATRX knockdown	Bld@ K-562
HeLa-S3|HeLa_RNA Polymerase 2 ChIP-Seq|HELA cell culture	Utr@ HeLa
NB4(leukemic)	Bld@ NB-4
H1 hESCs-SUZ12 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-SIRT6 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-SAP30 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-PHF8 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-P300 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-JMJD2A ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-JARID1C ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-JARID1B ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-HDAC6 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-HDAC2 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-EZH2 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
H1 hESCs-CHD7 ChIP-seq|H1 ES cells were grown in TeSR media on Matrigel (Cellular Dynamics)	PSC@ hESC H1
K562-SUZ12 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-SIRT6 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-RNF2 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-RNAPIIS5P ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-REST ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-PCAF ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-P300 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-NSD2 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-NCOR ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-MI2 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-LSD1 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-KAT3A/CBP ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-JARID1C ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-HP1g ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-EZH2 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-ESET ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-CHD7 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-CBX8 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
K562-CBX2 ChIP-seq|K562 erythrocytic leukaemia cells (ATCC CCL-243)	Bld@ K-562
NCCIT|NCCIT|embryonic carcinoma cells	PSC@ NCCIT
siRNF20-transfected NCCIT|NCCIT|embryonic carcinoma cells	PSC@ NCCIT
siEGFP-transfected NCCIT|NCCIT|embryonic carcinoma cells	PSC@ NCCIT
HCT116|SP1 ChIP-seq - HCT116	Dig@ HCT 116
293T-Rex|293T-Rex, CBX2 ChIP	Kid@ 293
293T-Rex|293T-Rex, PCGF4 ChIP	Kid@ 293
293T-Rex|293T-Rex, RYBP ChIP	Kid@ 293
293T-Rex|293T-Rex, RING1B ChIP	Kid@ 293
293T-Rex|293T-Rex, H2AK119Ub1 ChIP	Kid@ 293
293T-Rex|293T-Rex, H3K27me3 ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-CBX2.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-PCGF6.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-PCGF5.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-PCGF4.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-PCGF2.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-PCGF1.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-RYBP.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, FH-RING1B.HA ChIP	Kid@ 293
293T-Rex|293T-Rex, input	Kid@ 293
patient B input|t(8;21) AML patient Blast cells	Bld@ Leukemia, Myeloid
patient A input|t(8;21) AML patient Blast cells	Bld@ Leukemia, Myeloid
Blast cells from human patient B with t(8;21) AML|t(8;21) AML patient Blast cells	Bld@ Leukemia, Myeloid
Blast cells from human patient A with t(8;21) AML|t(8;21) AML patient Blast cells	Bld@ Leukemia, Myeloid
HUVEC_p65_10 ng/ml_TNF_30min|Human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_p65_without_TNF|Human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_PolII_10 ng/ml_TNF_30min|Human umbilical vein endothelial cells	CDV@ HUVEC
HUVEC_PolII_without_TNF|Human umbilical vein endothelial cells	CDV@ HUVEC
GM12871|GM12871|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed.|mesoderm	Bld@ GM12871
GM12869|GM12869|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed.|mesoderm	Bld@ GM12869
GM12870|GM12870|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed.|mesoderm	Bld@ GM12870
GM12867|GM12867|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed.|mesoderm	Bld@ GM12867
GM12868|GM12868|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1459, treatment: Epstein-Barr Virus transformed.|mesoderm	Bld@ GM12868
HPdLF|HPdLF|periodontal ligament fibroblasts	Oth@ HPdLF
HRCEpiC|HRCEpiC|renal cortical epithelial cells|mesoderm	Kid@ HRCEpiC
NH-A|NH-A|astrocytes (also called Astrocy)|ectoderm	Neu@ NH-A
BE(2)-C/Tet-Off/Myc-HOXC9|BE2C/Tet-Off/HOXC9_Doxy-_6d_Input|Sympathetic nervous system|Neuroblastoma	Neu@ BE(2)-C
Human tonsilar germinal center B cells|Human tonsilar germinal center B cells (CD77+)	Bld@ B-Lymphocytes
Human tonsilar nave B cells|Human tonsilar nave B cells (IgD+)	Bld@ B-Lymphocytes
OCI-Ly8|Diffuse Large B-cell Lymophoma	Bld@ OCI-LY8
OCI-Ly1|Diffuse Large B-cell Lymophoma	Bld@ OCI-LY1
HEK293T|Human Embryonic Kidney Cell 293T|human embryonic kidney cells	Kid@ 293
HEK293T|Whole Cell Extract_ChIP-seq (input control)|human embryonic kidney cells	Kid@ 293
HEK293T|AFF4_ChIP-seq|human embryonic kidney cells	Kid@ 293
iPSC-derived NSCs bearing homozygous LRRK2(G2019S) mutation at passage 15|NSCs	PSC@ iPS derived neural cells
iPSC-derived NSCs bearing homozygous LRRK2(G2019S) mutation at passage 10|NSCs	PSC@ iPS derived neural cells
wild-type iPSC-derived NSCs at passage 15|NSCs	PSC@ iPS derived neural cells
wild-type iPSC-derived NSCs at passage 10|NSCs	PSC@ iPS derived neural cells
iPSCs bearing homozygous LRRK2(G2019S) mutation|iPSCs	PSC@ iPS cells
wild-type iPSCs|iPSCs	PSC@ iPS cells
hGBM1 + Dox + Arvanil + BMP7 INPUT (ATF3)|Glioblastoma Multiforme stem like	Neu@ GBM1-HAM
hGBM1 + Dox + Arvanil + BMP7 ATF3|Glioblastoma Multiforme stem like	Neu@ GBM1-HAM
hGBM 5 INPUT|Glioblastoma Multiforme stem like	Neu@ GBM1-HAM
hGBM 5 BMI1|Glioblastoma Multiforme stem like	Neu@ GBM1-HAM
hGBM 1 INPUT (BMI1)|Glioblastoma Multiforme stem like	Neu@ GBM1-HAM
hGBM 1 BMI1 REP 2|Glioblastoma Multiforme stem like	Neu@ GBM1-HAM
hGBM 1 BMI1|Glioblastoma Multiforme stem like	Neu@ GBM1-HAM
hNPCs INPUT|Foetal Neural Progenitor cells	Neu@ Fetal neural progenitor cells
hNPCs BMI1|Foetal Neural Progenitor cells	Neu@ Fetal neural progenitor cells
MCF-7|Chromatin IP against yeast specific Antibody|human breast adenocarcinoma	Brs@ MCF-7
MCF-7|Chromatin IP against RNA Pol II|human breast adenocarcinoma	Brs@ MCF-7
NB4 cells|NB4 cells	Bld@ NB-4
HCT116 colorectal cancer cells|HCT116 cancer cells	Dig@ HCT 116
untransduced|human myoblasts	Myo@ Myoblasts
lenti-DUX4-fl|human myoblasts	Myo@ Myoblasts
Cell culture|HCT116	Dig@ HCT 116
Embryonic Stem Cells|Embryonic Stem Cells	PSC@ Embryonic Stem Cells
THP-1|THP-1, control ChIP-Seq|monocytic cells	Bld@ THP-1
THP-1|THP-1, PU.1 ChIP-Seq|monocytic cells	Bld@ THP-1
THP-1|THP-1, RXR ChIP-Seq|monocytic cells	Bld@ THP-1
THP-1|THP-1, PPARg ChIP-Seq|monocytic cells	Bld@ THP-1
Monocytes-CD14+_RO01746|Monocytes-CD14+|Monocytes-CD14+ are CD14-positive cells from human leukapheresis production, from donor RO 01746 (draw 1 ID is RO 01746, draw 2 ID is RO 01826), Monocytes-CD14+_RO01746 and Monocytes-CD14+_RO01826 are being used as replicates, newly promoted to tier 2: not in 2011 analysis|mesoderm	Bld@ Monocytes-CD14+
GM19238|B-lymphocyte, lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed	Bld@ GM19238
GM19239|B-lymphocyte, lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed	Bld@ GM19239
GM19240|B-lymphocyte, lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, treatment: Epstein-Barr Virus transformed	Bld@ GM19240
MDA-231|MDA-231_LacZ|MDA-231 cell line overexpressing human HOTAIR using LacZ probe	Brs@ MDA-MB-231
MDA-231|MDA-231_shEZH2_HOTAIR|MDA-231 cell line overexpressing human HOTAIR with EZH2 knocked down	Brs@ MDA-MB-231
RKO|RKO_input DNA|human colon carcinoma	Dig@ RKO
RKO|RKO_HBO1_ChIPseq|human colon carcinoma	Dig@ RKO
Primary Cell|CD4 Primary Cells|None|CD4	Bld@ CD4+
Primary Cell|Mobilized CD8 Primary Cells|None|CD8+	Bld@ CD8+
Primary Tissue|Fetal Skin|UW|None	Epd@ Fetal skin
Stellate|Human Hepatic Stellate Cells, Liver that was perfused with collagenase and sellected for hepatic stellate cells by density gradient|endoderm	Liv@ Hepatic Stellate Cells
Huh-7.5|Hepatocellular carcinoma, hepatocytes selected for high levels of hepatitis C replication|endoderm	Liv@ HuH-7
8988T|human pancreas adenocarcinoma (PA-TU-8988T), established in 1985 from the liver metastasis of a primary pancreatic adenocarcinoma from a 64-year-old woman - DSMZ|endoderm	Pan@ PA-TU-8988T
Hepatocytes|Primary Human Hepatocytes, liver perfused by enzymes to generate single cell suspension|endoderm	Liv@ Hepatocytes
GM19239|B-Lymphocyte, Lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM19239
GM19238|B-Lymphocyte, Lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM19238
Osteobl|normal human osteoblasts (NHOst)|mesoderm	Bon@ Osteobl
GM18507|Lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM18507
A549|epithelial cell line derived from a lung carcinoma tissue. (PMID: 175022), This line was initiated in 1972 by D.J. Giard, et al. through explant culture of lung carcinomatous tissue from a 58-year-old caucasian male. - ATCC|endoderm	Lng@ A549
GM19240|B-Lymphocyte, Lymphoblastoid, International HapMap Project, Yoruba in Ibadan, Nigera, Treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM19240
HTR8svn|trophoblast (HTR-8/SVneo) cell line, a thin layer of ectoderm that forms the wall of many mammalian blastulas and functions in the nutrition and implantation of the embryo|Blastula	Oth@ HTR8svn
Huh-7|Hepatocellular carcinoma|endoderm	Liv@ HuH-7
HPDE6-E6E7|pancreatic duct cells immortalized with E6E7 gene of HPV|endoderm	Pan@ HPDE6
Medullo|Medulloblastoma (aka D721), surgical resection from a patient with medulloblastoma as described by Darrell Bigner (1997)|ectoderm	Neu@ Medullo
NHEK|epidermal keratinocytes|ectoderm	Epd@ NHEK
Melano|epidermal melanocytes|ectoderm	Epd@ Melanocytes
H9ES|human embryonic stem cell (hESC) H9|inner cell mass	PSC@ hESC H9
Chorion|chorion cells (outermost of two fetal membranes), fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes.|extraembryonic mesoderm, trophectoderm	Oth@ Chorion
SK-N-SH_RA|neuroblastoma cell line, treatment: differentiated with retinoic acid. (Biedler, et al. Morphology and Growth, Tumorigenicity, and Cytogenetics of Human Neuroblastoma Cells in Continuous Culture. Cancer Research 33, 2643-2652, November 1973.)|ectoderm	Neu@ SK-N-SH
GM12891|B-lymphocyte, lymphoblastoid, International HapMap Project, CEPH/Utah pedigree 1463, treatment: Epstein-Barr Virus transformed|mesoderm	Bld@ GM12891
H1-hESC|inner cell mass	PSC@ hESC H1
ECC-1|epithelial cell line derived from an endometrium adenocarcinoma, fetal membranes were collected from women who underwent planned cesarean delivery at term, before labor and without rupture of membranes|epithelia	Utr@ ECC-1
PANC-1|pancreatic carcinoma, (PMID: 1140870) PANC-1 was established from a pancreatic carcinoma, which was extracted via pancreatico-duodenectomy specimen from a 56-year-old Caucasian individual. Malignancy of this cell line was verified via in vitro and in vivo assays.	Pan@ PANC-1
SK-N-MC	Neu@ SK-N-MC
K562|mesoderm	Bld@ K-562
SK-N-SH|neuroblastoma, newly promoted to tier 2: not in 2011 analysis, the SK-N-SH line was established from a neuroblastoma in a 4 year old individual.	Neu@ SK-N-SH
GATA2 ChIP-seq CD34+ progenitors BMP|Hematopoietic Stem &amp; Progenitor Cells	Bld@ CD34 Hematopoietic stem cells
HUVECs_statin-4h|Human umbilical vein cells	CDV@ HUVEC
HUVECs_DMSO-4h|Human umbilical vein cells	CDV@ HUVEC
HUVECs_NS|Human umbilical vein cells	CDV@ HUVEC
HumanFetaltHeart_polII|heart|fetus (gestational week 16)	CDV@ Heart
HumanFetaltHeart_acCBP-p300|heart|fetus (gestational week 16)	CDV@ Heart
HumanAdultHeart_acCBP-p300|heart|adult (45yr)	CDV@ Heart
HeLa|RNA Pol II siRNA Gdown1	Utr@ HeLa
HeLa|RNA Pol II siRNA Control	Utr@ HeLa
HeLa|Gdown1 Flavo	Utr@ HeLa
HeLa|Gdown1 Control	Utr@ HeLa
HeLa|RNA Pol II Flavo 60min	Utr@ HeLa
HeLa|RNA Pol II Flavo 5min	Utr@ HeLa
HeLa|RNA Pol II Control	Utr@ HeLa
VCS2|prostate cancer Cells	Prs@ VCS2
VCaP|prostate cancer Cells	Prs@ VCaP
U937|CEBPA_U937	Bld@ U-937
U937|Input ChIP-Seq U937 DMSO	Bld@ U-937
U937|TCF7L2 ChIP-seq U937 BIO	Bld@ U-937
U937|SMAD1 ChIP-Seq U937 BMP4	Bld@ U-937
U937|CEBPA ChIP-Seq U937 DMSO	Bld@ U-937
U937|CEBPA ChIP-Seq U937 BIO	Bld@ U-937
K562|Input ChIP-Seq K562 BIO	Bld@ K-562
K562|SMAD1 ChIP-Seq K562 dorso	Bld@ K-562
K562|SMAD1 ChIP-Seq K562 bmp4	Bld@ K-562
K562|GATA2 ChIP-seq K562 BMP	Bld@ K-562
K562|GATA2 ChIP-seq K562 BIO	Bld@ K-562
K562|GATA1 ChIP-seq K562 BMP	Bld@ K-562
K562|GATA1 ChIP-seq K562 BIO	Bld@ K-562
Input ChIP-seq CD34+ progenitors BMP|Hematopoietic Stem &amp; Progenitor Cells	Bld@ CD34 Hematopoietic stem cells
LY2|Mammary gland epithelial cells, input|mammary gland epithelial cells	Brs@ LY2
LY2|Mammary gland epithelial cells, tamoxifen treated, SRC1 ChIP|mammary gland epithelial cells	Brs@ LY2
LY2|Mammary gland epithelial cells, untreated, SRC1 ChIP|mammary gland epithelial cells	Brs@ LY2
HEK293|HEK293|embryonic kidney. (PMID: 11967234)|mesoderm	Kid@ 293
GM12878|B lymphoblasts	Bld@ GM12878
Blood monocytes/macrophages|Blood monocytes/macrophages	Bld@ Macrophages
LNCaP|LNsip53|prostate adenocarcinoma cells	Prs@ LNCAP
LNCaP|LNCaP|prostate adenocarcinoma cells	Prs@ LNCAP
ChIP-Seq_Carrier_EBV-transformed_IgG|EBV-Transformed B lymphocytes|whole blood	Bld@ B-Lymphocytes
ChIP-Seq_Carrier_EBV-transformed_H3+|EBV-Transformed B lymphocytes|whole blood	Bld@ B-Lymphocytes
ChIP-Seq_Carrier_EBV-transformed_H3K4me3|EBV-Transformed B lymphocytes|whole blood	Bld@ B-Lymphocytes
ChIP-Seq_Carrier_EBV-transformed_H3K27me3|EBV-Transformed B lymphocytes|whole blood	Bld@ B-Lymphocytes
ChIP-Seq_Carrier_EBV-transformed_H2A.Z|EBV-Transformed B lymphocytes|whole blood	Bld@ B-Lymphocytes
lymphoblastoid cell line	Bld@ Lymphoblastoid cell line
Primary Tissue|Fetal Muscle, Lower Limb|UW|None	Myo@ Fetal muscle
Primary Tissue|Fetal Muscle, Upper Trunk|UW|None	Myo@ Fetal muscle
MCF7|E2 treated MCF7 H3K4me2	Brs@ MCF-7
MCF7|untreated MCF7 H3K4me2	Brs@ MCF-7
H1299 Cell line|Lung carcinoma|Immortalized	Lng@ NCI-H1299
RWPE-1|RWPE1_FLAG_ETV1	Prs@ RWPE-1
RWPE-1|RWPE1_FLAG_ERG	Prs@ RWPE-1
RWPE-1|RWPE1_GABPA	Prs@ RWPE-1
RWPE-1|RWPE1_ETS1	Prs@ RWPE-1
RWPE-1|RWPE1_FLAG_control	Prs@ RWPE-1
RWPE-1|RWPE1_Input	Prs@ RWPE-1
PC3|PC3_JUND	Prs@ PC-3
PC3|PC3_ETV4	Prs@ PC-3
PC3|PC3_Input	Prs@ PC-3
BJ-tert|BJ-tert	Epd@ BJ
Hela|Hela	Utr@ HeLa
LNCaP-1F5|rIgG ChIP-seq|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|GR-siFoxA1_ChIP-seq|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|GR_ChIP-seq|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|DHS-seq_siFoxA1|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|DHS-seq|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|H3K4me2_ChIP-seq_siFoxA1|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
LNCaP-1F5|H3K4me2_ChIP-seq|Prostate epithelial cells derived from metastatic prostate carcinoma	Prs@ LNCAP
NHEK|NHEK_PolII|normal epidermal keratinocytes	Epd@ NHEK
NHEK|NHEK_cMYC|normal epidermal keratinocytes	Epd@ NHEK
K562|K562_INPUT|chronic myeloid leukemia	Bld@ K-562
HUVEC|HUVEC_INPUT|umbilical vein endothelial cells	CDV@ HUVEC
HUVEC|HUVEC_cMYC|umbilical vein endothelial cells	CDV@ HUVEC
HepG2|HepG2_INPUT|liver carcinoma cells	Liv@ Hep G2
HelaS3|HelaS3_INPUT|cervical carcinoma	Utr@ HeLa
H1_ES|H1_ES_PolII|embryonic stem cells	PSC@ hESC H1
H1_ES|H1_ES_cMYC|embryonic stem cells	PSC@ hESC H1
GM12878|GM12878_INPUT|lymphoblastoid cells	Bld@ GM12878
NB4|NB4 cells (leukemic), untreated, H4K20me3 ChIP-Seq|leukemic cells	Bld@ NB-4
NB4|NB4 cells (leukemic), untreated, H3K4me3 ChIP-Seq|leukemic cells	Bld@ NB-4
NB4|NB4 cells (leukemic), untreated, H3K4me1 ChIP-Seq|leukemic cells	Bld@ NB-4
NB4|NB4 cells (leukemic), untreated, p300 ChIP-Seq|leukemic cells	Bld@ NB-4
NB4|NB4 cells (leukemic), untreated, H2A.Zac ChIP-Seq|leukemic cells	Bld@ NB-4
NB4|NB4 cells (leukemic), untreated, H2A.Z ChIP-Seq|leukemic cells	Bld@ NB-4
AML patient cells (leukemic), untreated, NlaIII NA-Seq|leukemic cells|acute myeloid leukemia (AML)	Bld@ Leukemia, Myeloid
APL patient cells (leukemic), untreated, NlaIII NA-Seq|leukemic cells|acute promyelocytic leukemia (APL)	Bld@ Leukemia, Myeloid
primary epidermal keratinocytes; normal, human neonatal foreskin (origin: ATCCA ref. PCS-200-010)|primary epidermal keratinocyte	Epd@ Keratinocytes
CUTLL1|CUTLL1: H3K27me3 Chromatin IP|T lymphocyte|T lymphoblastic leukemia/lymphoma	Bld@ CUTLL1
CUTLL1|CUTLL1: H3K4me3 Chromatin IP|T lymphocyte|T lymphoblastic leukemia/lymphoma	Bld@ CUTLL1
CUTLL1|CUTLL1: H3K4me1 Chromatin IP|T lymphocyte|T lymphoblastic leukemia/lymphoma	Bld@ CUTLL1
CUTLL1|CUTLL1: ZNF143 Chromatin IP|T lymphocyte|T lymphoblastic leukemia/lymphoma	Bld@ CUTLL1
control input sample|umbilical vein endothelial cells	CDV@ HUVEC
CMK|CMK|human acute megakaryocytic leukemia cells, established from the peripheral blood of a 10-month-old boy with Down's syndrome and acute megakaryocytic leukemia (AML M7) at relapse in 1985 - DSMZ. (PMID: 3016165)	Bld@ CMK
Th1|Th1|primary human Th1 T cells|mesoderm	Bld@ Th1 Cells
H1-hESC|H1-hESC|Human Embryonic Stem Cells|embryonic stem cells	PSC@ hESC H1
HSMMtube|HSMMtube|Normal Human Skeletal Muscle Myotubes|mesoderm	Myo@ HSMM
Monocytes-CD14+|Monocytes-CD14+|Monocytes-CD14+ are CD14-positive cells from human leukapheresis product|Monocytic	Bld@ Monocytes-CD14+
Th2|Th2|Primary human Th2 T cells|mesoderm	Bld@ Th2 Cells
TKO2|TKO2_input|blood	Unc@ Unclassified
TKO2|TKO2_H3K36me2_rep2|blood	Unc@ Unclassified
TKO2|TKO2_H3K36me2_rep1|blood	Unc@ Unclassified
KMS11|KMS11_Input|blood	Bld@ KMS-11
KMS11|KMS11_H3K36me2_rep2|blood	Bld@ KMS-11
KMS11|KMS11_H3K36me2_rep1|blood	Bld@ KMS-11
Kasumi-1 input|Kasumi-1	Bld@ Kasumi-1
Peripheral blood MNC CD34+ from non-t(8;21) AML patient|Peripheral blood MNC CD34+	Bld@ CD34+
Kasumi-1|Kasumi-1	Bld@ Kasumi-1
Peripheral blood MNC CD34+ from non-t(8;21)AML patient|Peripheral blood MNC CD34+	Bld@ CD34+
Kasumi-1 control (without transfection)|Kasumi-1	Bld@ Kasumi-1
Kasumi-1 control|Kasumi-1	Bld@ Kasumi-1
MCF-7|MCF-7 breast cancer cells, untreated, p300 ChIP|breast cancer cells	Brs@ MCF-7
MCF-7|MCF-7 breast cancer cells, E2-treated, p300 ChIP|breast cancer cells	Brs@ MCF-7
MCF-7|MCF-7 breast cancer cells, untreated, GATA3 ChIP|breast cancer cells	Brs@ MCF-7
MCF-7|MCF-7 breast cancer cells, E2-treated, GATA3 ChIP|breast cancer cells	Brs@ MCF-7
VCaP|VCaP prostate cancer cells, 2hr DHT treated, EZH2 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr ETOH treated, EZH2 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr DHT treated, HDAC3 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr ETOH treated, HDAC3 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr DHT treated, HDAC2 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr ETOH treated, HDAC2 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr DHT treated, HDAC1 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr ETOH treated, HDAC1 ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 18hr DHT treated, ERG ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr DHT treated, ERG ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 0hr treated, ERG ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 18hr DHT treated, AR ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 2hr DHT treated, AR ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, 0hr treated, AR ChIP DNA|prostate cancer cells	Prs@ VCaP
VCaP|VCaP prostate cancer cells, input|prostate cancer cells	Prs@ VCaP
NCC_NR2F1/2_input|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_NR2F2|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_NR2F1|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_FAIRE|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_H3K4me3|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_H3K4me1|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_H3K27ac|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_H3K27me3|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_input|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
NCC_p300|Neural crest cells (hNCC) derived from H9 ESC	PSC@ hESC derived neural crests
Primary Tissue|Fetal Muscle, Upper Limb Skeletal|UW|None	Myo@ Fetal muscle
Primary Tissue|Fetal Spleen|UW|None	Oth@ Spleen
Primary Cell|CD20 Primary Cells|None|CD20+	Bld@ CD20+
breast adenocarcinoma cell line|MCF7 cell line stably expressing HA ER E2F1 5'NLS MB mutant	Brs@ MCF-7
breast adenocarcinoma cell line|MCF7 cell line stably expressing HA ER E2F1N/C mutant	Brs@ MCF-7
HCC-1428/LTED cells|HCC-1428	Brs@ HCC1428
MCF-7/LTED cells|MCF-7	Brs@ MCF-7
Primary Cell|Mobilized CD34|none|CD34+	Bld@ CD34+
Primary Cell|Mobilized CD56 Primary Cells|None|CD56+	Bld@ CD56+
iPS DF 4.7 Cell Line|Cell Line|Derived from newborn foreskin fibroblast: Cat# CRL-2097TM, ATCC|None|Induced pluripotent stem cell	PSC@ iPS cells
iPS DF 6.9 Cell Line|Cell Line|Derived from newborn foreskin fibroblast: Cat# CRL-2097TM, ATCC|None|Induced pluripotent stem cell	PSC@ iPS cells
iPS DF 19.11 Cell Line|Cell Line|Derived from newborn foreskin fibroblast: Cat# CRL-2097TM, ATCC|None|Induced pluripotent stem cell	PSC@ iPS cells
iPS DF 19.7 Cell Line|Cell Line|Derived from newborn foreskin fibroblast: Cat# CRL-2097TM, ATCC|None|Induced pluripotent stem cell	PSC@ iPS cells
Primary Cell|Mobilized CD34 Primary Cells|None|CD34+	Bld@ CD34+
Hematopoietic Stem &amp; Progenitor Cells, H3K79me2 ChIP|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
Hematopoietic Stem &amp; Progenitor Cells, H3K27me3 ChIP|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
Hematopoietic Stem &amp; Progenitor Cells, input|CD133+ expanded umbilical cord blood (UCB) cells	Bld@ Hematopoietic Stem Cells
K562|Chromatin IP with NFYB Ab	Bld@ K-562
K562|Chromatin IP with NFYA Ab	Bld@ K-562
K562|Chromatin IP with PRAME serum	Bld@ K-562
K562|Chromatin IP with preimmune serum (control for PRAME ChIP)	Bld@ K-562
HMVEC-dBl-Ad|HMVEC-dBl-Ad|adult blood microvascular endothelial cells, dermal-derived|mesoderm	CDV@ HMVEC
Th1|Th1|primary human Th1 T cells	Bld@ Th1 Cells
GM06990|GM06990|lymphoblastoid (CEPH)|CEPH/Utah - European Caucasion; Epstein-Barr Virus	Bld@ GM06990
SK-N-SH_RA|SK-N-SH_RA|neuroblastoma cell line differentiated w/ retinoic acid|SK-N-MC was isolated in September of l971 and was found to have moderate dopamine - beta - hydroxylase activity as well as formaldehyde induced fluorescence indicative of intracellular catecholamines. - ATCC	Neu@ SK-N-SH
NHDF-Ad|NHDF-Ad|adult dermal fibroblasts|mesoderm	Epd@ NHDF
HAEpiC|HAEpiC|amniotic epithelial cells	Oth@ HAEpiC
NCCIT|NCCIT, H3Kac ChIP|embryonic carcinoma cells	PSC@ NCCIT
NCCIT|NCCIT, H3K79me3 ChIP|embryonic carcinoma cells	PSC@ NCCIT
NCCIT|NCCIT, H3K79me2 ChIP|embryonic carcinoma cells	PSC@ NCCIT
NCCIT|NCCIT, H3K79me1 ChIP|embryonic carcinoma cells	PSC@ NCCIT
NCCIT|NCCIT, H3K36me3 ChIP|embryonic carcinoma cells	PSC@ NCCIT
NCCIT|NCCIT, H3K4me3 ChIP|embryonic carcinoma cells	PSC@ NCCIT
NCCIT|NCCIT, H2BUb1 ChIP|embryonic carcinoma cells	PSC@ NCCIT
NCCIT|NCCIT, input|embryonic carcinoma cells	PSC@ NCCIT
JURL_MK1|Input, human CML cell line	Bld@ JURL-MK1
JURL_MK1|ChIPSeq, human CML cell line	Bld@ JURL-MK1
H9 hESC|EOMES ChIP fraction: early endoderm (hESC differentiated towards endodermal fate 48h)|early endoderm 48h	PSC@ hESC derived mesendodermal cells
H9 hESC|Input DNA: H9 human embryonic stem cell (hESC)|embryonic stem cell	PSC@ hESC H9
Jurkat|Jurkat T lymphoma cells with 25 ug/ml DRB treatment, pol II ChIP|T lymphoma cells	Bld@ Jurkat
Jurkat|Jurkat T lymphoma cells with 10 ug/ml DRB treatment, pol II ChIP|T lymphoma cells	Bld@ Jurkat
Jurkat|Jurkat T lymphoma cells with DMSO mock treatment, pol II ChIP|T lymphoma cells	Bld@ Jurkat
CD4+ T cells, control ChIP|CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
CD4+ T cells, YY1 ChIP|CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
CD4+ T cells, HMGN1 ChIP|CD4+ T cells	Bld@ CD4-Positive T-Lymphocytes
blood cells|HL-60 cells	Bld@ HL-60
GM18507|lymphoblastoid cells	Bld@ GM18507
Primary pro-erythroblasts derived ex vivo from CD34+ multipotential hematopoietic progenitors|Pro-erythroblasts	Bld@ CD34 Hematopoietic stem cells
Primary Tissue|fetal adrenal|UW|None	Oth@ Adrenal Glands
LN229 glioma cancer cells|Normal IgG ChIP	Neu@ LN-229
LN229 glioma cancer cells|Sox2 ChIP	Neu@ LN-229
HeLa S3|HeLa cell culture, input	Utr@ HeLa
HeLa S3|HeLa cell culture, p68 ChIP	Utr@ HeLa
APL pz74 (leukemic)|hematopoietic cell|leukemic	Bld@ Leukemia, Myeloid
CD34+ nr30 (normal)|hematopoietic cell|normal	Bld@ CD34 Hematopoietic stem cells
CD34+ nr29 (normal)|hematopoietic cell|normal	Bld@ CD34 Hematopoietic stem cells
DFB cells|DFB malignant melanoma cell line	Epd@ DFB
GIST|GIST48 Cells, ChIP fraction	Dig@ GIST-48
GIST|GIST48 Cells, input	Dig@ GIST-48
tissue - metastatic prostate cancer tissue - Chromatin IP against PolII	Prs@ Prosate cancer cells
tissue - metastatic prostate cancer tissue - Chromatin IP against H3K27me3	Prs@ Prosate cancer cells
tissue - metastatic prostate cancer tissue - Chromatin IP against H3K9me3	Prs@ Prosate cancer cells
tissue - metastatic prostate cancer tissue - Chromatin IP against H3K4me3	Prs@ Prosate cancer cells
tissue - metastatic prostate cancer tissue - Chromatin IP against ERG	Prs@ Prosate cancer cells
tissue - metastatic prostate cancer tissue - Chromatin IP against AR	Prs@ Prosate cancer cells
RWPE - GUS control stable cell line - Chromatin IP against ERG	Prs@ RWPE-1
RWPE - ERG overexpression stable cell lline - Chromatin IP against ERG	Prs@ RWPE-1
LNCaP - regular medium - Chromatin IP against ERG	Prs@ LNCAP
VCaP - regular medium - Chromatin IP against ERG	Prs@ VCaP
VCaP - R1881 - Chromatin IP against AR	Prs@ VCaP
VCaP - Ethanol - Chromatin IP against AR	Prs@ VCaP
LNCaP - R1881 - Chromatin IP against AR	Prs@ LNCAP
LNCaP - Ethanol - Chromatin IP against AR	Prs@ LNCAP
LnCaP - 1nm R - Chromatin IP against AR	Prs@ LNCAP
LnCaP - 10nm R - Chromatin IP against AR	Prs@ LNCAP
22RV1 - no treat - Chromatin IP against AR	Prs@ 22Rv1
VCaP - siERG - Chromatin IP against ERG	Prs@ VCaP
VCaP - siERG - Chromatin IP against AR	Prs@ VCaP
VCaP - NT - Chromatin IP against ERG	Prs@ VCaP
VCaP - NT - Chromatin IP against AR	Prs@ VCaP
LnCaP - regular medium - Chromatin IP against H3K36me3	Prs@ LNCAP
LnCaP - regular medium - Chromatin IP against H3K4me3	Prs@ LNCAP
LnCaP - regular medium - Chromatin IP against H3K9me3	Prs@ LNCAP
VCaP - regular medium - Chromatin IP against H3K36me3	Prs@ VCaP
VCaP - regular medium - Chromatin IP against Polll	Prs@ VCaP
VCaP - regular medium - Chromatin IP against Pan-H3	Prs@ VCaP
VCaP - regular medium - Chromatin IP against H3K27me3	Prs@ VCaP
VCaP - regular medium - Chromatin IP against H3K4me3	Prs@ VCaP
VCaP - R1881 - Chromatin IP against H3K4me3	Prs@ VCaP
GM10861|lymphoblastoid, GM10861, input|lymphoblastoid	Bld@ Lymphoblastoid cell lines
GM10855|lymphoblastoid, GM10855, input|lymphoblastoid	Bld@ Lymphoblastoid cell lines
LnCaP - regular medium - Chromatin IP against H3K4me2	Prs@ LNCAP
LnCaP - regular medium - Chromatin IP against H3K4me1	Prs@ LNCAP
LnCaP - regular medium - Chromatin IP against FoxA1	Prs@ LNCAP
VCaP - regular medium - Chromatin IP against H3K4me2	Prs@ VCaP
VCaP - regular medium - Chromatin IP against H3K4me1	Prs@ VCaP
VCaP - regular medium - Chromatin IP against FoxA1	Prs@ VCaP
VCaP - regular medium - Chromatin IP against Ace-H3	Prs@ VCaP
LnCaP - regular medium - Chromatin IP against Ace-H3	Prs@ LNCAP
VCaP - regular medium - Chromatin IP against H3K9me3	Prs@ VCaP
LnCaP - R1881 - Chromatin IP against Polll	Prs@ LNCAP
LnCaP - Ethanol - Chromatin IP against Polll	Prs@ LNCAP
LnCaP - R1881 - Chromatin IP against H3K27me3	Prs@ LNCAP
LnCaP - Ethanol - Chromatin IP against H3K27me3	Prs@ LNCAP
LnCaP - R1881 - Chromatin IP against H3K9me3	Prs@ LNCAP
LnCaP - Ethanol - Chromatin IP against H3K9me3	Prs@ LNCAP
VCaP - R1881 - Chromatin IP against Polll	Prs@ VCaP
VCaP - Ethanol - Chromatin IP against Polll	Prs@ VCaP
VCaP - R1881 - Chromatin IP against H3K27me3	Prs@ VCaP
VCaP - Ethanol - Chromatin IP against H3K27me3	Prs@ VCaP
VCaP - Ethanol - Chromatin IP against H3K4me3	Prs@ VCaP
VCaP - Ethanol - Chromatin IP against H3K9me3	Prs@ VCaP
hiPS-11a|Cell Line|induced pluripotent cells|none|undifferentiated	PSC@ iPS cells
hASC, Whole Cell Extract (input control)|Adipose stromal cell (ASC) pre-adipocytes and adipocytes	Adp@ Adipose stromal cell
Primary Tissue|Brain - Frontal cortex|NA|None	Neu@ Adult brains
human cord blood CD4+ cell, activated and IL-4 treated, 4h|CD4+ T cells|cord blood	Bld@ CD4-Positive T-Lymphocytes
human cord blood CD4+ cell, activated, 4h|CD4+ T cells|cord blood	Bld@ CD4-Positive T-Lymphocytes
human cord blood CD4+ cell, activated and IL-4 treated, 1h|CD4+ T cells|cord blood	Bld@ CD4-Positive T-Lymphocytes
human cord blood CD4+ cell, activated, 1h|CD4+ T cells|cord blood	Bld@ CD4-Positive T-Lymphocytes
human cord blood CD4+ cell, 0h|CD4+ T cells|cord blood	Bld@ CD4-Positive T-Lymphocytes
RD|RD, input|rhabdomyosarcoma	Myo@ RD
HepG2|HNF4g_ChIPSeq|hepatocellular carcinoma	Liv@ Hep G2
HepG2|HNF4a_ABdomain_ChIPSeq|hepatocellular carcinoma	Liv@ Hep G2
HepG2|HNF4a_Fdomain_ChIPSeq|hepatocellular carcinoma	Liv@ Hep G2
CD4+ T cell|activated CD4+ T cell	Bld@ CD4-Positive T-Lymphocytes
BJ|BJ primary foreskin fibroblasts, p53 knockdown IP|foreskin fibroblasts	Epd@ BJ
BJ|BJ primary foreskin fibroblasts, wildtype p53 IP|foreskin fibroblasts	Epd@ BJ
BJ|BJ primary foreskin fibroblasts, BRD7 knockdown IP|foreskin fibroblasts	Epd@ BJ
BJ|BJ primary foreskin fibroblasts, wildtype BRD7 IP|foreskin fibroblasts	Epd@ BJ
Jurkat E6-1|Jurkat E6-1 cell line	Bld@ Jurkat (Clone E6-1)
Human foreskin fibroblast hTERT cell line	Epd@ Dermal fibroblast
HEK293T|HEK293T cell line	Kid@ 293
Saos-2|Saos-2 cell line|osteosarcoma	Bon@ Saos-2
IMR90hTert_SNAP45|IMR90hTert	Lng@ IMR-90
IMR90hTert_Input|IMR90hTert	Lng@ IMR-90
IMR90hTert_Brf1|IMR90hTert	Lng@ IMR-90
IMR90hTert_Bdp1|IMR90hTert	Lng@ IMR-90
IMR90hTert_RPC4|IMR90hTert	Lng@ IMR-90
IMR90|Chromatin IP against Mock	Lng@ IMR-90
Input DNA|Jurkat, clone E6-1 T lymphocyte	Bld@ Jurkat (Clone E6-1)
CBP ChIP|Jurkat, clone E6-1 T lymphocyte	Bld@ Jurkat (Clone E6-1)
RUNX ChIP|Jurkat, clone E6-1 T lymphocyte	Bld@ Jurkat (Clone E6-1)
ETS1 ChIP|Jurkat, clone E6-1 T lymphocyte	Bld@ Jurkat (Clone E6-1)
K562|Chromatin IP against GATA2	Bld@ K-562
K562|Chromatin IP against GATA1	Bld@ K-562
Primary Cell|CD34 Primary Cells|none|CD34	Bld@ CD34+
Normal Mouse IgG ChIP	Unc@ Unclassified
H1	PSC@ hESC H1
CD133+ primary hematopoietic stem cells/progenitor cells (HSCs/HPCs)	Bld@ Hematopoietic Stem Cells
Jurkat	Bld@ Jurkat
Hues8	PSC@ hESC HUES8
islet cell	Pan@ Pancreatic islets
K-562|myeloblast	Bld@ K-562
SU-DHL-5|Cell Line|NA|Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma|B cell	Bld@ SU-DHL-5
KARPAS-422|Cell Line|NA|Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma|B cell	Bld@ B-Lymphocytes
K-562|Cell line|mesoderm|Chronic myelogenous leukemia|Unknown	Bld@ K-562
U-266|Cell Line|NA|Multiple myeloma|Plasma cell	Bld@ U-266
DG-75|Cell Line|NA|Sporadic Burkitt lymphoma|B cell	Bld@ DG-75
Z-138|Cell Line|NA|Mantle cell lymphoma, aggressive|B cell	Bld@ Z-138
HH1299|liver	Lng@ NCI-H1299
HH1320|liver	Liv@ HH1320
muscle|adult	Myo@ Muscles
brain|adult	Neu@ Adult brains
Non-immunoprecipitated sample (	Unc@ Unclassified
Immunoprecipitated by anti-PolII Histone antibody in human SAEC	Lng@ SAEC
Immunoprecipitated by anti-H3K9me3 Histone antibody in human SAEC	Lng@ SAEC
Immunoprecipitated by anti-H3K9K14Ac Histone antibody in human SAEC	Lng@ SAEC
Immunoprecipitated by anti-H3K4me3 Histone antibody in human SAEC	Lng@ SAEC
Immunoprecipitated by anti-H3K4me1 Histone antibody in human SAEC	Lng@ SAEC
Immunoprecipitated by anti-H3K36me3 Histone antibody in human SAEC	Lng@ SAEC
Immunoprecipitated by anti-H3K27me3 Histone antibody in human SAEC	Lng@ SAEC
Immunoprecipitated by anti-H3K27Ac Histone antibody in human SAEC	Lng@ SAEC
HAoEC|IHEC31|Human Aortic Endothelial Cells|the endothelium of blood vessels|aortic endothelial cells|dead	CDV@ HAoEC
HUVEC|IHEC30|Human Umbilical Vein Endothelial Cells|the endothelium of blood vessels|endothelial cell of umbilical vein|alive	CDV@ HUVEC
HUVEC|IHEC29|Human Umbilical Vein Endothelial Cells|the endothelium of blood vessels|endothelial cell of umbilical vein|alive	CDV@ HUVEC
HUAEC|IHEC28|Human Umbilical Artery Endothelial Cells|the endothelium of blood vessels|endothelial cell of umbilical artery|alive	CDV@ HUAEC
HCAEC|IHEC26|Human Coronary Artery Endothelial Cells|the endothelium of blood vessels|endothelial cell of coronary artery|dead	CDV@ Coronary artery endothelial cells
HPAEC|IHEC25|Human Pulmonary Artery Endothelial Cells|the endothelium of blood vessels|pulmonary artery endothelial cell|dead	CDV@ HPAEC
HAoEC|IHEC24|Human Aortic Endothelial Cells|the endothelium of blood vessels|aortic endothelial cells|dead	CDV@ HAoEC
HENDC|IHEC23|Human Endocardial Cells|the endothelium of blood vessels|endocardial cell|dead	CDV@ Endocardial cells
SH-SY5Y cells	Neu@ SH-SY5Y
